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ABSTRACT
The effects of thyroid hormones on intermediary metabolism
have been investigated in hyperthyroid and hypothyroid man and in
experimentally induced thyroid disease in the rat. Glucose metabolism
was investigated by measurement of blood glucose, fasting and in
3 14
response to meals and by using both H-3-glucose and C-l-glucose
as tracers in kinetic studies. Analysis of glycerol clearance from
blood following bulk infusions of glycerol permitted evaluation of
gluconeogenesis. Circulating NEFA and glycerol levels and glycerol
kinetic data permitted assessment of lipolysis. Ketogenesis was
investigated in vivo by measurement of circulating ketone body
concentrations and by ketone body kinetic studies using both
14 14
C-3-acetoacetate and C-3-hydroxybutyrate. Influences of
hyperthyroidism on ketone body production in vitro were examined in
isolated rat hepatocytes. Sensitivity of glucose metabolism, lipolysis
and ketogenesis in vivo in man were evaluated by the euglycaemic
clamp technique.
Thyroid hormone excess in man caused fasting hyperglycaemia
and a 50% increase in total glucose turnover. Much of this increase
could be accounted for by increased cycling between glucose and
glucose-derived 3-carbon intermediates with only a modest increase
in irreversible glucose disposal. Although fasting blood lactate,
pyruvate and alanine concentrations were normal, increased recycling
and accelerated glycerol clearance suggested enhanced gluconeogenesis.
Carbohydrate intolerance to meals was also evident. In hypothyroidism
fasting blood glucose concentrations were normal despite a decrease
in glucose production and delayed glycerol clearance. Carbohydrate
intolerance to meals was less marked than in thyrotoxic subjects.
Lipolysis was increased in hyperthyroid man as evidenced by
increased blood glycerol and plasma NEFA concentrations and an
increase in endogenous glycerol production. Glycerol production
I
was decreased in hypothyroidism although plasma NEFA concentrations
were normal. Ketone body concentrations were increased in
hyperthyroidism and ketone body production was increased 4-fold.
Ketone body production estimates were normal in hypothyroidism.
Experimental hyperthyroidism in rats increased ketone body production
by isolated hepatocytes suggesting an increase in hepatic ketogenic
potential.
In the rat hyperthyroidism was associated with hypoinsulinaemia.
Hyperglycaemia, lipolysis and ketogenesis in hyperthyroid man
occurred despite apparantly normal peripheral insulin concentrations
suggesting either relative hyposecretion of insulin and/or insensitivity
to endogenous insulin. Euglycaemic clamp studies suggested normal
sensitivity to exogenous insulin in terms of glucose metabolism but
a decrease in sensitivity of lipolysis whilst insulin clearance was
similar to controls.
Thyroid hormones exert stimulating effects on glucose, fatty
acid and ketone body metabolism which are not associated with a
compensatory increase in insulin secretion.
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Acac, acetoacetate; A. T. P. , adenosine triphosphate; ADP, adenosine
diphosphate; AMP, adenosine monophosphate; ACT, acyl carnitine
transferase; BOH, 3-hydroxybutyrate; BSA, bovine serum albumin;
CaCl^, calcium chloride; CoA, coenzyme A; cpm, counts per minute;
C.V., coefficient of variation; DIT, diiodotyrosine; DNA, deoxyribonucleic
acid; DHSS, Department of Health and Social Security; DHAP,
dihydroxyacetone phosphate; d. p. m. , disintegrations per minute;
EGTA, ethylene glycol tetra acetic acid; EDTA, ethylene diamine tetra
acetic acid; EPR, endogenous production rate; FAD(H), oxidised flavine
adenosine dinucleoti.de (reduced form); nGPD, a glycerophosphate
dehydrogenase; GTT, glucose tolerance test; G6PD, glucose-6-phosphate
dehydrogenase; HC1, hydrochloric acid; HEPES, N^-hydroxyethyl
piperazine ethane sulphuric acid; H^SO^, sulphuric acid; HgSO^,
mercuric sulphate; IBW, ideal body weight; KB, ketone bodies; kiu,
kallekrein inhibitory units; KOH, potassium hydroxide; KC1, potassium
chloride; M, molar; MCR, metabolic clearance rate; MIT, monoiodotyrosine;
MgSO , magnesium sulphate; mRNA, messenger ribonucleic acid;
-j- -j-
Na K ATPase, sodium-potassium dependent adenosine triphosphatase;
N, Normal; NaOH, sodium hydroxide; NaHCO^, sodium hydroxide;
NaCl, sodium chloride; NAD(H), oxidised nicotinamide-adenine
dinucleotide (reduced form); NADP(H) oxidised nicotinamide-adenine
dinucleotide phosphate (reduced form); NEFA, non-esterified fatty acid;
O.D., optical density; PCA, perchloric acid; PDH, pyruvate
dehydrogenase; Ra, rate of appearance; Rd, rate of disappearance;
RT, turnover; rT^, reverse T^; r. p. m. , revolutions per minute;
RNA, ribonucleic acid; S.A. , specific activity; SSPG, steady state
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plasma glucose; T^, triiodothyronine; T^, thyroxine; TBG, thyroid
binding globulin; TBPA, thyroid binding prealbumin; TCA, tricarboxylic
99
acid cycle; T , radioactively labelled technicium; TKB, total ketone
bodies; TSH, thyroid stimulating hormone; TRH, thyrotrophin
releasing hormone; V.D. , volume of distribution; VLDL/, very low
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aims
1. To investigate the effects of hyper and hypothyroidism
on circulating hormone and intermediary metabolite concentrations
in fed and fasted man.
2. To investigate the effects of hyper and hypothyroidism
on glucose production, glucose utilisation and Cori (glucose-
lactate) cycle activity in man.
3. To establish a simple test of gluconeogenic capacity and
apply it to patients with hyper and hypothyroidism.
4. To investigate the cause(s) of previously reported glucose
intolerance in hyperthyroid subjects.
5. To investigate the effects of thyroid hormones on ketone
body kinetics in man.
6. To assess the effects of thyroid hormones on ketone body




4. 1. THYROID HORMONE PHYSIOLOGY
The thyroid gland synthesises and secretes two metabolically
active iodothyronine compounds (Sterling, 1974). L. Thyroxine
was first identified in 1915 (Kendal, 192.9) and subsequently purified
and characterised by Harrington in 1926. Triiodo-L-thyronine,
the second major hormone was identified in 1952 by Gross and
Pitt-Rivers.
(a) Thyroid hormone synthesis and secretion
Inorganic iodide from dietary sources, water, fish and
iodised salt is absorbed in the small intestine and accumulated by the
thyroid against a concentration gradient. Within the thyroid iodide is
oxidised and transferred to tyrosine by a haem containing particulate
bound peroxidase the activity of which can be stimulated by thyroid
stimulating hormone (TSH), cyclic adenosine monophosphate (cyclic
a.m.p.), prostaglandins and adrenaline (Ahn & Rosenberg, 1970).
Receptor tyrosine residues are in the macroglobulin protein
thyroglobulin and are iodised first in position 3 then position 5 to form
monoiodotyrosine (MIT) and diiodotyrosine (DIT). Following this,
secondary coupling occurs within the thyroglobulin molecule to form
thyroxine (T^)(DIT + DIT) and triiodothyronine (T^) (DIT + MIT). The
precise mechanism of this step is uncertain. The structures of
tyrosine, DIT, MIT, T^ and T^ are shown in Figure 4:1.
Follicular colloid is the major store of thyroid hormones and
about 1% of this store is released into the circulation each day.
Thyroglobulin is incorporated into the thyroid cell by pinocytosis,
broken down by lysosomal proteases and peptidases and and
are released from the gland (Seljelid, 1962). Any liberated MIT or
DIT is deiodinated within the cell, the iodine being conserved and
recycled. TSH stimulates both endocytosis and protease activity.
Normal daily T production rate lies between 80-100 pg (Nicoloff
et al. 1972) and the production rate between 25-40 pg daily (Singe
& Nicoloff, 1972). There is now also substantial evidence that
30-40% of the endogenous T^ pool is derived from extrathyroidal
conversion of T^ to T^ (Pitman et al. 1971).
(b) Thyroid hormone transport in blood
T^ and T^ circulate in association with plasma proteins.
Three thyroid hormone binding proteins have been described:
i) thyroxine binding globulin (TBG), a single chain
glycoprotein with a high affinity for T^ and a rather lower affinity
for T^. It is of low capacity with a single binding site for T^ (or T^
(Robbins, 1975) and is able to bind 15-30 pg of T^/100 ml.
ii) thyroxine binding prealbumin (TBPA), a stable tetramer
of identical subunits arranged round a central slot containing two
identical binding sites for thyroid hormones (Blake et al. 1975). It
is of higher capacity than TBG with a binding capacity of about 55 pg
T4/IOO ml, but of lower affinity.
iii) Albumin. Thyroid hormones may be bound to albumin but
its affinity for T^ is very low although its capacity is large.
Approximately 70% of circulating T^ and 77% of T^ is bound
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to TBG under normal conditions. The remainder is bound to TBPA
(10% T4, 8% T3) and albumin (20% T4 and 14% T3). The
concentration of total T^ in serum normally lies between 60 and
150 nmol/1 and total T^ between 1 . 3 and 3. 0 nmol/1. Thus the total
T^/T^ ratio in blood is about 50 : 1. A small fraction of T^ (0. 015%)
and T^ (0. 5%) circulate free and determine the metabolic status of
the individual. Direct measurements of free T^ give normal values
between 10-22 pmcd/l and free T^ between 5-10pmdl/l (Ekins &; Ellis,
1975) giving a free T^ : T^ ratio of 2 : 1. A rapid exchange equilibrium
exists between bound and free hormones. Only the free forms of
thyroid hormones can enter target tissues and exert their actions
(Thorson et al. 1969). In addition to their function of transporting
T^ and T^ from the thyroid gland to peripheral tissues, binding
proteins also prolong hormone availability by retarding the rate of
transcapillary diffusion, provide a buffering action to dampen the
effects of transient perturbations of thyroid hormones, act as a
reservoir for extra-thyroidal hormone storage and prevent loss of
thyroid hormones in urine.
(c) Thyroxine and Triiodothyronine metabolism
The half life of T^ in plasma is 6-7 days and that of T^ 24-30h
in euthyroid adults. Daily production of T is 80-100 pg derived entirely~fc
from the thyroid. Daily T^ production is 25-40 pg approximately 40%
coming from extrathyroidal T^ to T^ conversion (Pittman et al. 1971).
A number of tissues are capable of transforming T^ to T^ by
monodeiodination including liver, kidney, heart and anterior pituitary
7.
(Hoffenberg, 1973). Reverse ^ 3'5'triiodothyronine) can
also be formed by monodeiodination. Current evidence suggests that
this may be a degradative step since rT^ has negligible metabolic
activity. Production of rT^ is increased in a number of acute or chronic
stressful states (acute illness [Harvey, 1971], starvation [Ingenbleek
& Bekers, 1976] and cirrhosis [Chopra et al. 1974] ). Concomitant
with a rise in rT^ is a fall in production. Thus monodeiodination
of provides the body with either a highly active metabolite,
(most if not all the effects of T . result from this interconversion) or4 '
one that is inert, This may represent a control mechanism at
the cellular level (Burr et al. 1975),
(d) Disposal of thyroid hormones
Deiodination is the major catabolic step in the degradation of
both T^ and T^ (Soffer et al. 1973) (Figure 4:2). Iodine is lost in the
urine (Berson & Yalow, 1954). The thyroxine nucleus may then be
subjected to oxidative deamination or transamination leading to
production of lactate, pyruvate and acetate. A small quantity (less
than 20%) of hormone is conjugated in the liver and excreted in the bile
(Taurog et al. 1952). Enterohepatic cycling probably does not occur
Galton, 1972).
(e) Control of thyroid hormone secretion (Fig. 4:3)
The level of iodothyronine production by the thyroid is almost
entirely determined by the circulating TSH concentration, and the
negative feedback effect of thyroid hormones on TSH secretion is




FIGURE 4:1. Simplified diagram showing a synthesis of








FIGURE 4:3. Control of Thyroid Hormone Secretion
(after Evered, D. C. 1976)
releasing hormone (TRH) have been extensively studied (Snyder &
Utiger, 1972). Small supplements of will block TSH release
and this cannot be overcome by increased quantities of TRH. It has
been observed in animals that the blocking of the effect of TRH does
not occur unless T^ is administered one hour or more before TRH
and that prior administration of actinomycin D inhibits the blocking
action of T^. These observations suggest that T^ blocks the effect of
TRH by stimulating the synthesis of an intermediate compound,
probably a peptide.
A reduction in thyroid hormone concentration leads to an
increase in basal TSH levels and an enhanced TSH response to TRH
although there is no evidence of enhanced TRH production. It seems
likely that the response to the hypothyroid state is mediated by a
reduction in a thyroid hormone dependent inhibitor of TSH release.
These steps would depend on the presence of a basal level of TRH
secretion.
(f) Cellular actions of thyroid hormones
Insight into the cellular action(s) of thyroid hormones is limited
compared to the understanding of the mechanisms of actions of other
hormones with more sharply defined target tissues. This may be
surprising since the overall importance of the thyroid has been
recognised for almost 100 years (Kocher, 1883). The lack of specific
target tissue suggests that thyroid hormones control processes that are
common to all target tissues and underlie their diverse metabolic effects,
i) Mitochondria and Mitochondrial Receptors
Increased oxygen consumption in human hyperthyroidism was
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first noted in 1895 (Magnus Levy). After in vivo administration of
or to animals, oxygen consumption is increased in heart,
liver, muscle, kidney and white blood cells (Barker & Schwartz, 1953)
although not all tissues behave in this way. Gonadal tissue, lymph
nodes, spleen and notably brain do not increase their oxygen
consumption when exposed to thyroid hormones (Barker & Klitgaard,
1952). Once the function of the mitochondria (which are involved in
over 90% of total body oxygen consumption) became known, investigation
of the mitochondria as sites of action of thyroid hormones naturally
proceeded. Three separate groups reported that could uncouple
oxidative phosphorylation both in vitro and in vivo (Hoch & Lipman,
1954; Lardy & Feldatt, 1951; Marti.no & Hess, 1955). Several problems
emerged however. Firstly the doses of required to produce this
phenomenon were extremely large (4-8 mg/day for several days).
Secondly, D thyroxine, was equally effective an uncoupling agent in vitro
despite its lack of effect in the whole animal. Thirdly, mitochondria
isolated from skeletal muscle of thyrotoxic humans showed tightly
coupled oxidative phosphorylation (Stocker et al. 1968). Clearly
therefore this effect is unphysiological.
Thyroid hormones clearly do however have effects on
mitochondria. Increased rates of cytochrome synthesis (Booth &
Holloszy, 1975), increased amounts of mitochondrial cristae (Reith
et al. 1973), increased mitochondrial turnover (Gross, 1971) and
increased incorporation of amino acids into mitochondrial proteins
(Herd et al. 1974) have all been reportedly induced by thyroid
hormones in vitro or in vivo. It is as yet unclear whether these
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effects are primary or secondary to an effect of thyroid hormones
elsewhere, particularly on the nucleus. However, the demonstration
of high affinity binding sites in mitochondria (Sterling & Milch,
1975) suggests the possibility of a physiological action of thyroid
hormones at the level of this organelle.
ii) Nuclei and Nuclear Receptors
There has been a spate of publications describing binding
sites for (and T ) on nuclei following the original report by
Oppenheimer (1972) and there has been growing interest in these
sites as a possible point of initiation of thyroid hormone action
(De Groot & Strausser, 1974; Samuels et al. 1974; Spindler et al. 1974).
Nuclear receptors have been characterised as non-histone
proteins associated with nuclear chromatin (Surks et al. 1973) which
exhibit a limited capacity and a high affinity as well as a high degree
of specificity for iodothyronines.
Five general lines of evidence lend support to the idea that
nuclear receptors may be the site of initiation of thyroid hormone
action.
1. Studies of various rat tissues have clearly indicated the
widespread nature of nuclear receptor sites. The binding capacity
per mg. DNA varies from tissue to tissue but the percentage of total
available sites occupied is remarkably constant under physiological
conditions. This would suggest that the association constant is also
identical and that the receptor sites from various tissues are
chemically identical.
2. There is a strong correlation between nuclear binding of
thyroid hormone analogues and their known thyromimetic effects
(Koerner et al. 1975).
3. There is a correlation between the number of nuclear receptors
per gram of tissue or per gram of DNA and the responsiveness (in
terms of oxygen consumption) of the tissue concerned. Tissues
considered responsive, such as liver, pituitary, heart and kidney
have a higher density of receptor sites than those considered
unresponsive such as testis and spleen. Brain however has a density
of binding sites intermediate between responsive and unresponsive
tissues yet does not increase its oxygen consumption in response to
T^ (Barker &: Klitgaard, 1952). The role of thyroid hormones on
central nervous system function is clearly established however.
4. T^ appears to stimulate transcription of DNA (Tata & Widnell,
1966) perhaps through increased activity of RNA polymerase (Dillman
et al. 1977) although this is not clearly defined. Enhanced formation
of two species of mRNA coding for proteins known to be stimulated by
T , pituitary growth hormone and a 2u globulin (Seo et al. 1977;
Kurtz et al. 1976) have been reported. This is compatible with the
view that the primary effect of T^ is to stimulate an as yet undefined
number of genes. The concept that thyroid hormone action depends on
subsequent protein synthesis is supported by experiments showing
inhibition of T^ effects by agents known to block protein synthesis at
the transcriptional or translational level (Sellinger & Lee, 1964;
Samuels & Schapiro, 1976; Dillman et al. 1977).
5. The relationship between nuclear occupancy and response,
both in vivo and in vitro, are compatible with a 'nuclear' hypothesis
(Oppenheimer et al. 1977; Samuels et al. 1976) although the expected
proportional relationship has not been shown in all instances. It is
also known that the principal of negative self-regulation (down-
regulation), clearly defined for the interaction between insulin and
other polypeptides and their respective membrane binding sites
(Gavin et al. 1974) may apply to and its nuclear receptor (Samuels
et al. 1976).
It appears most likely therefore that thyroid hormones,
principally T^, act on nuclear receptors to increase protein synthesis.
Many of the changes observed in mitochondria may be secondary to this.
However, the demonstration of mitochondrial receptors and the
observation that some 'in vitro1 effects on mitochondrial function
cannot be inhibited by agents which block protein synthesis (Segal &
Gordon, 1977) raises the possibility that some thyroid hormone action
may be mediated by non-nuclear mechanisms.
iii) Post-receptor mechanisms
It remains unclear whether thyroid hormones induce an
overall increase in protein synthesis or induce synthesis of one or a
very few key proteins which underlie the developmental, physiological
and toxic effects attributed to thyroid hormones. Studies of the
mechanisms of induction by have been confined to only a few
selected proteins. In rat liver, the proteins which have received most
attention are a-2u globulin, malic enzyme and a -glycerophosphate
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dehydrogenase (ffGPD).
The physiological role of n-2u globulin is unknown. It is
synthesised in the male rat liver and found in increased concentrations
in the hepatic cytosol in experimental hyperthyroidism, exported into
the plasma and excreted in the urine (Roy, 1953). There are no
indications that a 2u gobulin is essential for thyroid hormone actions
since in rats there are no established sex differences with regard to
tissue response.
Synthesis of both mitochondrial or glycerophosphate
dehydrogenase and malic enzyme in rat liver are known to be
dependent on thyroid hormone status (Lee & Lardy, 1965; Lardy et al.
I960). Both these enzymes function as components of hydrogen shuttles
which transfer reducing equivalents into mitochondria to be oxidised in
the phosphorylating system. This allows glycolysis to continue
without accumulation of lactate. Thus hormonally induced changes in
these enzymes could stimulate both oxidative phosphorylation and
glycolysis. However thyroid hormone induced changes are both
species and tissue specific. Some mammals show no changes in
mitochondrial a GPD despite thyroid hormone induced increases in
basal metabolic rate (Lee et al. 1970). In man although hepatic a GPD
may not increase in response to T^ administration (Nolte et al. 1972)
adipose tissue a GPD does (Bray, 1969). The precise role played by
these enzymes in thyroid hormone effects is uncertain.
Because of the tight coupling of oxidation and phosphorylation
in man consideration has been given to ATP consuming processes
which could account for the increased rate of oxygen consumption seen
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in hyperthyroidism. The energy consumption of active sodium-
potassium transport has therefore attracted much attention. Several
studies have suggested that injection in rats enhances the synthesis
of Na+/K+ dependent ATPase (Ismail-Beigi & Edelman, 1970; Lo &
Edelman, 1976) which is responsible for maintaining the sodium-
potassium gradients between cellular and extracellular compartments.
Based on experiments with tissue fragments and tissue slices,
Ismael-Beigi and Edelman (1971) proposed that the extra uptake of
oxygen in hyperthyroid liver and skeletal muscle was almost entirely
-J- -J-
due to increased energy expenditure by Na /K ATPase. However,
in perfused rat liver studies, Folke and Sestoft (1977) suggested that
+ +
T^ treatment caused only a modest increase in Na /K transport and
could not account for any major part of increased hepatic oxygen uptake.
Similar findings have also been reported for adipose tissue (Fain &
Rosenthal, 1971), kidney (Silva et al. 1976) and muscle (Biron et al.
1979). Reasons for the discrepancies are uncertain but may relate to
experimental design. It is known that intracellular sodium
concentrations are increased in incubated liver slices, thus stimulating
Na/K ATPase towards maximal activity while in isolated perfused
livers, physiological ion concentrations are maintained (Clariet &
Mazet, 1972).
More recently, the concept of increased substrate cycle activity
being responsible for increased ATP consumption has been proposed
(Sestoft, 1980). The unidirectionality of flow through metabolic
pathways is ensured by a few so called "key" reactions which are
displaced far from equilibrium. During reverse conversion these
energy barriers are bypassed by other reactions which are also
irreversible and catalysed by different enzymes. If the antagonistic
reactions operate simultaneously there is no net flux of metabolites
but only a "futile" recycling, the net balance of which is the wasteful
hydrolysis of ATP. Such a 'futile' or substrate cycle is shown in
Figure 4:4. Since these processes are characterised by energy
dissipation (i. e. heat production), they have a possible role in the
regulation of thermogenesis (Newsholme, 1978). Also substrate
cycles might provide amplification mechanisms for allosteric control
of metabolism. This theory, which stemmed from analysis of the
cycle shown in Figure 4:4 (Newsholme & Crabtree, 1976) allows the
prediction that small changes in an effector might provide much
larger changes in net flux, the extent of amplification depending on the
rate of futile cycling. Changes in substrate cycle activity in hyper
or hypothyroid man could thus account for some of the clinical
features and metabolic abnormalities encountered in these disease
states. There is indirect evidence, particularly with regard to lipid
metabolism, that this may occur in hyperthyroidism. Lipolysis and
triglyceride synthesis are known to proceed simultaneously in
adipocytes from hyperthyroid subjects (Eaton et al. 1965; Fisher &
Ball, 1967). Increased futile cycle activity in the glycolytic pathway
has also been recently described in hyperthyroid rats with decreased
activity in hypothyroidism (Okajima & Ui, 1979). Futile cycle
activity has not however been examined directly in hyper or
ATP ADP
*■ 6-PHOSPHATE 1-6 DIPHOSPHATE ►
I Phosphofructokinase
H Fructose diphosphatase
FIGURE 4:4. Illustration of futile cycle activity here
represented by the fructose 6 phosphate-fructo
1-6 diphosphate cycle.
hypothyroid man.
However, whether these postulated changes in substrate
cycle activity represent specific enzyme induction by thyroid
hormones is unknown as is the degree to which they determine
overall changes in energy conservation.
4. 2. REGULATION OF INTERMEDIARY METABOLISM
The purpose of this section is to describe the basic reactions
of fat, carbohydrate and protein metabolism in both the fed and starved
states, together with an account of the major actions of the main
anabolic and catabolic hormones. The main emphasis will be on
tissue-tissue interactions rather than on intracellular mechanisms.
This outline is intended to serve as a basis for subsequent chapters
and also as an introduction to the role of thyroid hormones in the
regulation of metabolism.
(a) Carbohydrate Metabolism
i) Post absorptive man
Glucose occupies a central role in carbohydrate
metabolism (Johnston & Alberti, 197 6). It serves as an optimal
fuel for many tissues and as an obligatory fuel for brain (except
during starvation) red cells and renal medulla. Reserves are found
in the form of glycogen in many tissues but only liver can use this
glycogen to provide new glucose in the circulation. Other tissues
lack glucose-6-phosphatase and, although they can provide fuel for
their own use which may be extremely important in, for instance,
exercising muscle, they cannot directly provide glucose for other
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tissues. Liver glycogen stores are limited, and, if no other source
of glucose were available, would be exhausted after about 12 hours.
In fasted man there is a daily requirement of about 160 g glucose per
70 kg body weight (Cahill & Owen, 1968). After an overnight fast
about 25% of this comes from glycogen whilst the rest is made de novo.
This also occurs primarily in the liver. The kidney produces about
10% of new glucose during short-term fasting although this may increase
to 50% as fasting proceeds.
Lactate, pyruvate, glycogenic amino acids (mainly alanine),
and glycerol are the main glucose precursors. Lactate provides some
15% of glucose in post-absorptive man. This is one limb of the Cori
cycle. Glucose produced by the liver enters different tissues and is
metabolised through glycolysis to pyruvate. A proportion of pyruvate
enters the tricarboxylic acid cycle while some, through the lactate
dehydrogenase reaction, forms lactate. Any lactate and pyruvate
not metabolised is released into the circulation and returns to the
liver to be reconverted to glucose thus completing the Cori cycle
(Fig. 4:5). The Cori cycle therefore serves as a means of preserving
carbohydrate not required in a particular tissue.
Amino acids are the other major glucose precursors and
quantitatively the most important is alanine which provides 5-10% of
glucose after an overnight fast (Felig, 1973). It is derived from the
amination of pyruvate in peripheral tissues, particularly muscle and
approximately half of the amino groups released from muscle are in
the form of alanine (Fig. 4:6). Alanine is in equilibrium with lactate
and pyruvate and may be considered not only as a transport form of
amino groups but also as a transport form of carbon, much of which
is derived from the carbon skeletons of amino acids. A certain,
important fraction of alanine is also derived from glutamine
metabolism in the gut. Once in the liver, alanine is transaminated
with oxaloacetate yielding pyruvate and aspartate. Pyruvate passes
through the normal gluconeogenic pathway while aspartate passes its
amino group into the urea cycle. Other amino acids may also act as
glucose precursors but are quantitatively less important.
The other main glucose precursor is glycerol released from
adipose tissues (Fig. 4:7). Under normal conditions this is a minor
contributor (1-3%) to glucose production and only assumes importance
in chronic starvation.
In short term starvation glycogen and gluconeogenesis combine
to produce about l^Og glucose per day. If starvation continues glycogen
stores are exhausted and gluconeogenesis becomes the sole source of
glucose. Tissue glucose utilisation falls as a result of inhibition by
non-esterified fatty acids and ketone bodies (Newsholme 1976). The
brain adapts to ketone body utilisation and glucose requirements fall
even further (Owen et al. 1967). Glucose production falls and amino
acids are therefore conserved with lactate, pyruvate and glycerol
contributing a greater proportion of the carbon skeletons. Blood
glucose concentrations fall slightly.
ii) Fed Man
Even after ingestion of large amounts of carbohydrate
there is remarkably little fluctuation in blood glucose concentrations
with values remaining between 4 and 8 mmol/1 in normal individuals.
FIGURE 4:5. The Glucose-Lactate (Cori) Cycle.
G-6-P = Glucose-6-Phosphate.
TCA = Tricarboxylic Acid Cycle.
FIGURE 4:6. The Glucose-Lactate-Alanine Cycle
G-6-P = Glucose-6-Phosphate.

















FIGURE 4:7. Integrated carbohydrate, fat and protein metabolism
The liver is the most important organ of glucose disposal and all
glucose absorbed must first enter the liver by way of the portal
circulation. Approximately 60% of a glucose load is disposed of in
the liver (Felig et al. 1975), some going to glycogen and some being
converted to fatty acids and triglycerides. Glucose metabolised
peripherally serves to replenish glycogen stores as well as providing
immediate fuel requirements.
(b) Lipid Metabolism
Lipids provide two potentially useful fuels which are used
directly by tissues, non-esterified fatty acids (NEFA) and ketone
bodies. In addition triglycerides are distributed throughout the body
by the lipoprotein carrier system and are either stored for future use
(the only important long term storage form of calories) or used
immediately once degraded into fatty acids and glycerol,
i) Post absorptive man
In the post absorptive state there is a requirement for
non-carbohydrate calorie sources so that glycogen stores are not
depleted too rapidly and protein reserves needlessly converted to
glucose. Fatty acids, directly and indirectly, provide these calories.
Fatty acid release from triglyceride stores is controlled by glucose
availability and the prevailing hormone environment (vide infra).
Normally there is continual cycling in the adipocyte whereby
triglycerides are broken down (lipolysis) by hormone - sensitive
lipase and resynthesised (reesterification). Lipolysis results in the
formation of NEFA and glycerol. This glycerol cannot be re-utilised
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because of low glycerol kinase activity in adipose tissue (Arner et al..
1976) and is used in the liver for gluconeogenesis. For reesterification
to occur or-glycerophosphate is required and this is synthesised from
glucose. If glucose is not available either due to a low extracellular
concentration (e. g. during starvation) or to inability to enter the cell
(e. g. in insulin deficiency) then there will be insufficient a -glycero¬
phosphate synthesis and NEFA will be released into the circulation.
Progressively more NEFA are released as starvation continues and
NEFA themselves form a useful fuel. Most tissues, apart from red
cells and nervous tissue have the capacity to use them. They provide
a rich source of calories (9 kcal/ g compared to 4 kcal/ g for
carbohydrate) and may be used in preference to glucose by some tissues.
Resting muscle derives 90% of its energy requirements from fatty acids
and ketone bodies and only during exercise do glucose and/or glycogen
become significant fuels for muscle.
NEFA also serve as precursors in the liver for ketone body
synthesis. NEFA enter the liver down a concentration gradient. Once
in the cytosol they can either be reesterified to triglyceride or be
transported into the mitochondria via the acyl carnitine transferase
system (McGarry & Foster 1976). Once with the mitochondria, NEFA
are oxidised to acetyl CoA and may be metabolised to acetoacetate and
3-hydroxybutyrate via the 3 -hydroxy-3-methyl-glutaryl CoA pathway.
In post absorptive man the preferred route of disposal of NEFA is
towards ketone body synthesis. Ketone bodies cannot be used for fuel
in the liver. They enter the circulation for utilisation elsewhere and
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in prolonged starvation may be oxidised by brain.
The main importance of fats as fuels is their role in
preserving glucose in the starved state for use by obligatory tissues.
This indirectly spares protein which would otherwise become severely
depleted.
ii) Fed Man
In fed man blood levels of usable fat fuels fall to very
low concentrations and metabolism is directed towards storage. Fatty
acids derived from ingested triglyceride reach the liver via the portal
and systemic circulation but are now directed towards reesterification
rather than to mitochondrial p oxidation. Newly synthesised triglyceride
is released into the circulation as very low density lipoprotein (VLDL).
When VLDL enter adipose tissue capillaries, they are partially
degraded by lipoprotein lipase derived from capillary endothelial cells.
Released fatty acids enter adipocytes and are encorporated into fat
stores. In contrast, in muscle capillaries, lipoprotein lipase is
inhibited in the fed state so that fatty acids are not released in muscle.
During fasting the reverse situation holds and fatty acids are released
from VLDL in muscle but not in adipose tissue.
Chylomicrons derived from the diet which bypass the liver in
the thoracic duct are subject to similar treatment to VLDL.
This seemingly complex series of pathways whereby fats are
used or stored is due to the chemical properties of triglycerides and
NEFA. Triglycerides are water insoluble and must be transported as
lipoproteins to make them water soluble. Alternatively, if all fats
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were transported as NEFA, problems may arise as fatty acids are
toxic and in high concentrations may cause haemolysis, cardiac
arrhythmias and cell wall destruction.
(c) Protein Metabolism
Tissue proteins are continually synthesised and degraded. In
a normal adult on a protein free diet there are obligatory nitrogen
losses of 50-60 mg/kg/day. The recommended daily intake of protein
for an adult is 0. 6 g/kg/day. Requirements are influenced by the
specific aminoacid content of protein in that lack of an essential aminoacid
can prevent protein synthesis. The essential amino acids in man are
leucine, isoleucine, lysine, methionine, cystine, phenylalanine, tyrosine,
threanine, valine and tryptophan. Overall protein synthesis rates in
man range from 2 to 5 g/kg/day.
In any tissue the aminoacids released by protein degradation
can follow one of three pathways. They can be reincorporated into
protein, released from the tissue or metabolised. Branched chain
amino acids (valine, leucine and isoleucine) are metabolised mainly in
muscle. Their amino groups are donated to pyruvate to form alanine
which is then released. Other amino acids also donate amino groups
to pyruvate and also to glutamate forming glutamine. Carbon skeletons
enter the glycolytic or tricarboxylic acid pathways and contribute to the
formation of lactate and pyruvate. The amount of amino acid released
or oxidised in tissues depends on the relative activities of the relevant
pathways with decreased amino acid availability causing an increase in
the activity of amino acid activating enzymes and a decrease in activity
of amino acid oxidases. Protein breakdown also appears to be
responsive to changes in ketone body concentrations. When the latter
are high, such as in starvation, protein breakdown is inhibited.
The liver is able to oxidise all natural amino acids, except the
branched chain amino acids. Amino groups are used for urea formation
which is controlled primarily by amino acid availability. Some of the
amino acids arriving at the liver are also used for plasma protein
synthesis and some of the amino acid mobilisation seen in starvation
may be directed towards maintainance of plasma protein concentrations
rather than to providing precursors for gluconeogenesis.
(d) Hormone Action
The complex series of reactions described requires careful
regulation. The system is designed to suit the normal human state;
that is periods of feeding, or anabolism, are interdigitated with periods
of starvation or catabolism. A group of hormones is responsible for
the regulation and coordination of these processes. Insulin is the prime
anabolic hormone while Cortisol, catecholamines and glucagon are
hormones of starvation or fuel mobilisation (catabolism). Growth
hormone has a mixed role in that it is geared mainly to promote protein
synthesis and to achieve this it has certain catabolic effects on lipid and
carbohydrate metabolism. The role of thyroid hormones within this
system is unknown.
i) Insulin (Table 4:1)
All the actions of insulin are directed towards anabolism
(Steiner &: Frankell, 1972). In carbohydrate metabolism insulin promotes
the entry of glucose into tissues such as muscle and adipose tissue,






























but not liver. Insulin has, however, a major effect on glucose
prosphorylation in many tissues through stimulation of hexokinase
and glucokinase activity. Glycogen synthesis is stimulated partly by
an inhibition of cyclic AMP formation. Insulin also stimulate s
glycolysis mainly through activation of phosphofructokinase and
pyruvate kinase. Pyruvate conversion to acetyl CoA is also enhanced.
Although these would appear catabolic rather than anabolic, the acetyl
CoA formed is directed, in the liver, to fatty acid synthesis. At the
same time, insulin inhibits gluconeogenesis thus sparing the incoming
gluconeogenic precursors such as amino acids. The net effect is a
sharp reduction of hepatic glucose output when insulin concentrations
rise. These hepatic processes are very sensitive to small increments
in insulin concentrations and are more sensitive than the uptake of
glucose by extrahepatic tissues.
As in other tissues, insulin promotes glucose uptake and
metabolism in the adipocyte. Increased reesterification of fatty acids
will result and fatty acid release from the adipocyte will decrease. At
the same time insulin inhibits lipolysis so blood glycerol release will
also decrease. Insulin stimulates adipose tissue lipoprotein lipase so
that more fatty acids enter the adipocyte and are stored as triglyceride.
These fatty acids will derive from dietary fats and from de novo hepatic
fatty acid synthesis. Muscle lipoprotein lipase is inhibited and fatty
acid release in muscle is inhibited.
Insulin promotes protein anabolism. Amino acid transport is
increased and the intracellular amino acid pool increases. Insulin also
directly stimulates protein synthesis but it is uncertain whether insulin
has any direct inhibitory effect on protein degradation.
Insulin secretion is stimulated primarily by glucose and
amino acids, these effects being enhanced by gut hormones, particularly
GIP. After meals, insulin will direct metabolism towards anabolism.
Insulin effects are mediated through cell surface receptors which
have been identified in many tissues such as liver, adipose tissue,
muscle, lung, monocyte and lymphocyte. Most of the actions of
insulin can be accounted for by these cell surface interactions, although
recent work suggests that insulin may also have actions within the cell.
ii) Glucagon (Table 4:2)
In carbohydrate metabolism glucagon exerts its main effects
in the liver. Glucagon acutely raises hepatic glucose production and
hence blood glucose concentrations through stimulation of glycogenolysis.
This is mediated by cyclic AMP, glucagon being one of the polypeptide
hormones whose cell surface receptors are linked to adenyl cyclase.
This effect of glucagon is short lived and persists for only one to two
hours. Glucagon has a more prolonged effect on gluconeogenesis and
stimulates it both directly, by an effect on cyclic AMP, and indirectly,
by enhanced hepatic uptake of the major amino acid precursor, alanine.
This is associated with increased urea synthesis. There is no evidence
that glucagon has any effect on extra hepatic glucose metabolism.
In lipid metabolism glucagon again has relatively minor
extrahepatic effects under normal conditions. It can stimulate
lipolysis thereby increasing NEFA release from adipose tissue but this
is significant only when insulin deficiency coexists (Alberti &
33.
Nattrass, 1977). In contrast to insulin glucagon promotes fatty acid
entry into mitochondria, perhaps by inhibiting acetyl CoA carboxylase,
thus decreasing malonyl CoA levels in the liver and hence increasing
ketogenesis (McGarry et al. 1978). The balance between insulin and
glucagon appears to determine the fate of fatty acids in the liver, their
relative proportions determining whether ketogenesis or triglyceride
synthesis predominates (Parilla et al. 1974). Although glucagon has
effects to increase hepatic protein synthesis and amino acid uptake, the
metabolic significance of these actions is unclear.
iii) Cortisol (Table 4:3)
Despite earlier ideas that Cortisol had only a "permissive"
role in metabolic control, it is now clear that Cortisol has an important
role in metabolic homeostasis (Alberti et al. 1977). While most of the
'anti-insulin' effects of glucagon are situated in the liver Cortisol has a
major extra hepatic role as well. Cortisol inhibits glucose uptake
by peripheral tissues and this has a glucose sparing effect. In addition
Cortisol is the most important proteolytic hormone and increases the
flow of amino acids to the liver. Simultaneously the flow of carbon
skeletons, lactate and pyruvate is increased. Cortisol enhances
gluconeogenesis in the liver and induces several key gluconeogenic
enzymes as well as enzymes of amino acid metabolism.
In adipose tissue reesterification of fatty acids is reduced
because of diminished glucose entry. NEFA circulate to the liver where
they will be incorporated into triglycerides or, when insulin is
deficient, will increase ketogenesis.










































Amino acid uptake and-
degradation (liver)
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iv) Catecholamines (Table 4:4)
The prime importance of catecholamines is to increase
circulating fuel supplies regardless of the metabolic status of the body
at any specific time (Young & Lansberg, 1977). They have a potent
effect on hepatic glycogenolysis, providing more circulating glucose,
and increase peripheral glycogen breakdown, providing immediate
fuels within tissues. They have a weaker effect on gluconeogenesis
although by stimulating peripheral glycolysis, they increase the flow
of lactate back to the liver.
Catecholamines also stimulate glycolysis, regardless of the
presence of insulin, acting through cyclic AMP. As a result of
increased flow of NEFA to the liver ketone body formation is increased.
Catecholamines may also have a direct effect on hepatic ketogenesis
per se as well as the indirect effect of the increase in the supply of
NEFA.
The relationship between thyroid hormones and catecholamines
has been widely investigated and will be discussed later in this
chapter.
vi) Growth Hormone (Table 4:5)
Growth hormone has both anabolic and catabolic properties
which are directed towards the preservation of proteins. In addition, it
has long and short term effects which may differ, some being mediated
through the somatomedins which are formed in the liver under the
influence of growth hormone. Growth hormone may cause an acute
rise of glucose uptake in muscle but chronic elevation of growth hormone
concentration results in inhibition of glucose entry and enhanced



































hepatic gluconeogenesis. At the same time alternative fuels to
glucose are provided through stimulation of lipolysis, enhanced
ketogenesis and increased peripheral uptake and oxidation of fatty
acids. The effects on protein metabolism are more straightforward
with growth hormone stimulating both amino acid uptake and protein
synthesis.
(e) Hormone-Hormone Interactions
Apart from the individual effects of hormones on metabolism,
each of the hormones has effects on the secretion of others. Glucagon
in physiological concentrations stimulates the secretion of insulin,
growth hormone and perhaps Cortisol. The effect on insulin secretion
means that many of the effects of glucagon are masked unless insulin
secretion is impaired.
In contrast catecholamines inhibit insulin secretion and promote
glucagon secretion so that lipolysis, ketogenesis, glycogenolysis and
gluconeogenesis will all be increased. Cortisol increases insulin
secretion, although this may be secondary to hyperglycaemia,and also
mobilises the other catabolic hormones. These various interactions
are finely regulated in normal man and designed to maintain
appropriate fuel supply at all times.
(f) Hormone-Metabolite Integration
The metabolic adjustments to the fasted state described above
can largely be explained in hormonal terms. As blood glucose
concentration falls so insulin secretion decreases and glucagon
concentration rises slightly. There is a relative excess of catabolic
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hormones over insulin. Lipolysis therefore increases and ketogenesis
occurs partly as a result of this and partly because of a more ketogenic
'set' of the liver. The brain responds to increased ketone body
concentrations by adapting to ketone body utilisation and glucose
utilisation falls. Simultaneously, through the 'glucose-fatty acid1
cycle, peripheral glucose utilisation decreases. Glucose production
falls and amino acids are spared.
In the fed state the hormonal response to a mixed meal
comprises an increase initially in insulin and glucagon secretion. The
latter is secreted in response to protein feeding and serves to inject
glucose into the system so that hypoglycaemia is prevented. Insulin
causes its well known anabolic effects. Later, growth hormone
secretion occurs which further conserves amino acids and stimulates
protein synthesis.
4. 3. KNOWN EFFECTS OF THYROID HORMONES ON THE
REGULATION OF INTERMEDIARY METABOLISM
This section describes the known effects of thyroid hormones
on intermediary metabolism. Much of the work referenced has been
published since work on this thesis was begun in 1979 and has been





Mild elevation of fasting blood glucose concentrations have
been observed in most, (Ikejeri et al. 1978; Doar et al. 1969;
Lamberg, 1965) but not all studies (Saunders et al. 1980) in
hyperthyroid man. Fasting hyperglycaemia may result from increased
glucose production, decreased glucose utilisation or a combination of
the two. Most studies have suggested that hepatic glucose production
in hyperthyroidism is increased (Saunders et al. 1980; Perez et al.
1981) although conflicting data have recently been reported (Wahren
et al. 1981). Increased glucose production by the liver may result
from increased glycogenolysis and/or increased gluconeogenesis.
Hepatic glycogen stores are decreased in fasting hyperthyroid man
(Movitt et al. 1963; Pipher & Poulsen, 1947) and animals (Battarbee,
1974). Whether this reflects increased glycogenolysis or decreased
glycogen synthesis is uncertain. However, depletion of glycogen
stores occurs more rapidly in perfused hyperthyroid rat livers than
in control livers (Laker & Mayes, 1981) suggesting that glycogenolysis
is increased.
The effect of thyroid hormone excess on gluconeogenesis in man
is uncertain. Studies using the isolated perfused rat liver preparation
have yielded conflicting results. Some have shown that the uptake of
all the major gluconeogenic precursors (lactate [Menahan & Weiland,
1969], alanine [Singh & Snyder, 1978] and glycerol [Krebs &:
Freedland, 1965]) is increased while hepatic glucose output is also
increased.
These results are consistent with data showing increased
activity of key enzymes in the gluconeogenic pathway (Maley, 1957;
Tata et al. 1963) particularly pyruvate carboxylase (Bottiger et al. 1970)
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Other studies have shown that although uptake of lactate and pyruvate
is increased, hepatic glucose output is normal (Laker & Mayes, 1981)
and it has been suggested that these metabolites are directed more
towards oxidation than gluconeogenesis. In addition, recent studies
by Bartels and Sestoft (1980) have suggested that gluconeogenesis
from lactate in hyperthyroid rat livers is not increased when
physiological concentrations of lactate (1 mmolar) in the perfusate
are used whilst, when supraphysiological (10 mmolar) concentrations
are used (as in previous studies) an increase is observed.
In the intact rat, isotopic kinetic studies have shown an increase
in hepatic glucose output together with an increase in the rate of Cori
cycle (glucose-lactate) activity (Okajima & Ui, 1979), suggesting a
primary increase in gluconeogenesis. These studies have also shown
increased futile cycle activity in the gluconeogenesis-glycolysis
pathway at the glucose-glucose-6-phosphate and fructose-1 -phosphate-
fructose 1, 6-diphosphate levels. Such increases in substrate/futile
cycle activity provide a potential source of ATP utilisation and,may be
partly responsible for thyroid hormone induced calorigenesis. These
avenues have not been explored in hyperthyroid man. Splanchic
balance studies have been performed (Wahren et al. 1981) and have
shown that despite increased hepatic uptake of all the gluconeogenic
precursors, suggesting increased gluconeogenesis, hepatic glucose
production is reduced. This may have been due to diminished hepatic
glycogen stores.
b) Hypothyroidism
Fasting hypoglycaemia has previously been reported in 1
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hypothyroid man, particularly those in myxoedema coma (Nickerson ,
et al. I960), but this is uncommon (Lamberg, 1965). Most studies
in man have shown a 10-15% reduction in fasting blood glucose in
hypothyroid subjects compared to controls (McDaniel et al. 1977;
Lamberg, 1965; Levy et al. 1970; Shah et al. 1975; Aranda et al.
1972). Hepatic glucose production, assessed by isotopic kinetic
studies, is normal in hypothyroid man (Saunders et al. 1980) but
reduced in hypothyroid rats (Okajima & Ui, 1979). Few data are
available concerning glycogen metabolism in hypothyroid man. In
the intact hypothyroid rat, hepatic glycogen stores are normal
(Battarbee, 1974) and the rate of depletion of glycogen stores in the
perfused hypothyroid rat liver (Laker & Mayes, 1981) is also normal.
Incorporation of glucose into glycogen however is reduced in hypothyroid
rats (Okajima & Ui, 1979).
Similarly, little is known about gluconeogenesis in hypothyroid
man, although gluconeogenesis from alanine has been shown to be
normal in infants with congenital hypothyroidism (Hayek, 1979). In
perfused rat liver studies, again conflicting results have been reported.
Diminished glucose production from lactate has been reported
(Menahan & Weiland, 1969) perhaps because of decreased pyruvate
carboxylase activity (Weinberg & Utter, 1979). Laker and Mayes (1981)
found that hepatic glucose production and glycogenolysis (and
therefore, by implication, gluconeogenesis) were normal whilst
hepatic uptake of lactate and pyruvate was diminished. They postulated
/
that this decreased precursor uptake was the result of decreased
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hepatic energy requirement. Glucose production from glycerol
(Sestoft et al. 1977) may also be decreased in hypothyroidism. In
the intact rat, isotopically determined hepatic glucose production is
decreased as is Cori cycle activity (Okajima & Ui, 1979). This again
suggests a decrease in gluconeogenesis.
ii) Fed Man
a) Hyperthyroidism
Intolerance to oral glucose has been reported in up to 57%
of patients with hyperthyroidism (Krienes et al. 19 65) depending on
criteria used. A number of mechanisms have been proposed. Increased
absorption of hexoses from the gastrointestinal tract (Althausen &
Stockholm, 1938) and rapid gastric emptying (Holdsworth & Besser,
1968) have been suggested as causes of the early and exaggerated blood
glucose responses seen during oral glucose tolerance tests.
Alternatively, abnormalities of insulin secretion and/or action have
been proposed. However, detailed measurements of plasma insulin
levels during oral glucose tolerance tests have failed to clarify the
issue. Insulin secretion has been found to be normal (Hales & Hyams,
1964; Holdsworth & Besser, 1968) increased (Field et al. 1966; Doar
et al. 1969) or decreased (Levy et al. 1969; Andreani et al. 1970).
Holdsworth and Besser (1968) also pointed out that although insulin
release in hyperthyroid subjects may be comparable to that of controls,
it may be insufficient in proportion to the blood glucose stimulus. It
has been suggested that thyroid hormone excess may cause pancreatic
damage (Hoist, 1921). Such damage may be temporary after short term
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exposure or permanent following prolonged exposure to thyroid
hormones (Houssay, 1946). More recent studies in the rat have
suggested that insulin secretory capacity is decreased in hyperthyroidism
(Lenzen et al. 1975) and that this may be the result of increased
[3-adrenergic tone (Watchenberg et al. 1978). An alteration in the
pattern of insulin secretion has also been reported by Sestoft and Heding
(1981) in hyperthyroid subjects. They have demonstrated that a
larger proportion than normal of "insulin" measured by radioimmunoassay
both basally and during oral and intravenous glucose challenge may
in fact be proinsulin which cross reacts in the assay. Thus "true"
insulin secretion may be decreased in hyperthyroidism. In addition it
is conceivable that proinsulin may cause some degree of insulin
resistance by competing with "true" insulin for its receptor.
Insulin sensitivity has variously been reported as normal
(Elrick et al. 1961), decreased (Ikejiri et al. 19 77; Doar et al. 1969)
or increased (Hagen, I960; Elgee & Williams, 1955; Maracek et al.
1973). These studies have however based their conclusions on the
rate of fall of blood glucose concentrations following oral glucose or
intravenous insulin administration. No studies of insulin sensitivity
at physiological blood glucose levels and in the absence of counter-
regulatory hormone secretion have appeared in the literature.
Insulin clearance has been reported to be increased (Elgee &
Williams, 1955; Mariacek et al. 1973) or normal (Wajchenberg, 1978).
Increased insulin clearance would not however explain glucose
intolerance as insulin clearance is inextricably linked to insulin action
(Terris & Steiner, 1975).
Recently, suggestions have been made that glucagon may be
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an important mediator of both fasting hyperglycaemia and glucose '
intolerance in hyperthyroidism. Fasting plasma glucagon levels
have been reported to be increased with impaired suppression after
oral glucose (Kabadi & Eistenstein, 1980a). Insensitivity of the
pancreatic alpha cells has been proposed as the mechanism of these
phenomena, and support for this theory comes from the finding of an
impaired rise in plasma glucagon following protein feeding (Kabadi &
Eisenstein, 1980b). The reason for impaired alpha cell responsiveness
is unknown.
b) Hypothyroidism
Blood glucose concentrations following oral glucose
challenge have been found to be decreased in hypothyroidism (Holdsworth
& Besser, 1968) as a result of a decrease in gastric emptying rate or
of decreased hexose absorption from the gastrointestinal tract
(Stockholm & Althausen, 1938). Glucose intolerance has also been
reported (Gutman et al. 1972; Wilder 1926; Jackson et al. 1970). The
available data regarding insulin secretion in hypothyroid man is
conflicting with low (Shah & Cerchio, 1973; Jolin et al. 1970), normal
(Hales & Hyams, 1964; Holdsworth & Besser, 1968) or increased
(Jackson et al. 1970) serum insulin responses to oral glucose challenge
being reported. The presence of normal or elevated blood glucose
concentrations with normal or increased plasma insulin levels suggests
insulin resistance (Holdsworth & Besser, 1968; Jackson et al. 1970;
Andreani et al. 1970; Elrick et al. 1961). Other studies have however
concluded that insulin sensitivity in hypothyroid man is normal, based
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on a normal rate of development of hypoglycaemia during insulin
stress tests (Iwatsubo et al. 1967; Brauman & Courvilain, 1968).
These studies do not however take into account possible impairment
of counter regulatory hormone responses which could also explain
these findings. Conversely, the finding of normal or low serum insulin
levels in the face of impaired glucose tolerance suggests hyposecretion
of insulin (Shah & Cerchio, 1973; Malaise et al. 1967; Milcu et al.
1975). This may be a result of decreased insulin release (Malaise
et al. 1967) or synthesis (Milcu et al. 1975). The pattern of insulin
secretion, as regards insulin : proinsulin ratio, in hypothyroid man is
unknown. The role of glucagon in carbohydrate metabolism in
hypothyroidism has not previously been investigated.
(b) Lipid Metabolism
i) Post absorptive man
a) Hyperthyroidism
Hyperthyroidism is accompanied by marked increases in
circulating levels of non-esterified fatty acids (NEFA) (Rich et al. 1959;
Harlan et al. 1963) and glycerol (Tibbling et al. 1969) during fasting.
These findings suggest increased lipolysis and NEFA release from
adipose tissue. In addition the turnover of both glycerol (Tibbling et al.
1969) and NEFA (Saunders et al. I98O) are increased in fasting
hyperthyroid man. Not only is NEFA turnover increased but also
14
more is oxidised as determined by increased production of
14
expired air following intravenous C-palmitate administration. In vitro
experiments have also suggested that, even during fasting, triglyceride
synthesis as well as breakdown is increased in the adipocyte (Fisher &
Ball, 1967). The ATP requirement for reesterification of fatty acids
may account for the increased rate of oxygen uptake in vitro (Fisher
& Ball, 1967). This increased rate of reesterification in hyperthyroid
adipose tissue continues even under conditions with a high rate of
lipolysis (Deykin & Vaughan, 1963). Thus lipolysis and reesterification
constitutes a substrate cycle in adipose tissue which works at
increased rate in hyperthyroidism.
The mechanism of this increase in lipolysis is probably
multifactorial. Considerable attention has been focused on the
interrelationship between catecholamines and thyroid hormones in
the regulation of lipolysis. Infusion of catecholamines into hyperthyroid
subjects leads to an enhanced lipolytic response (Harlan et al. 1963)
as judged by the increase in circulating NEFA levels. The finding of
decreased circulating catecholamine levels in hyperthyroid subjects
(Christensen, 1973) lead to the hypothesis of increased 'sensitivity'
to catecholamines as the underlying mechanism. Adipose tissue from
hyperthyroid rats had been shown to demonstrate both increased adenyl
cyclase activity (Brodie et al. 1966) and an increased lipolytic response
to catecholamines (Debons & Schwartz, 1961; Fisher & Ball, 1967).
In adipose tissue from hyperthyroid man, cyclic AMP levels are
increased both basally and during incubation with adrenaline (6 pmol/l)
and noradrenaline (6 pmol/l) (Arner et al. 1979). Basal glycerol
release is normal but increases by 50% after incubation with the
catecholamines. These results suggest an enhanced lipolytic response
to catecholamines which may be due to increased (3 adrenergic
sensitivity.
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The failure of plasma NEFA and blood glycerol levels to
suppress in hyperthyroid subjects following propranolol administration
(Beylot et al. 1980; Saunders et al. 1980; Ortigosa et al. 1976) is
therefore surprising but may reflect inadequate |3 blockade (the mean
daily dose of propranolol in these studies was only 120 mg) or
an additional a component (Arner et al. 1979).
An alternative explanation for increased lipolysis in hyperthyroidism
may lie in a reduction of the peripheral effects of insulin (Wennlund
et al. 1981). Using isolated segments of adipose tissue from
hyperthyroid subjects, these authors have shown decreased sensitivity
of adipocytes to the antilipolytic effects of insulin with a normal
maximal response (indicating a right shift of the dose-response curve).
They have also demonstrated a simultaneous and significant increase
in lipogenesis again suggesting the possibility of enhanced futile cycle
activity.
Glycerol released during lipolysis is taken up almost
exclusively by the liver for gluconeogenesis and its turnover is
proportional to its concentration in blood (Bortz et al. 1972).
In addition to reesterification, NEFA may also be oxidised
peripherally in increased amounts (Saunders et al. 1980) or alternatively
may be transported to the liver for further metabolism. Recent
studies in hyperthyroid man have shown enhanced ketonaemia during
prolonged fasting (Bartels et al. 1979; Beylot et al. 1980; Carter et al.
1975). This may be a consequence of increased hepatic NEFA supply
(Hagenfeldt et_al. 1981),enhanced hepatic ketogenic capacity or a
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combination of these two processes. Enhanced hepatic ketogenic
capacity has been demonstrated in isolated livers from thyrotoxic rats
(Laker & Mayes, 1981; Keyes & Heimberg, 1979). It has been
suggested that this ketogenic 'set' of the liver may be mediated by a
(3 adrenergic mechanism (Beylot et al. 1980). Increased activity of
carnitine acyl transferase (necessary for the transfer of long chain
fatty acids into the mitochondria ) has also been suggested as a
mechanism (Van Tol, 1971). The rate of ketogenesis from medium
chain NEFA, which is independent of carnitine acyl transferase
activity, is not influenced by thyroid status (Bartel & Sestoft, 1980).
Although production and utilisation of ketone bodies in normal man is
proportional to ketone body concentrations in blood, no studies of
ketone body kinetics in hyperthyroid or hypothyroid man have been
made.
b) Hypothyroidism
In hypothyroidism, plasma NEFA levels have been
reported as decreased (Harlan et al. 1963; Nikkila & Kekki, 1972) or
normal (Hamburger et al. 1963; Saunders et al. 1980) with decreased
(Lin 1977) or normal (Saunders et al. 1980) blood glycerol levels.
NEFA turnover is normal with normal NEFA oxidation (Saunders et al.
1980). The interrelationship between thyroid status and catecholamines
and their effects on lipolysis has also been examined within the context
of hypothyroidism. Circulating levels of both adrenaline and
noradrenaline are increased in hypothyroidism (Christensen, 1973).
However, most studies have shown decreased lipolysis in response to
50.
catecholamines both in vivo (Rosenqvist & Hylander, 1981) and in
isolated human adipose tissue (Hamburger et al. 1963; Rosenqvist,
1972). These results suggest that hypothyroidism is associated with
decreased sensitivity of adipose tissue to the |3 adrenergic effect of
catecholamines. The underlying mechanism(s) is uncertain.
In vitro rat studies have also suggested that lipogenesis in
adipocytes is also decreased (Bray & Goodman, 19 68; Bates et al. 1955).
The combination of decreased lipolysis and lipogenesis in the adipocyte
may reflect decrease adipose tissue futile cycle activity in
hypothyroidism.
Little is known concerning intrahepatic fatty acid metabolism
in hypothyroid man. Perfused rat liver studies however have shown
that hypothyroid livers oxidise and esterify fatty acids at normal
rates (Laker & Mayes, 1981). These findings are consistent with
the findings of normal fatty acid turnover in hypothyroid man
(Saunders et al. 1981). Rates of production and utilisation of ketone
bodies in hypothyroid man are unknown although in vitro rat studies
have suggested that ketogenesis may be either increased (Laker &
Mayes, 1981) or decreased (Keyes & Heimberg, 1979). Circulating
blood ketone body levels in hypothyroid man after an overnight fast
are normal (Saunders et al. 1980).
ii) Fed Man
a) Hyperthyroidism
Little data is available concerning the response of lipid
metabolism to feeding in either hyper or hypothyroidism in man.
Following oral glucose, circulating NEFA levels fail to return to
normal in hyperthyroidism (Ortigosa et al. 1976) suggesting that
lipolysis may not b,e completely suppressed. This may be because of
resistance to insulin action in the adipocytes of hyperthyroid
subjects (Wennlund et al. 1981). These and other authors (Fisher &
Ball, 1967) have demonstrated impaired insulin mediated suppression
of glycerol release from hyperthyroid human adipocytes. It has been
proposed that this decreased insulin action may be the result of
decreased insulin sensitivity (either decreased receptor number or
receptor affinity) as maximal responsiveness is normal.
lipid metabolism, although these findings have not necessarily been
obtained from feeding studies. In hyperthyroid man triglyceride
concentrations in blood and triglyceride turnover are increased, although
proportional clearance is decreased (Nikkila & Kekki, 1972).
Decreased clearance may result from decreased post-heparin
lipolytic activity in adipose tissue (Nikkila & Kekki, 1972; Arons et al.
1979). In the rat adipocyte, triglyceride synthesis may be increased
(Fisher & Ball, 1967) or decreased (Roncari & Murthy, 1975) whilst
in the rat liver triglyceride synthesis may be enhanced (Roncari &
Murthy, 1975) or diminished (Laker & Mayes, 1981; Keyes & Heimberg,
1980). Other studies have suggested that although net triglyceride
synthesis in hyperthyroid rat liver is decreased, hepatic triglyceride
turnover is increased (Glenny & Brindley, 1978).
Evidence,again from animal studies, suggests that hyperthyroidism
Thyroid hormones are known to have "anabolic" effects on
is associated with increased fatty acid synthesis both in liver and
adipose tissue (Dayton et al. i960; Diamant et al. 1972; Correze et al.
1977) with increased activity of both acetyl CoA carboxylase and fatty
acid synthetase ( key enzymes in fatty acid synthesis) (Diamant et al.
1972). However, diminished activity of these two enzymes in the
adipocyte has also been reported in hyperthyroid rats (Roncari &
Murthy, 1975).
b) Hypothyroidi sm
In hypothyroid subjects, again plasma NEFA levels show
impaired suppression following oral glucose (Gutman et al. 1972).
The reason for this is uncertain but in the presence of diminished
peripheral glucose utilisation (Okajima & Ui, 1979) it may reflect
impaired reesterification of NEFA by hypothyroid adipocytes.
Circulating triglyceride concentrations in hypothyroid man
have been reported to be either increased (Nikkila & Kekki, 1972;
Kirkeby, 1968) or normal (Kutty et al. 1968). Triglyceride synthesis
in hypothyroid rat liver (Keyes & Heimberg, 1979; Laker & Mayes, 1981)
and rat adipocyte (Fisher & Ball, 1967) is normal and it has been
postulated that increased circulating triglyceride levels (above) may
result from diminished triglyceride clearance. Decreased post
heparin lipolytic activity may be an important factor (Nikkila &
Kekki, 1972; Porte et al. 1966). Similarly, raised blood levels of
cholesterol particularly in low density and very low density
lipoproteins (LDL and VlDL) (Ballantyne et al. 1979) may be the




Available evidence suggests that thyroid hormones exert a
biphasic effect on protein metabolism. Small amounts of thyroid
hormones are necessary for protein synthesis whilst larger amounts
induce overall protein catabolism (Hoch, 1974).
Skeletal muscle weakness and wasting are common features of
the hyperthyroid state (Satayoshi et al. 1963; Fitch, 1968). Several
studies have suggested that hyperthyroidism increases protein degradation
in skeletal muscle in man (Carter et al. 1980; Bayley et al. 1981;
Burman et al. 1979; Burini et al. 1981) and this may be a major factor
in promoting muscle wasting. Thyroid hormones are known to increase
lysosomal proteases in skeletal muscle (De Marti.no & Goldberg, 1978)
and thyrotoxicosis is associated with creatinuria and negative nitrogen
balance (Carter et al. 1975; Carter et al. 1977). Animal studies have
suggested that thyroid hormones may play an essential role in the
mobilisation of body proteins during starvation (Li & Goldberg, 1976)
causing enhanced release of amino acids from muscle for use in
gluconeogenesis. In prolonged starvation however, urine nitrogen excretion
falls even in severely thyrotoxic rats. The basis of this inhibition of
protein degradation during long term starvation is unknown.
In experimental hypothyroidism, depressed growth rates and
depressed protein synthesis have been reported (Flaim et al. 1978) and
these can be reversed by thyroxine (Goldberg et al. 1980). Decreased
protein degradation has also been reported in hypothyroidism
(Goldberg et al. 1980) and can be stimulated by thyroid hormones.
These sequential changes are paralleled by changes in muscle
proteolytic enzyme activity (De Martino & Goldberg, 1978; De Martino
etal. 1977).
4. 4. METHODS OF INVESTIGATING METABOLISM
Several different techniques have been employed to investigate
the effects of thyroid hormone excess and deficiency on intermediary
metabolism in man in this thesis. This section is intended to give
an overall assessment of the advantages and limitations of these
techniques which will be described in detail in the appropriate
chapters.
(a) Diurnal Hormone-Metabolite Profiles
This method has been used in chapters 7 and 8. It provides
data concerning the blood levels of various hormones and metabolites
after an overnight fast and during a 12 h period of normal meals and
activity. Measurement of the concentration of a substrate in blood is
an indirect method of assessing its metabolism. Blood is easily
accessible and the method simple. The concentration of a substrate
in blood is the balance between its rate of production and utilisation
and changes in substrate concentrations may reflect changes in either
of these processes. For some substrates, during health,conconcentration
in blood is proportional to turnover (glycerol [Tibbling, 1969],
nonesterified fatty acids [Saunders et al. 1980]) but for many
important metabolites this relationship does not hold. The proportional
relationship between turnover and blood concentrations may also not
hold in disease states. However, this type of integrated approach may
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highlight areas of abnormal metabolism (i. e. meal intolerance) which
merit further investigation. Although mechanisms of production of
abnormalities may be suggested (elevated blood glucose concentrations
with elevated plasma insulin suggesting insulin resistance) specific
studies must be designed to test these hypotheses.
(b) Tolerance (clearance) Tests
This type of test involves the administration of a substrate load
directly (intravenously) or indirectly (orally) to the substrate pool. The
substrate can be given directly as a bolus and the subsequent clearance
assessed by the decline in concentration in serial blood samples. This
may allow assessment of metabolic clearance rate (MCR) back to basal
values. (MCR = Dose administered/J [substrate] dt). Substrate
o
can also be directly administered as a continuous infusion until a
steady equilibrium concentration is achieved when the infusion rate is
equal to the rate of utilisation. Metabolic clearance then equals infusion
ratej(Equilibrium concentration - basal concentration). These techniques
are relatively simple and are safe. They give information concerning the
rate at which added substrate is removed and reveal more about maximal
metabolic capacity rather than subtle alterations in regulatory processes.
Interpretation of data obtained using these studies must be made
with caution. Administration of a substrate load may alter its metabolism
by several methods. For example, infusion of ketone bodies (Bradley
et al. 1981) may alter ketone body utilisation (Reichard et al. 1974)
simply because of increased blood concentrations, by inducing insulin
secretion (Balasse & Neef, 1975; Madison et al. 1964; Miles et al. 1981),
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by directly inhibiting lipolysis (Bjorntop, 1966) and also ketone bodies
may be lost in the urine. Also no direct quantification of ketone body
or other substrate production can be made from this type of experiment
although it can be inferred from clearance rates and basal concentrations.
Of the oral tolerance tests, the most commonly used in clinical medicine
is the glucose tolerance test (GTT). The GTT is used primarily as a
screening and diagnostic procedure for diabetes mellitus. It has several
drawbacks amongst which is relatively poor reproducibility (McDonald
et al. 1965). Despite its long usage there is no universally accepted
way of standardising the test methodology or the manner of evaluating
test results (Meinert 1972; Duffy et al. 1973; Billewicz 1974). In
addition, the GTT is highly unphysiological and bears little resemblance
to carbohydrate tolerance as it affects individual subjects from day to
day. Free glucose is not present in normal food and ingestion of
50-100 g of carbohydrate without any accompanying protein or lipid is
extremely rare in normal life. For clinical investigation 'meal'
tolerance tests therefore provide a more physiological model for
assessment of metabolic abnormalities produced by hormone excess
or deficiency (Le Febvre &: Luyckx, 1976; Owens et al. 1979;
Lenner, 1976).
(c) Catheterisation Techniques including "Arterialisation" of
Venous Blood
The above methods for investigating metabolism give no
direct measurements of production or utilisation of a substrate by any
particular organ or tissue. By placing a catheter in the artery
serving and the vein draining a particular organ or tissue the net
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amount of substrate produced or utilised can be determined. A
measurement of arterial and venous substrate concentrations together
with an estimate of blood flow through the organ or tissue is required
and the production or utilisation is given by the expression;
Production/Utilisation = A-V difference x Blood Flow
The technique of arterial-venous sampling has been successfully
applied to determine metabolic balance across human forearm
(Hagenfeldt & Wahren, 1968; Foster et al. 1972; McGuire et al. 1976).
However, arterial puncture is not always successful and is associated
with a small but significant morbidity (Machleder et al. 1972;
Campion et al. 1971). An alternative method is retrograde blood
sampling from 'arterialised' hand veins where local heat increases
blood flow whilst, because the hand contains little muscle, oxygen and
substrate uptake are not significantly increased. A method for this
technique is described in this thesis. Arterialisation may assume
particular importance in determining whole body turnover of substrates,
particularly ketone bodies (Keller 1981). Venous sampling reflects
local exchange and may thus lead to an overestimate of whole body
turnover. A similar technique has recently been validated for glucose
and alanine kinetics (Adumrad et al. 1981).
Alternatively, knowledge of splanchnic metabolism of substrates
may be obtained using catheters in the hepatic vein and an artery
(Hagenfeldt et al. 1981; Wahren et al. 1981). This technique is invasive
and ethical considerations limit its application. There are also
technical difficulties with sampling. Streaming of blood may occur
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within the hepatic vein such that, if the catheter is not perfectly sited,
samples may not reflect splanchnic balance accurately. Also,
estimatic of splanchnic blood flow, frequently estimated using dyes
such as indocyanine green (Hagenfeldt et al. 1981) is fraught with
difficulty and misleading results may be obtained.
(d) Isotope Dilution Studies
The precise definition of disorders of carbohydrate and lipid
metabolism together with the elucidation of the homeostatic
mechanisms that maintain circulating concentrations of glucose,
glycerol and NEFA and ketone bodies are areas in which isotope
turnover studies have played a significant role,
i) Tracer considerations
An ideal tracer should have the following properties:
1) It should be negligible in quantity with respect to tracee (so that
the administration of tracer will not of itself produce changes in the
system under study).
2) It should be similar to the tracee in all physical, chemical
and biological properties such that its metabolism would be identical
with that of the tracee.
3) Where radioactive isotopes are used, they should not be
sequestered in critical portions of cells as is thymidine (Quastler &
Sherman, 1959) or in critical organs as is radioiodine in the thyroid
(Baumann 1895) and the radiation dose should not constitute an
unreasonable risk to the subject. Cumulative dose experiments following
14
the administration of such compounds as C-glycine (Berlin et al.
1973) together with shorter term estimates of CO excretion following
14
administration of such compounds as C glucose and lactic acid
(Searle, 1976) indicate that those considerations can be reasonably
14" 3
met with C and H labels used in the study of carbohydrate and lipid
metabolism in man.
ii) Tracer Assay
In dealing with metabolising systems it must always be
remembered that the instant a tracer is introduced into the system, it
becomes subject to all the biological transformations the tracee is
undergoing. The primary measurement in turnover studies involves,
for the single injection experiment, the rate of loss of tracer and for
the continuous infusion experiment the degree of dilution of tracer
by tracee. A prime consideration then is that the assay for tracer
14 3
activity or specific activity is measuring the activity ( C, H-common
13 2 \
radioactive labels; or C, H, - common stable isotope labels) that
is only associated with the injected tracer metabolite. For example,
in the measurement of glucose and/or lactate turnover rates in man,
the injected glucose or lactate tracers are rapidly interconverted in
appreciable quantities. It therefore becomes necessary to isolate
physically those metabolites one from another, and from other
circulating compounds into which their carbon skeletons may be
transformed prior to any assessment of isotopic content. Techniques
which have been used for the physical separation of glucose from its
circulating metabolite derivatives have included ion exchange
chromatography to exclude charged molecules (Reichard et al. 1963),
IRREVERSIBLE TRACER
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FIGURE 4:8. Recycling of radioactive label illustrated by the use
of the reversible tracer -1-glucose.
and isolation of specific chemical derivatives of glucose such as
the phenyl glucose osazone (Searle & Chaikoff, 1952), the osotriozole
(Steel et al. 1957) and the potassium salt of gluconic acid (Blair &
Segal, I960). Hydrogen labels on the glucose molecule (Katz et al.
1974) are metabolised to water and may be excluded from specific
activity assay by a much simpler technique, i. e. by freeze drying,
iii) Recycling of Label (Fig. 4:8)
As already described, glucose and lactate are constantly
being interconverted. This cyclic phenomenon begins with the
metabolism of glucose via the Embden-Meyerhoff pathway and
terminating with the synthesis of glucose from lactic acid is
formally known as the Cori cycle (Cori 1933). In addition to the
problem of assaying tracer activity that is associated with and only
with the tracer molecule, it is necessary to confirm that the tracee
entering the system does not contain label that would distort the
accuracy of the measurement. These problems arise if estimates of
turnover are made with carbon labelled glucose. When hydrogen
labelled glucose is used the label is oxidised to water as the glucose is
metabolised. This not only simplifies the assay of isotope associated
with tracer molecule but also eliminates recycling (Katz et al. 1974).
If however, an estimate of Cori cycle activity is required, the
combination of carbon (reversible) and hydrogen (irreversible)
glucose tracers can then be used, differences in determined turnover
rates being due to recycling of carbon label (Streja et al. 1977).
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iv) Stable versus Radioactive Isotope Tracers
13
The stable isotopes of carbon and other elements have
been available in limited quantity for many years and indeed their use
14
in the biological sciences predates the use of carbon. Until
recently, little use has been made of stable isotopes as tracers.
Firstly they are difficult and expensive to prepare; secondly,
instrumentation necessary for their detection and assay (not widely
available) has been expensive and difficult to maintain; and thirdly,
until recently the detection of stable isotope tracers has been considerable
less sensitive than those available for detecting radioactive tracers.
This latter problem has meant that the amount of "tracer" injected in
previous studies may have perturbed the system under investigation
(Bier et al. 1973; Shreene, 1973). Countering all these arguments is
the advantage that they are not radioactive. For studies in children
and pregnant women and repetitive studies in any subject they are the
only method of choice. Recent advances in methods of detection of the
stable isotopes and their increased availability (Haig et al. 1981) offers
the hope that they will be increasingly used in clinical medicine pnd research.
v) Experimental Techniques
1. Steady state systems
Input equals output (Ra = Rd) and the concentration of
substrate in the sampling pool remains constant over the period of the
study in a steady state system. Two basic experimental techniques
for the study of turnover have evolved over the years.
1) Single injection (bolus) technique
A simple injection of isotopically labelled substrate (tracer)
is administered at zero time of the experiment. Subsequent analysis
of blood or plasma samples collected at specific time intervals
thereafter provides data relative to the time course of the decay in
the specific activity (ratio of tracer concentration to that of tracee,
c.p.m. /mg or atom per cent excess) of the tracer as shown in
Figure 4:9- For glucose kinetics, the area under the glucose specific
activity (SA) decay curve can be computed and knowing the quantity of
tracer injected, glucose turnover may be calculated:
The derivation of this formula is as follows (Fig. 4:10). If a dose of
%
tracer (D ) is injected into a pool with constant appearance (Ra) and
disappearance (Rd) of tracer (i. e. a steady state system) from which
*
glucose concentration and radioactivity (y ) can be measured, the
tracer will be removed from the pool at the same rate as the tracee
(Rd). The dose of tracer injected must equal the total amount of tracer
removed in time;


















FIGURE 4:9. Schematic representation of a glucose specific
activity time curve following a simple bolus
dose of tracer activity.
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Rd
FIGURE 4:10. Schematic representation of a glucose pool to
which a quantity of tracer (D*) is administered.
Ra = rate of appearance of substrate,
Rd = rate of dissappearance. ^glucose] =
concentration of glucose and y = c.p.m. in
a sample taken from the glucose pool.
Rd = Ra = Rt = D ' (cpm)
/sAdt
o
where Rt = glucose turnover.
Several methods can be used to measure further kinetic parameters,
e. g. glucose pool, mean residence time and volume of distribution.
Pool size may be calculated from the known quantity of tracer injected
and the zero time intercept of the final slope of the course, thus
POOL = cpm = mmol (Searle, 1976)
cpm/mmol
The volume of distribution occupied by the substrate pool (an
apparant volume) may then be obtained by dividing the mass of the
pool by its concentration at the sampling site (usually blood or plasma)
SPACE = mmol/mmol/1 = litres
This quantity is usually represented as a fraction of the body weight.
Alternatively pool size may be estimated by the methods of Shipley
and Clarke 1972.
CO
MEAN RESIDENCE TIME = J(tx SA) dt
(MRT) _pSAdt
0
POOL = RT x MRT
VOLUME OF = POOL x 100
DISTRIBUTION BODY WT x [GLUCOSE]
Single injection techniques have the advantages of being shorter and
thus the steady state is more likely to be maintained throughout.
Errors may however arise because interpreting the data requires
extrapolation of the SA decay curve to time (t) = 0 and to SA "=£=• 0.
Accuracy of the method is thus affected by the number and weighting
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of the points on the curve. Accuracy will be improved if a large
number of samples are taken at the rapidly changing points on the
specific activity decay curve (Hetenyi & Norwich, 1974).
2. Continuous Infusion Techniques
A continuous infusion of tracer (with or without a priming
dose) is administered throughout the experiment. Analysis of blood
or plasma samples taken over the period of the experiment provide the
data relative to the time course of the establishment of an asymptotic
tracer specific activity curve, (as shown in Fig. 4:11.) from which, as
in the case of the single injection technique, pool size, space and
turnover rate may be calculated. Fig. 4:11a represents a continuous
infusion without a priming dose. Turnover rate may be calculated
directly from the final asymptotic portion of the curve and the
known rate of isotope infusion.
Turnover rate = cpm infusedAnin= mmol
cpm/mmol min
Then, by extrapolating the asymptote to zero time and subtracting the
ascending specific activity from that value, one can construct a curve
(T-§-) that describes the turnover characteristics of the system. The
remaining indices of the system, pool size and space can be determined
taking turnover rate and substrace concentration into account. An
alternative method which considers the dilution kinetics of the priming
dose associated with a continuous infusion procedure may be
employed (Wall et al. 1957) Fig. 4:11b. Errors in determining volume
of distribution may still occur from extrapolating SA to t = 0.
Time
FIGURE 4:11 (a).Schematic representation of the plasma substrate
specific activity time curve during a continuous
infusion of tracer activity. Decay curve labelled
tj derived from specific activity data as
described in the text.
FIGURE 4:11 (b).Schematic representation of a plasma substrate
specific activity time curve during a primed
continuous infusion of tracer activity.
3. Non-steady state systems
Input is greater than or less than output and in such a
system the concentration of tracee, by definition, must change. The
most commonly used method for estimating Ra and Rd in these
circumstances is the primed continuous infusion technique as described
above. This method however assumes that steady state conditions are
observed for at least the first 90-120 minutes of the infusion while
steady state tracer values are achieved (i. e. the method is not
completely non-steady state). Changes in Ra and Rd are then predicted
[Sa1+sa2] x ac
by the formulas Ra = I - pV ( ~4~t— ^
1(SA1 + SA2)
Rd = Ra - (pv -AS.)
where I = infusion rate of tracer
p = pool fraction
V = volume of distribution
c = concentration of tracee
C = change in tracee concentration between sample
times (t^ - tj )
^ sa = change in specific activity between sample times
(sa2-sai)
a , = t2 - t,
Note that these formulae relate the combined observations for C and sa
to predict changes in Ra and Rd.
The effect of non-steady state systems on tracer kinetics is
best conceptualised by considering a single pool undergoing constant
infusion of tracer. The pool contains unlabelled solute in continually
varying amount, Q, dissolved in water occupying an assumed constant
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volume. Thus as Q changes, the concentration (C) changes
proportionally. Assume initially that the system is in steady state
until a platea.u is reached. If the rate of input of solute is then reduced
abruptly, one may predict that C will fall (thus also Q) and SA will
increase. If input rate were increased above output, the reverse effect
would be expected. If a constant input rate is now assumed but output
rate is reduced, SA will not change but C will increase. An increase
in output rate likewise will not affect SA, however C will decline. Thus
the combined observations for C and SA versus time should predict a rise
or fall in either input or output rate.
Note that where SA and C are constant, Ra (i. e. the steady state
exists), RA predicted by these formula
I = _L ( = P* )
1 (SA + SA ) SA ( fSAdt )
(J
and Ra = Rd (i. e. the same formulae for steady state kinetics).
The methods described for investigating steady and non steady
state kinetics make no assumptions about the number of compartments
into which tracee equilibrates (i. e. they are non-compartmental analyses),
and have been commonly used for the investigation of glucose
(Streja et al. 1977; Reichard et al. 1963) and ketone body (Keller et al.
1981; Balasse & Neef, 1975) kinetics in man.
vi) Ketone Body Kinetics - growing debate
Assessment of the kinetics of ketone body metabolism
by isotope experiments poses problems since acetoacetate (Acac) and
(3 hydroxybutyrate (BOH) are interconverted too rapidly to be considered
as independent substrates but too slowly for their specific
radioactivities to become equal following the administration of either
14 14
3- C-Acac or 3- C-BOH (i. e. isotopic disequilibrium occurs). All
investigators (Balasse, 1978, 1979; Keller et al. 1978, 1981) except
Barton (1976, 1980) and Bates (1971) have attempted to circumvent
this problem by using the combined SA of Acac and BOH to quantify
total ketone body (TKB) turnover. It is now not clear whether this
approach is valid.
It has recently been suggested that this method may lead to
incorrect estimates of disposal and plasma clearance rates for ketone
bodies. It has been proposed by Barton (1980) that either separate
14 14
injections of C-Acac and C-BOH on separate occasions or
14 3
simultaneous administration of C-Acac and H-BOH could provide a
more accurate means of estimating the individual plasma clearance
rates and more generally, the kinetics of the two ketones. BOH can be
tritiated in either the 2 or 4 position. However, when converted to
acetoacetate (either in vivo or during the assay procedure) tritium
labels in either of those positions become unstable and may interchange
with hydrogen ions in any aqueous medium. Using tritiated BOH as
tracer would thus yield misleading results (Nosadini &: McCulloch -
14
Unpublished observations). Administration of C Acac on separate
occasions to the same subjects was therefore performed in this thesis.
Using the data from these experiments, Cobelli and coworkers
(Cobelli et al. 1982) have described a 4 compartment model of ketone
body kinetics. The principal drawbacks with this method are
a) two experiments must be performed on each subject to complete one
study and b) the subject must be in the same metabolic condition during
each experiment, particularly with regard to ketone body concentrations
in blood. Several studies have proved unsuitable because of this
latter prerequisite.
Since the 4 compartment model has been entirely developed by
others, the data presented in this thesis will be tbosederived using the
combined specific activities of Acac and BOH.
(e) Assessment of insulin sensitivity in man
Many of the metabolic abnormalities noted in hyper and
hypothyroid subjects may be related to sensitivity or resistance to
endogenous or exogenous insulin. There is however marked variability
in the reported findings which may be related to experimental design.
The most common method for assessing insulin sensitivity in
man is the insulin stress test. This test involves the administration of
exogenous insulin and subsequent analysis of the rate of fall of blood
glucose or the nadir of blood glucose achieved (Abrams et al. 1934;
Fraser et al. 1941; Himsworth & Kerr, 1939)- Such tests may evoke
unpleasant or even dangerous symptoms of hypoglycaemia and certainly
invoke the release of counter-regulatory hormones including
catecholamines, Cortisol, glucagon and growth hormone. The use of
relatively high doses of insulin may also complicate interpretation of
the results (Norgaard et al. 1929). Alternatively the rate of clearance
of a glucose load may be used as an index of insulin sensitivity
(Heller et al. 1968) but such tests may induce unphysiologically high
blood glucose values and glycosuria. In addition, possible insulin
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hyposecretion or the secretion of biologically inactive insulin may
confuse the results. Recently, the euglycaemic clamp technique has
been developed and applied to several disease states (Olefsky &
Kolterman, 1981; De Fronzo et al. 1979). Two basic methods of
glucose clamping have evolved, although the underlying principals of
the two methods are similar. In both, insulin is infused intravenously
to achieve steady state insulin levels in blood. Glucose is infused to
maintain blood glucose at basal values. The amount of glucose (M)
infused is taken to be equal to the amount of glucose metabolised and
is used as the index of insulin sensitivity.
The first method uses a closed-loop feed back glucose-controlled
glucose infusion by means of the Miles biostator (Artificial Pancreas).
The biostator is programmed to deliver glucose in response to a fall
in blood glucose values and to maintain blood glucose at the selected
(basal) value (Home et al. 1981). Blood glucose values are continuously
monitored using a glucose oxidase/oxygen electrode.
The second technique in common use is that developed by
De Fronzo (De Fronzo et al. 1979). Again insulin is infused
exogenously but blood glucose is monitored intermittantly (every
5 minutes) by any rapid method. Blood glucose is maintained constant
by infusion of glucose the rate of which is altered to maintain
euglycaemia as guided by a pre~set formula which takes account of
direction and rate of change of blood glucose values and body weight.
Both types of clamp measure glucose in "arterialised" blood. The
latter technique has the advantage that it can be performed without a
biostator and is therefore considerably cheaper.
A further technique for assessment of insulin sensitivity has
recently been described (Reaven et al. , 1977). This technique involves
the quadruple infusion of adrenalin, propranolol, insulin and glucose.
Adrenalin is administered to inhibit endogenous insulin secretion by
its a stimulating effects and the p blocker to inhibit the (3 effects of the
infused adrenalin. Insulin and glucose are infused in fixed amounts
and the index of sensitivity is the final steady state plasma glucose
(SSPG) achieved. The lower the SSPG, the greater the insulin
sensitivity. The infusion of insulin and propranolol may have direct
effects however on the sensitivity of peripheral tissues to insulin and
the technique does not allow quantification of endogenous glucose
production as the other techniques do when combined with administration
of labelled glucose.
(f) Animal Models (Isolated Hepatocyte Techniques)
Although extrapolation of results achieved using animal studies
to the situation in man may be misleading, certain types of experiments
for ethical reasons can only be performed using animal tissues. The
liver occupies a central position in body metabolism and its size,
softness and relative homogeneity have made it a favourite organ for
biochemical investigation. For the study of intact liver functions
under controlled conditions, perfused rat liver preparations have
been extensively used. This experimental system is excellent for many
purposes but has several major shortcomings: (1) the liver as a organ
is not completely homogenous containing up to 40% non parenchymal
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cells (Daoust, 1958); (2) it is difficult to test experimental treatments
simultaneously; and (3) the viability of an isolated liver can be
maintained only for a limited period of time. Numerous attempts have
been made to overcome these problems by the isolation and purification
of intact parenchymal rat liver cells.
The early mechanical and chemical methods for liver cell
preparation were relatively successful in converting liver to a suspension
of isolated cells, but unfortunately, nearly all such cells were damaged.
The introduction of"collagenase as a liver dispensing enzyme (Howard
et al. 1967) greatly facilitated the preparation of intact cells and the
use of physiological liver perfusion to make the tissue uniformly
accessible to the action of collagenase (Berry & Friend, 1969) made it
possible to prepare intact liver cells in high yield. Isolated
parenchymal cells are now increasingly being used as an experimental
tool and the method of preparation is described in detail in the relevant
chapter. It should be pointed out however that cell function in such
preparations may not be identical with cell function in the intact liver
model where cells are intimately related, one to another. Isolated cells
are exposed on all sides to incubation medium, unlike the situation in
perfused liver studies.
In this thesis the use of the hepatocyte method to investigate
ketogenesis from palmitic acid is particularly appropriate. Changes
in ketogenesis may occur because of events in adipose tissue or events
within the liver. The observation of increased ketogenesis in
hyperthyroidism (Beylot et al. 1980; Bartels & Sestoft, 1979) in man
gives no information about the role the liver may play in such a
process. Experiments using isolated animal tissues are required to
resolve this question.
5. APPROACHES
5.1. Diurnal hormone-metabolite profiles have been examined in
hyper and hypothyroid subjects before and during appropriate therapy
and in matched controls.
5. 2. Glucose turnover (assessed using H-3 glucose as tracer)
and recycling from glucose derived 3-carbon intermediates
(assessed by analysis of decay of specific activity of simultaneously
administered C-l-glucose) has been examined in hyperthyroid and
hypothyroid subjects before and during therapy and in matched
controls.
5.3. Gluconeogenic capacity from glycerol has been assessed in
hyper and hypothyroid subjects and controls by analysing clearance
of glycerol (0. 1 mmol/kg) administered by bolus intravenous
injection.
5.4. Insulin sensitivity has been assessed in hyperthyroid and
control subjects using a euglycaemic clamp technique by means of
the biostator (Miles) ("artificial endocrine pancreas").
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5.5. Ketone body kinetics have been assessed in hyper thyroid and
hypothyroid subjects before and during therapy and in controls by
analysis of decay of specific activity of C-3-hydroxybutyrate and
C acetoacetate.
5. 6. The effects of thyroid hormones on ketogenesis by isolated rat
hepatocytes have been assessed by
a) incubating hepatocytes from normal fed and starved rats
with 10 M triiodothyronine in the presence and absence of ImM
palmitic acid substrate.
b) incubating hepatocytes from normal and thyrotoxic fed
and starved rats in the presence and absence of 1 mM palmitic acid
substrate.
c) measuring blood concentrations of ketone bodies,
intermediary metabolites and insulin in fed and starved normal and
thyrotoxic rats.
6. MATERIALS AND METHODS
Only those methods or techniques common to most or all
experiments are described here. Special techniques are described in
detail in individual results chapters (glucose turnover, ketone body
turnover, glucose clamping, isolated hepatocytes etc.) (see Declaration).
6.1. CANNULAE
17 and 19 gauge teflon cannulae (Venflon, Viggo, Helsinborg)
were used in all experiments and were inserted intravenously using
1 % lignocaine as local anaesthetic.
6. 2. METABOLITES
i. Collection
1-2 ml. blood for glucose, lactate, pyruvate, alanine,
glycerol, 3-hydroxybutyrate and acetoacetate were taken into 5 ml.
chilled 5% perchloric acid for deproteinisation. Samples were
centrifuged immediately, separated and frozen at -20°C. All samples
were analysed within 24h.
Blood for non-esterified fatty acid estimation was taken into
lithium heparin tubes, centrifuged, separated and the plasma frozen at
-20°C until assayed.
ii. Assay
For metabolites a-f below, enzymatic fluorimetric
continuous flow assays were used on Technicon Autoanalyser II
Equipment (Technicon Instrument Co. Ltd. , Basingstoke, Hants, U. K. )
(Lloyd et al. , 1978).
These assays depend on the change in NAD/NADH or NADP/
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NADPH measured fluorimetrically at 340 n metres. The specific
reactions are listed below,
a) Glucose
Hexokinas(
Glucose + ATP ——-———Glucose-6-Phosphate + ADP
Glucose-6-Phosphate + NADP + ■ 6-Phosphogluconate
+ NADPH + H+




Lactate NAD Lactate ^ Pyruvate + NADH + H+
c) Pyruvate
Lactate








Glycerol + ATP — ^ L-Glycerol-1 -Phosphate + ADPkinase ^
Glycerol-3-
L-Glycerol-1-Phosphate + NAD — : ^ Dihydroacetone
Phosphate , __. _—




D-(-) 3 Hydroxybutyrate + NAD ~~ ~ ^ Acetoacetate
Dehydrogenase + NADH
Within batch and between batch coefficients of variation were between
0.4 and 4.4% for all these metabolites except 3-hydroxybutyrate where
CV's were higher at lower concentrations.
Acetoacetate in blood was measured using a kinetic spectrophotometry
method (Price et al, 1977) which allows low concentrations of
acetoacetate to be measured with good precision using a reaction rate
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analyser (LKB 8600, LKB Instruments, Addington Road, Croydon,
Surrey). The reaction (which is monitored for 60 seconds) is shown below.
g) Acetoacetate + NADH 3 Hydroxybutyrate^ ^ Hydroxybutyrate + NAD
Dehydrogenase
Acetoacetate is particularly unstable and if left at room temperature
in PCA extracts, 60% will decarboxylate to acetone within 24 h. Samples
were frozen at -20°C and assayed within 24h when expected loss is
less than 5%. Within and between batch variation ranged from 4-6%
in PCA.
h) Non esterified fatty acids (NEFA)
Plasma non esterified fatty acids were measured by a modification
of the method of Ho and Meng, described by Turnell et al. 1980. This
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method was a Dole type extraction with formation of Cobalt soaps.
Between batch coefficient of variation at 1. 1 2 mmol/1 was 7%.
6.3. HORMONES
i. Collection
Blood for insulin, growth hormone, c.-peptide, thyroxine,
triiodothyronine and thyroid stimulating hormone were taken into plain
glass tubes. The serum was separated and frozen at -20 °C until
assayed. For plasma glucagon 2. 25 ml blood was taken into tubes
containing 2500 kiu trasylol and 9- 3 mg ethylendiaminetetracetate
(EDTA) in 0. 25 ml. Samples were centrifuged and separated
immediately and stored at -20 °C until assayed.
ii. Assays
a) Insulin
Serum insulin was measured using a double antibody
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radioimmunoassay technique (Soeldner & Stone, 1965). Within and
between batch variation were 5% and 12-14% respectively.
b) Glucagon
Plasma glucagon was measured by a double antibody
radioimmunoassay employing wick chromatography (jOrskov et al. 1968).
Between batch CV for this assay is 9%.
c) Growth Hormone
Serum growth hormone was measured by double antibody
radioimmunoassay based on the method of Hartog et al. (1964).
d) C -peptide
C«peptide concentrations were measured by radioimmuno¬
assay with ethanol precipitation using a 'kit' supplied by Novo Industries,
Copenhagen. Intraassay CV for this method is 7%.
e) Thyroxine
Serum thyroxine was measured by radioimmunoassay
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using a commercially available kit (Malinkrodt, RIA-MAT ^4)'
f) T riiodo thyronine
Serum triiodothyronine was measured by a double antibody
radioimmunoassay method described by Hesch & Evered (1973).
g) Thyroid Stimulating Hormone
Serum thyroid stimulating hormone was measured by
double antibody radioimmunoassay (Hall et al. 1971).
6. 4. STATISTICAL ANALYSES
Statistical analyses were performed using Students paired and
unpaired t-tests as appropriate. Measurements which were normally
distributed are shown in the text as mean _+ standard error of the
mean (SEM). Certain measurements, ketone bodies, insulin and
glucagon were log normally distributed and statistical analyses were
therefore performed on log transformed data. These measurements
are shown in the text as mean and range. Correlations were sought
by the method of least squares or by the Spearman ranking method
as appropriate.
6. 5. INFORMED CONSENT AND ETHICAL APPROVAL
Oral consent was obtained from all patients and control
subjects after full explanation of the aims, procedures and risks
involved in each study. The patients general practitioners were
informed by letter of any patients inclusion in a study and an entry was
made in the patients case records.
All studies had the approval of the Ethical Committee of
Newcastle Area Health Authority (Teaching). Where radioisotopes
were used, study design conformed with the regulations set down by
the DHSS Isotopes Advisory Panel.
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7. diurnal metabolic profiles in hyperthyroidism
7.1. introduction
Numerous, often conflicting, metabolic abnormalities have been
described in hyperthyroid man. Fasting blood glucose concentrations
have been reported to be normal (Kabadi & Eisenstein, 1980;
Saunders et al. 1980) or elevated (Doar et al. 1969; Levy et al. 1970)
with normal (Macho, 1958) or abnormal tolerance to oral (Hales &
Hyams,19 64; Marks et al. I9 60) or intravenous glucose (Doar et al.
1969). Peripheral insulin responses to oral glucose have also been
described as normal (Andreani et al. 1970), enhanced (Doar et al. 1969)
or impaired (Malaisse et al. 1967). Plasma non-esterified fatty acid
(NEFA) concentrations (Doar et al. 1969; Harlan et al. 1963) and
turnover (Sanders et al. 1980) may be increased with enhanced ketosis
during starvation (Beylet et al. 1980). A fuller account of metabolic
abnormalities is given in the Introduction (4. 3. ). Little is known however
about the effects of thyroid hormone excess on hormone and
intermediary metabolite levels during fasting and following mixed meals.
The purpose of this study was to investigate these effects in
hyperthyroid subjects before and after treatment and in euthyroid
controls.
7. 2. SUBJECTS AND METHODS
Subjects
Nine (eight female, one male) patients with hyperthyroidism
were compared with sixteen (thirteen female, three male) normal
controls (Table 7:1). No subject had a personal or family history of
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diabetes and none was on any medication at the time of the initial study.
Patients had Graves' disease on the basis of clinical features, such
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as ophthalmopathy, and an absence of thyroid nodules on Tc
scanning.
Hyperthyroid subjects were restudied when clinically euthyroid
and when thyroid function tests had been normal for at least 2 months
(Table 7:1). Treatment consisted of carbimazole 30-45 mg daily
with subsequent addition of thyroxine to maintain normal circulating
serum thyroxine and serum thyroid stimulating hormone concentrations.
Antithyroid therapy was taken on the day of repeat study. The mean
interval between studies was 7 months (range 5-10).
Protocol
Intravenous teflon cannulae were inserted at 08. 00 hours after
an overnight (10 h) fast and subjects remained recumbent until
08. 30 hours. Basal samples for hormone and metabolite estimations
were withdrawn at 08. 25 and 08. 30 hours when breakfast was taken.
Lunch was at 12. 00 hours and dinner at 18. 00 hours with snacks at
10.00 and 15.30 hours. Blood samples were withdrawn at 30 min
intervals until 20. 00 hours. Meals were standard hospital meals
containing approximately 2500 calories with 45% carbohydrate 40%
fat and 15% protein by weight. All subjects consumed a daily intake
of 250 g of carbohydrate for at least 48 h before study. After breakfast,
subjects were mobile and encouraged to take gentle exercise
throughout the test but remained at rest for at least 10 min before
each sample time.
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Chemical Methods
Hormone and metabolite concentrations were measured as
described in Chapter 6.2. and Chapter 6.3. Possible interference
in metabolite assays by carbimazole was excluded by addition of this
drug in a concentration of 1 0 mg/1, far in excess of expected plasma
values, to paired blood samples.
Statistical analyses were performed using Student's paired
and unpaired t-tests as appropriate. Certain measurements (ketone
bodies, insulin and growth hormone) were log-normally distributed
and stati stical analysis was performed on log transformed data.
Correlations were sought by the least squares method or the Spearman
Rank method where appropriate. Values in the text are given as
the mean + standard error of the mean (SEM) or mean (range).
7.3. RESULTS
1. Fasting metabolite and hormone levels in untreated
hyperthyroidism
(a) Metabolite concentrations. Fasting blood glucose
concentrations were elevated in untreated hyperthyroidism (5. 5 +
0.1 mmol/1, hyperthyroid subjects; 4.8 + 0.1 mmol/1, controls;
P 4. 0.01). Concentrations of the gluconeogenic precursors, lactate,
pyruvate and alanine were similar in hyperthyroid and control subjects
(Table 7:2).
Fasting blood glycerol concentrations were elevated in
hyperthyroidism (0.15_+0.02v. 0.08 + 0. 01 mmol/1, P-^C 0.001) as
were plasma non-esterified fatty acid levels (0. 9i +; 0. 06 v. 0. 03 mmo
P 4 0. 001). Blood ketone body concentrations were variable and did
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not differ between hyperthyroid and control subjects.
(b) Hormone concentrations. Fasting serum insulin and
growth hormone concentrations were similar in hyperthyroid subjects
and controls (Table 7:2).
2. Diurnal hormone and metabolite profiles in untreated
hyperthyroidism
(a) Metabolite concentrations. Blood glucose profiles over
12 h are shown in Fig. 7:1. The peak blood glucose responses to
breakfast (7.3 + 0.4 v. 6.0^+0.2 mmol/1, P <T 0. 01) and lunch
(8. 0 + 0.4 v. 6. 1 _+ 0. 3 mmol/1, 0. 001) although synchronous in
both groups were exaggerated in hyperthyroidism. The mean blood
glucose concentration over the 12 h was also increased (Table 7:2).
Similarly, blood lactate and pyruvate concentrations after breakfast
and lunch were increased in untreated hyperthyroidism (Fig. 7:2) as
were the 12 h mean values for lactate and pyruvate (Table 7:2). Blood
alanine concentrations were similar in hyperthyroid subjects and
controls (Fig. 7:2, Table 7:2).
In control subjects, blood total ketone body, plasma NEFA
and blood glycerol concentrations fell with feeding and rose with
fasting before meals (Fig. 7:3). This diurnal pattern was preserved
in hyperthyroidism but the premeal peaks for blood ketone body,
plasma NEFA and blood glycerol levels were exaggerated. As a
result, the 12 h mean values for blood glycerol and plasma NEFA
were elevated in hyperthyroidism (Table 7:2).
(b) Hormone concentrations. Serum insulin and growth
hormone concentrations were similar in hyperthyroid and control
subjects over the 12 h (Fig. 7:1 and Table 7:2).
3. Effects of antithyroid therapy
(a) Fasting hormones and metabolites. Blocking-
replacement treatment had no effect on fasting blood glucose
concentrations (Table 7:2). Blood glycerol and plasma NEFA levels
decreased to normal, however, with therapy. Concentrations of
other metabolites, insulin and growth hormone were not influenced by
treatment.
(b) Diurnal hormone and metabolite profiles. Blood glucose
concentrations remained elevated in hyperthyroid subjects after
treatment (Fig. 7:1), with 12 h mean values higher than in controls
(6. 0 + 0. 1 v. 5. 5 + 0. 2 mmol/1, P £ 0. 05) (Table 7:2). Similarly,
hyper lactataemia and hyperpyruvicaemia persisted during antithyroid
therapy (Fig. 7:2 and Table 7:2). Treatment also resulted in a
significant increase in blood alanine concentrations, not evident in
the untreated state (Fig. 7:2).
Circulating ketone body, NEFA and glycerol concentrations
decreased with antithyroid therapy (Fig. 7:3) although the meal
related fluctuations were preserved. Plasma NEFA and blood glycerol
levels were suppressed to values below those found in controls
(Fig. 7:3 and Table 7:2).
Insulin and growth hormone concentrations were unaffected
by therapy. In untreated hyperthyroidism neither serum thyroxine nor
triiodothyronine levels correlated with fasting, peak or mean 12 h
++ + ++ ++ + ++ ++++++++ +
• • • • • • •
2.0
60
FIGURE 7:1. Blood glucose and serum insulin profiles in
hyperthyroid subjects before (• • ) and during
($ ®) therapy and in controls (SS H ). The
first sample was taken after an overnight fast.
Thereafter meals were taken at 08. 30, 12. 00 and
1 8. 00 hours with snacks at 1 0. 00 and 15.30 hours.
*P 4. 0. 05 hyperthyroid subjects before therapy v.
hyperthyroid subjects during therapy (**P £_0. 01)
+ P £ 0. 05 hyperthyroid subjects before therapy v.
controls (++ P < 0. 01). # P c. 0. 05 hyperthyroid
subjects during therapy v. controls (®@ P < 0. 01).
8.30 12.00 15.00 18.00 20.00
h
FIGURE 7:2. Blood alanine, lactate and pyruvate profiles in
hyper thyroid subjects before and during therapy and









FIGURE 7:3. Diurnal profiles of blood ketone bodies, plasma
non-esterified fatty acids and blood glycerol in
hyperthyroid subjects before and during therapy and
in controls. See legend to Figure 7:1 for symbols
and conditions.
94.
values for any of the hormones or metabolites measured.
7.4. DISCUSSION
The present study showed fasting hyperglycaemia in
hyperthyroid subjects. This could be a consequence of diminished
utilization or increased hepatic glucose production. The latter has
been noted by some (Saunders et al. 1980; Okajima & Ui, 1979), but
not all (Wahren et al. 1947) workers. Increased glucose production
may result from increased gluconeogenesis and/or increased
glycogenolysis. Hepatic glycogen stores are decreased in hyperthyroid
man (Pipher & Paulsen, 1947) although whether this is because of
increased utilization or decreased synthesis is uncertain. Recently,
studies in overnight fasted hyperthyroid man have shown increased
splanchnic uptake of the gluconeogenic precursors, lactate, pyruvate,
glycerol and alanine, largely due to increased fractional extraction
of these precursors but also, to a smaller extent, to increased hepatic
blood flow (Wahren et al. 1981). Similarly, the finding of increased
glucose production from glucose-derived 3-carbon intermediates in
experimental hyperthyroidism in animals (Okajima & Ui, 1979) suggests
an increase in gluconeogenesis. Confirmatory evidence has been
obtained from studies with perfused rat livers at high concentrations
of gluconeogenic precursors (Menahan & Weiland, 1969; Freedland &
Krebs, 1967) although not at physiological levels (Bartels & Sestoft,
1980).
In the present study, postprandial as well as fasting
hyperglycaemia was noted. Peak blood glucose concentrations
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occurred at the same time as in controls indicating that rapid absorption
of carbohydrate was not the major factor; a suggestion made by others
on the basis of glucose tolerance tests (Holdsworth & Besser, 1968).
Normal serum immunoreactive insulin levels were also
found. The combination of fasting hyperglycaemia, meal intolerance
and normal circulating insulin levels suggests insulin resistance.
Studies of insulin sensitivity in hyperthyroid man have been equivocal
showing a normal (Elrich et al, 1961), increased (Macho, 1958) or
decreased (West et al. 1975) blood glucose response to exogenous
insulin. Enhanced insulin degradation in hyperthyroidism, noted by
some (Elgee & Williams, 1955) but not all workers (Wajchenberg
et al. 1978), may not explain the coexistence of normal insulin and
elevated blood glucose concentrations as insulin degradation and
biological effect are inextricably linked (Terris & Steiner, 1975).
The important recent demonstration of elevated circulating
proinsulin concentrations with low C-peptide levels suggests that
true insulin secretion may be diminished in hyperthyroid man (Sestoft
& Heding, 1981). Proinsulin cross reacts with insulin in the assay
used in our radioimmunoassay as in many other studies. Thus 'true'
insulin levels may have been decreased in our patients. However,
even if proinsulin secretion were normal, the fact that insulin levels
were not raised in the presence of hyperglycaemia suggests
under secretion of insulin. The mechanism of insulin hyposecretion is
uncertain but has been attributed to increased adrenergic tone
(Wajchenberg et al. 1978).
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Recent work has suggested a role for glucagon in glucose
intolerance of hyperthyroidism (Kabadi & Eisenstein, 1980), some
hyperthyroid subjects showing elevated basal plasma glucagon levels
with impaired glucagon suppression following oral glucose challenge.
In addition, increased sensitivity to the cyclic AMP mediated effects
of glucagon has been proposed (Lamberg, 1965). This may be
important in decreasing glycogen stores in the liver of hyperthyroid
man and animals.
The elevated blood lactate and pyruvate responses to meals
is not readily explained. Blood lactate levels are also increased in
response to exercise in hyperthyroid man (Nazar et al. 1978). This
hyperlactataemia is abolished by (3-adrenergic blockade and increased
adrenergic tone has been suggested as a mechanism (Kaciuba-Uscilko
& Brezinska, 1975). Our subjects were resting and a thyroid hormone
mediated increase in peripheral glycolysis is a more likely mechanism.
Such an effect has been demonstrated in vivo (Araki et al. 1968).
The elevated circulating concentrations of glycerol and NEFA
after an overnight fast and before lunch and dinner reflect increased
adipose tissue lipolysis. Increased lipolysis in hyperthyroidism
has long been recognized (Marks et al. I960; Hesch & Evered, 1973)
and NEFA (Saunders et al. 1980) and glycerol turnover (Tibbling, 1969)
are elevated in fasting hyperthyroid man. This increase in lipolytic
activity could reflect either a direct effect of thyroid hormones
or potentiation of the lipolytic action of other hormones,
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particularly the catecholamines. Although plasma catecholamine
levels are not increased in hyperthyroidism (Christensen, 1973)
increased lipolysis may be due to increased |3 adrenergic responsiveness
(Arner et al. 1980). Enhanced ketogenesis with fasting has been
recognized recently in hyperthyroidism . (Beylot & Rioux, 1980).
Increased NEFA supply combined with relative insulin deficiency are
important and an additional direct ketogenic effect of thyroid hormone
excess on the liver has recently been described (Keyes & Heimberg, 1979).
Antithyroid treatment with carbimazole and thyroxine
replacement therapy did not restore blood glucose or gluconeogenic
precursor concentrations to normal. Similarly Kreines et al. (1965)
and Cavagnini et al. (1974) reported persistent intolerance to oral
glucose after antithyroid therapy while Saunders et al. (1980)
reported normalization of fasting glucose turnover by carbimazole
but blood lactate levels remained elevated. The reasons for the
persisting abnormalities are not apparent. All patients were clinically
and biochemically euthyroid and the decline in blood glycerol, ketone
body and plasma NEFA levels (to subnormal levels in the case of
glycerol) suggests that therapy adequately suppressed lipolysis and
ketogenesis. No direct effects of carbimazole on intermediary
metabolism, independent of its effect on thyroid function have been
reported and the effects of methimazole, a related drug, on glucose
turnover in the rat are restored to normal by thyroxine (Okajima &
Ui, 1979). Insulin secretion, assessed by peripheral insulin
concentrations did not alter although the proportion of 'true' insulin
to proinsulin may have increased. It is still possible, however, that
there may have been residual pancreatic hyposecretion or, particularly
had 'true' insulin secretion increased, persistent insulin resistance.
These may have contributed to the persistent carbohydrate intolerance
but do not explain the elevated post-prandial lactate and pyruvate
concentrations during antithyroid therapy. Finally, the duration of
therapy (6. 7 months) may have been inadequate. Studies in the rat,
however, suggest that normalization of glucose metabolism occurs after
5 weeks (Okajima &: Ui, 1979). Longer-term follow-up studies will be
necessary to resolve this question.
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8. diurnal metabolic profiles in hypothyroidism
8.1. INTRODUCTION
Animal studies have shown that experimental hypothyroidism is
associated with decreases in gluconeogenesis (Freedland & Krebs, 1967),
glycogenolysis (Battarbee, 1974), peripheral glucose utilisation
(Scow & Cornfield, 1954), lipolysis (Bray & Goodman, 1968),
lipogenesis (Bates et al. 1955) and protein turnover (Hoberman &
Graff, 1951).
In man fasting hypoglycaemia (Lamberg, 1965), impaired
tolerance to oral glucose (Crawford, 1940) with normal (Holdsworth
& Besser, 1968) or impaired (Shah & Cerchio, 1973) peripheral insulin
responses have all been reported. Decreased lipolysis, both in vivo
(Hamburger et al. 1963) and in isolated human adipocytes (Rosenqvist,
1972) has been demonstrated but little is known about the effects of
hypothyroidism on ketone body metabolism. (A fuller account of
metabolic abnormalities accompanying hypothyroidism is given in
the Introduction (4. 3)).
The effects of hypothyroidism on circulating hormone and
metabolite concentrations under normal circumstances are unknown and
the results of subsequent thyroid hormone replacement have not
previously been described. Hormone-metabolite profiles during a 1 2h
period of normal meals and activity have therefore been examined in
hypothyroid subjects before and during thyroxine replacement therapy
and in normal euthyroid controls.
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8. 2. PATIENTS AND METHODS
Eight (six female and two male) patients with hypothyroidism
were compared with sixteen control subjects of similar age, sex and
ideal body weight (Table 8:1). No subject had a personal or family
history of diabetes and none were on any medication at the time of
initial study. Liver function tests were normal. Hypothyroidism was
secondary to Hashimoto's thyroiditis in six subjects (on the basis of
spontaneous hypothyroidism occurring in subjects with circulating
antibodies to thyroid tissue), partial thyroidectomy for colloid goitre
in one subject and radioiodine therapy in one subject.
The protocol for the study was identical to that in Chapter 7.
Hypothyroid subjects were restudied when clinically euthyroid and
conventional thyroid function tests were normal. Treatment consisted
of L-thyroxine 100-200 pg daily to maintain normal circulating serum
thyroxine and serum thyroid stimulating hormone concentrations. The
mean interval between studies was 5.9 months.
Hormone and metabolite concentrations were measured as
described in 6. 2. and 6. 3.
Statistical analyses were performed using Student's paired and
unpaired t tests as appropriate. Certain measurements (ketone bodies,
glucagon and insulin) were log-normally distributed and statistical
analysis was performed on log-transformed data.
Correlations were sought by the method of least squares or
the Spearman ranking method where appropriate. Values in the text
are given as the mean + the standard error of the mean or as mean
(range)
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Results for serum thyroxine (T^) serum triiodothyronine (T )
serum thyroid stimulating hormone (TSH) and percent ideal body weight
(% IBW) are shown in Table 8:1. Serum T^ and T^ concentrations were
lower in hypothyroidism (P 2. 0. 001) than in controls and increased
to normal with thyroid hormone replacement. Serum TSH levels
were higher in hypothyroidism (P 0. 001) and fell, with treatment,
to normal values. Although there was a significant fall with thyroxine
therapy (P d 0. 05), percentage of ideal body weight in hypothyroid
subjects before and after therapy was similar to controls.
Fasting metabolites and hormones
Metabolite' concentrations. Fasting concentrations of blood
glucose and the gluconeogenic precursors, lactate, pyruvate, and alanine,
blood ketone bodies and plasma NEFA were similar in hypothyroid
patients and controls (Table 8:2). Blood glycerol concentrations were
however decreased in hypothyroidism (patients, 0. 06 + 0.01; controls,
0. 08 + 0. 01 mmol/1; P ( 0. 001).
Hormone concentrations. There were no significant differences
between fasting serum insulin, growth hormone and plasma glucagon
concentrations in hypothyroid and control subjects.
Effects of thyroxine therapy. Fasting blood concentrations of
glucose, lactate, pyruvate, alanine and 3-hydroxybutyrate were
unchanged by thyroxine replacement therapy. Blood acetoacetate levels
rose significantly [ during treatment 0.08 (0.03-0.1 6), untreated 0.04
(0. 02-0. 07) mmol/1; P 2. 0. 05]. Blood glycerol levels also rose
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( during treatment 0. 08 + 0. 01, untreated 0. 06 + 0. 01 mmol/1;
P 2. 0. 05). Serum insulin, growth hormone and plasma glucagon
levels were unchanged by thyroxine replacement.
Diurnal profiles
Metabolite concentrations. Mild hyperglycaemia was
apparent after breakfast in hypothyroid subjects (Fig.8:1) although the
glycaemic response to lunch and evening meal was normal. As a
result the mean 12-h blood glucose value was unaltered by hypothyroidism.
Blood lactate and pyruvate responses to meals were exaggerated and
mean 1 2h values for blood lactate (hypothyroid 1 . 08 + 0. 08; control
0. 77 + 0. 03 mmol/1; P 2. 0. 001) and blood pyruvate (hypothyroid 0. 10 _+
0.01; control 0. 08 + 0. 003 mmol/1; P 2 0. 01) were elevated in
hypothyroidism (Fig. 8:2) (Table 8:2). The ratio of blood lactate to
blood pyruvate in control subjects fell after each main meal (Table 8:3).
In hypothyroid subjects, lactate:pyruvate ratios rose with meals and
were significantly higher than in control subjects.
Blood alanine concentrations were similar in hypothyroid and
control subjects in the morning and early afternoon but were significantly
higher in hypothyroidism over the last 4 h of the study (Fig. 8:2). As a
result mean 12 h blood alanine levels (Table 8:2) were significantly
higher in hypothyroidism (0. 40 +_ 0. 02 v. 0. 33 _+ 0. 02 mmol/1, P 2 0. 05).
In control subjects, blood total ketone body, glycerol and plasma
non-esterified fatty acid (NEFA) showed a characteristic diurnal pattern
with rises in circulating levels of each metabolite before meals (Fig. 8:3).
In hypothyroidism, this diurnal pattern for blood glycerol and blood
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ketone bodies was lost. Blood glycerol levels were decreased
throughout the study period (0. 04 + 0. 01 v. 0. 08 + 0. 01 mmol/1,
P 4. o. 001). A similar, though less striking decrease was also
evident for blood ketone bodies before the evening meal. The rise in
ketone body concentrations between lunch and the evening meal,
assessed as the area under the ketone body curve, was decreased in
hypothyroidism (P c 0. 05). Plasma NEFA levels were comparable
in patients and controls.
Hormone concentrations. Serum insulin, growth hormone and
plasma glucagon levels did not differ in hypothyroid and control
subjects at any time.
Effects of thyroxine therapy. Thyroxine therapy did not restore
the blood glucose response to breakfast to normal but serum insulin
levels after meals were increased particularly in the evening, and
the mean 12 h serum insulin concentration was elevated (Table 8:2).
Plasma glucagon concentrations were not affected.
Mean 12 h values for blood lactate, pyruvate or alanine concentrations
(Table 8: 2) were also unaltered by thyroxine therapy, but blood glycerol
concentration rose significantly (untreated 0. 04 _+ 0. 01, during
treatment 0. 06 + 0. 01 mmol/1, P ^ 0. 01) although they remained lower
than in controls (0. 08 + 0. 01 mmol/1, P < 0. 05). Total ketone body
concentrations were unaltered by replacement therapy although a normal
diurnal pattern was restored.
Serum T^, T^ and TSH concentrations did not correlate with
blood levels of any of the hormones or metabolites measured in
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FIGURE 8:1. Blood glucose and serum insulin profiles in
hypothyroid subjects before (• •) and during
(• ♦) thyroxine therapy and in controls
(■ HI ). The first sample was taken after an
overnight fast. Thereafter meals were taken at
0830, 1200 and 1800h with snacks at 1030 and
1530 h. .2. 0. 05 hypothyroid subjects before
therapy v. hypothyroid subjects during therapy.
(**P 2. 0. 01). +P ^ 0. 05 hypothyroid subjects
before therapy v. controls ( + + = P <. 0.01).
• =P 2. 0. 05 treated hypothyroid subjects v.
















FIGURE 8:2. Blood alanine, lactate and pyruvate profiles in
hypothyroid subjects before and during thyroxine
therapy and in controls. See legend to Figure 8:1
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FIGURE 8:3. Diurnal profiles for plasma non-esterified fatty-
acids, blood ketone bodies and blood glycerol in
hypothyroid subjects before and during therapy
and in controls. For conditions and symbols
see Figure 8:1.
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TABLE 8:3. Blood lactate : pyruvate ratios before and 2 h after
the three main meals in hypothyroid subjects before
and during therapy and in controls.





Before breakfast 10.3 + 0.7 10.1+0.6 10. 2+0. 3 ns ns ns
2h after breakfast 11. 7 _+ 0. 6 10.6+^0.4 9. 7+0. 4 ns <0.05 ns
Before lunch 1 0. 3 _+ 0. 4 10.2 + 0.6 10.5+0.4 ns ns ns
2h after lunch 11. 5 + 0. 5 10.9 + 0.6 10. 2_+0.4 ns <0.05 ns
Before supper 10.6 + 0.3 1 0. 5 jl 0. 7 11. 2+0. 3 ns ns ns
2h after supper 1 2. 1 + 0. 8 11.6 + 0.3 10. 1+0. 4 ns <0. 05 <0.05
110.
hypothyroid subjects before or during therapy or in controls.
8.4. DISCUSSION
Previous studies in hypothyroid subjects have shown either
normal (Saunders et al. 1980) or decreased (Lamberg, 1965; Levy et al.
1970; Shah et al. 1972) fasting blood glucose concentrations. The
decrease in blood glucose has been attributed to both impaired hepatic
glycogenolysis (Battarbee, 1974) and impaired gluconeogenesis
(Bondy, 1949; Freedland & Krebs, 1967; Menahan & Weiland, 1969;
Sestoft et al. 1977). In the present study, fasting blood glucose
concentrations were normal. Glucose turnover is decreased in
hypothyroid rats (Okajima &c Ui, 1979) but in hypothyroid man, glucose
turnover has been reported to be normal (Saunders et al. 1980).
The blood glucose response to breakfast was mildly elevated
and the peak blood glucose value delayed in hypothyroidism. Absorption
of glucose from the gastrointestinal tract is delayed both in man
(Holdsworth &: Besser, 1968) and experimental animals (Althausen &:
Stockholm, 1980). This may explain the delay in blood glucose peak but
does not explain the exaggerated glycaemic response. This suggests
impaired peripheral utilization of glucose. A similar intolerance to oral
glucose has previously been noted (Gutman et al. 1978; Crawford 1940).
Fasting blood concentrations of the gluconeogenic precursors,
lactate, pyruvate and alanine were normal in the present and previous
(Saunders et al. , 1980) but not all (McDaniel et al. , 1977) studies.
Peripheral release of lactate (McDaniel et al. , 1977) and alanine
(Bondy, 1949; Ness et al. , 19 69) may be reduced in hypothyroidism but
the normal circulating levels suggest that any impairment of
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gluconeogenesis is not secondary to a reduction in precursor supply.
This suggests that lactate, pyruvate and alanine uptake by the liver is
decreased in hypothyroidism in proportion to the decrease in hepatic
glucose output.
The exaggerated lactate and pyruvate responses to meals may
be secondary to increased peripheral production or diminished clearance.
Most studies in hypothyroidism suggest diminished peripheral glucose
utilization and diminished lactate (Shamer et al, , 1971; Okajima & Ui,
1979) and pyruvate output (McDaniel et al. , 1977) from peripheral tissues.
Increased production of lactate and pyruvate after meals is therefore
unlikely as the cause of the hyperlactataemia and hyperpyruvicaemia,
making a defect in hepatic uptake more likely.
The ratio of blood lactate to blood pyruvate was elevated after
meals. This ratio may reflect the prevailing cytosolic redox state
which is in turn dependent on the transfer of reducing equivalents across
the mitochondrial membrane (Krebs et al. , 1975; Alberti Si Nattrass,
1977). Thyroid hormones are important in this transfer process
(Mullhoffer Sc Loy, 1974; Rognstadt, 1977; Sestoft, 1980), which may
therefore be deficient in hypothyroidism.
Fasting blood alanine concentrations were normal in
hypothyroidism and were only significantly greater than control values
during the last 4 h of the study. Hyperalaninaemia may be due either
to diminished alanine uptake for gluconeogenesis or alternatively to
a loss of the normal protein sparing effects of ketone bodies. Ketone
bodies are known to inhibit protein degradation and peripheral alanine
output (Sherwin et al. , 1976). The lower ketone body concentrations,
particularly during the afternoon period, could possibly be responsible
for the elevated blood alanine concentrations observed.
Alone among the gluconeogenic precursors, circulating blood
glycerol levels were diminished in hypothyroidism. This finding,
and the findings of other studies (Goodman & Bray, 1966; Fisher &
Ball, 1967) suggests decreased lipolysis. Thyroid hormones have
lipolytic actions in vitro (Vaughan, 1967), and a permissive effect for
the lipolytic actions of other hormones, particularly the catecholamines
both in vitro (Arner et al. , 19 79; Debons & Schwartz, 19 61) and in vivo
(Hamburger et al. , 1963). In hypothyroidism plasma catecholamine
levels may be increased (Christensen, 1972) and sensitivity to their
peripheral effects reduced (Goodman & Bray, 1966; Rosenqvist, 1972;
Reckless et al. , 1976). These changes may be mediated by altered
phosphodiesterase activity (Armstrong et al. , 1974). The presence of
normal rather than low plasma non-esterified fatty acid levels is not
readily explained but has previously been reported (Saunders et al. , 1980)
It is possible that despite diminished lipolysis, decreased NEFA uptake
by the hypothyroid liver balances the diminished release.
The hypoketonaemia observed may be secondary to diminished
lipolysis although substrate supply as judged by plasma NEFA
measurements appears adequate. Recent studies have suggested that
intrahepatic fatty acid oxidation and ketone body production may be
thyroid hormone dependent (Keyes fk Heimberg, 1979; Bartels &c Sestoft,
1980).
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Serum insulin levels in hypothyroidism have been reported to
be decreased (Okajima & Ui, 1979; Jolin et al. , 1970; Shah & Cerchio,
1973), normal (Holdsworth & Besser, 1968), or increased (Andreani
et al. 1968; Renauld et al. 1979), with a marked species variation.
Thyroxine is necessary for normal insulin secretion by isolated pancreatic
cells in vitro (Milcu et al. , 1975). In the present study serum insulin
concentrations were similar to control values in the presence of
elevated ambient blood glucose concentrations suggesting insulin
hypo secretion. The mechanism of this is uncertain. Elevated blood
glucose levels with insulin concentrations similar to controls also
suggest insulin resistance in hypothyroidism. Alternatively the insulin
measured by radioimmunoassay may be inactive. The pattern of insulin
secretion has not been examined however in hypothyroidism. Sensitivity
to exogenous insulin at physiological blood glucose concentrations
has previously been reported to be either normal (Iwatsubo et al. , 1967;
Brauman & Corvilain, 1968), or reduced (West et al. , 1975) in
hypothyroid man.
Some of the abnormalities described in hypothyroidism, in
particular the mild elevation in blood glucose and gluconeogenic
precursor concentrations have previously been described in obese
subjects (Doar & Wynn, 1970). The patients outlined in the present
study were within 10% ideal body weight with one exception. Abnormalities
in intermediary metabolite concentrations are not noted in patients
with sach mild obesity (Johnston et al. , 1981). Similarly weight change
with thyroxine therapy was small and could not explain any metabolic
changes noted.
Thyroxine therapy had no effect on circulating blood glucose
concentrations but did cause a significant elevation in the serum
insulin response to meals. This may reflect a permissive effect of
thyroid hormones on pancreatic insulin secretion. Blood lactate and
pyruvate responses to meals were not normalized by thyroxine
therapy and it is difficult to explain the persistent abnormality of
glucose or gluconeogenic precursor concentrations with treatment.
Thyroxine therapy did cause a significant elevation in blood
glycerol concentrations although levels remained lower than those
obtained in control subjects. This change presumably reflects a
thyroid hormone-induced effect on peripheral lipolysis.
Plasma glucagon levels were unaltered in hypothyroidism and no
effect of thyroid hormone therapy was seen. Plasma glucagon response
to protein meals has been shown to be impaired in hyperthyroid subjects
but no previous information on plasma glucagon levels in hypothyroidism
has been published. Growth hormone deficiency has previously been
demonstrated in hypothyroidism (Eisenberg et al. , 1972; Peake et al.
1973) but in the present study growth hormone levels were normal
and were unaffected by thyroid hormone replacement.
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9. GLUCOSE TURNOVER AND RECYCLING : EFFECTS OF
THYROID HORMONES
9.1. INTRODUCTION
In the preceding chapters elevated fasting blood glucose
concentrations were described in hyper thyroid subjects whilst the blood
glucose response to mixed meals was exaggerated. In hypothyrodism,
fasting blood glucose concentrations were normal with mild
hyperglycaemia after breakfast although meal tolerance thereafter
was normal. In addition blood levels of the gluconeogenic precursors
lactate and pyruvate were elevated after meals in both conditions
suggesting the possibility of altered Cori cycle activity whilst fasting
blood glycerol concentrations were increased in hyperthyroidism
and decreased in hypothyroidism. These studies however give no
quantitative information about glucose production and utilisation in
hyper and hypothyroidism. Administration of pharmacological
amounts of thyroid hormones to animals has produced more clear cut
results. Thus increases in glycogenolysis (Coggeshall & Green, 1933)
gluconeogenesis (Svedmyr, 1966) and glucose turnover (Okajima & Ui,
1979) have all been reported. Such experiments have also demonstrated
increased activity of certain substrate cycles, such as those between
glucose and glucose-6-phosphate (Okajima & Ui, 1979) and between
triglycerides and non-esterified fatty acids (Sestoft, 1980). In man
increased glucose turnover has been reported in hyperthyroidism and
3
normal turnover in hypothyroidism using H-3-glucose as tracer
(Saunders et al. 1980), and paradoxically decreased splanchnic glucose
output in hyperthyroidism using catheterisation techniques
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(Wahren et al. 1981), but substrate cycling between glucose and
glucose-derived 3-carbon intermediates has not been examined.
In the present study glucose turnover has been investigated in
fasting hyperthyroid and hypothyroid man before and during treatment
3
using H-3-glucose as tracer to indicate total glucose turnover.
In addition the possibility of cycling of glucose derived 3-carbon
intermediates has been investigated by simultaneous analysis of decay
14
of C-l-glucose specific activity.
9.2. SUBJECTS AND METHODS
Six hyperthyroid subjects, mean + SEM percent ideal body weight
(% IBW) 90 3 before therapy, 99 + 1% IBW after therapy (5 subjects),
were compared with six age-matched normal controls, 95 _+ 2% IBW
(Table 9:1). Hyperthyroidism was caused by Graves' disease in all
subjects, on the basis of clinical features and antibodies to thyroid
tissue components. No subject had a thyroid nodule on Tc99 scanning.
Hyperthyroid subjects were restudied after 5-8 months (Mean 5.9)
of antithyroid therapy (carbimazole 30-40 mg daily from diagnosis,
with L-thyroxine 100-150 pg daily added after 4-6 weeks). Circulating
thyroxine (T ). triiodothyronine (T^) and thyroid stimulating hormone
(TSH) concentrations were normal at the time of reinvestigation.
Seven hypothyroid patients, 121 3% IBW before therapy and
110 + 2% IBW after therapy (six subjects only) were compared with six
normal controls (111 _+ 4% IBW) (Table 9:1)- Hypothyroid subjects
were older than controls although the difference was not significant.
Hypothyroidism was secondary to Hashimoto's thyroiditis in all cases.
TABLE9:1*Characteristicsofhyperndyp thyro dpati ntsbefo edur gt e apyndco t l Sex Age %Idealbody weight Serumthyroxine (nmol/1) Serum triiodothyronine (nmol/l) Serumthyroid/ stimulating hormone(mu/l)Hyperthyroidy rt r iContr l duringtherapy 3MF 46+3 90+3 197+7 6.2+07 1.3+0.63M2F 44+3 99+1 84+• • 2.4+0 3.3+1 5•••4M2F 43+5 95+2 90+8 1.6+02 2.9+0.5Hypothyroid 2M5F 59+3 122+3 24+7 0.8+1 26.0+
***




Control 4M2F 45+6 111+4 104+ 2.0+ 2.9+05
*** •••
p<0.01untreatedpa i ntsvs.ap roprico t ols,
p<.0.01untreatedvstrea dp tients.






































































Patients were re-studied after 6 months therapy with L-thyroxine,
100-200 fa.g daily, when circulating T^, and TSH concentrations
were within the normal range.
No subject was on any medication at the time of initial study
and none had any other known disease nor family history of diabetes.
All subjects consumed in excess of 250 g of carbohydrate daily for
at least 48 h before study.
Protocol
After a 10 h (overnight) fast, indwelling intravenous teflon
cannulae (Venflon, Viggo, Helsinborg) were positioned in both
antecubital veins at 0800 h. Subjects remained recumbent throughout
the test and basal samples for hormones and metabolites were taken
at 0825 and 0830 h. Bolus intravenous injections of 50 pCi (1. 85 mBq)
of [ ^H] -3-glucose and 25 pCi (0. 925 mBq) of [*^C] -1-glucose
(Radiochemical Centre, Amersham, Bucks, U.K.) were given at
0830 h. Blood samples (10 ml) were taken at 1, 2, 3, 4, 5, 6, 8,
10, 12. 5, 15, 20, 30, 40, 50, 60, 75, 90 and 120 minutes after injection
for estimation of glucose specific activity, intermediary metabolites
and hormones.
Chemical Methods
Hormone and metabolite concentrations were measured as
described in 6. 2. and 6. 3. For measurement of radioactivity in
glucose samples were taken into heparinized tubes and the plasma
separated and stored at -20°C until assay. Plasma (0. 5 ml) was
deproteinised using 1 ml 5. 36% (w/v) barium hydroxide and 1 ml 5% (w/v)
zinc sulphate (Somogyi, 1945) and 7, 5 ml distilled water. The
supernatant was passed through a column containing 5 ml ion exchange
resin (AG2-x 8/B, Biorad Lab. , Richmond, California). The column
was washed with 10 ml distilled water and the eluate was freeze-dried,
resuspended in a toluene based scintillant (Cocktail T, Hopkins and
Williams, Chadwell Heath, England) and counted in a scintillation
counter (intertechnique, Middlesex, England) using an external standard
to correct for efficiency and overlapping. Recovery of standards was





Curves for [ H] glucose and [ C] glucose specific activity (SA)
against time were constructed. Values for glucose turnover, mean
residence time, glucose pool and glucose space were calculated
according to Shipley & Clark (1972) by the formulae:




Mean Residence Time (MRT) = (t x glucose SAdt)
J~°glucose SAdt
o
Glucose Pool = Glucose RT x MRT
Glucose Space = Glucose Pool x 100
body wt x glucose concentration
Metabolic clearance rates (MCR) were given by the formula
MCR = Glucose RT
Glucose Concentration
Values for glucose mean residence time, pool size, space and
metabolic clearance rates quoted in the text are those calculated from
1
3
the data given by analysis of [ H] -3-glucose specific activity.
Radioactive glucose "recycling", as defined by Streja et al.
was estimated by the difference between glucose turnover calculated
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by H-3-glucose and that by C-l-glucose (Recycling = RT H - RT C)
/ 3 ,
"Recycling" was also expressed as a percentage of total (RT H) glucose
turnover (% "recycling" = RT^H - RT x 100)
rt3h
Double exponential functions were fitted to the specific activity (SA) -
3 14
time (t) curves for H and C glucose by linear least squares
regression using an iterative program on a mini-computer (Apple II
Europlus, Cupertino, USA). For the number of data points (n = 17)
polyexponential regression provided a better estimate of t than the
trapezoidal rule where SA approximated towards zero. The correlation
of curve fit was 0. 95 (0. 92 - 0. 99).
Fuller consideration of the mathematical concepts are given in
the Introduction (4.4. d). Statistical analyses were performed using
Student's paired and unpaired t-tests as appropriate. Serum insulin
and plasma glucagon levels showed a logarithmic distribution and
statistical analyses were performed on log-transformed data.
Correlations were sought by the least squares method or the Spearman
Rank method as appropriate. Values in the text are given as mean +
standard error of the mean (SEM) or mean and range.
9.3. RESULTS
In both hyperthyroid and hypothyroid subjects serum thyroxine,
ti'iiodothyronine and thyroid stimulating hormone concentrations
returned to normal with treatment (Table 9:1)- Fasting blood glucose
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concentrations and blood concentrations of the gluconeogenic
precursors lactate, pyruvate and alanine were similar in hyper-
and hypothyroid subjects and control subjects and were unaltered by
therapy (Table 9:2). In hyperthyroidism fasting blood glycerol
concentrations were elevated compared with control values (0. 12 +
0. 02 vs 0. 06 + 0. 02 mmol/1, p 2 0. 05) and fell to normal with therapy.
Blood glycerol concentrations were normal in hypothyroidism. Serum
insulin and plasma glucagon concentrations were similar in all groups.
3
Total glucose turnover (RT [ H] ) was increased in hyperthyroidism
(18.2 + 1.0 vs 12. 4 + 0.9 pmol/kg/min, p 2 0.01) and decreased in
hypothyroidism (8.2 + 0.3 vs 11.7 + 1.2 pmol/kg/min, p 2 0. 01)
(Tables 9:3 and 9:4) and returned to normal with treatment. Glucose
turnover rates derived from the [ ] -1 -glucose data (RT[^C]) were
similar in hyperthyroid and control subjects (hyperthyroid, 13.4 + 1. 1
vs control, 11.2 + 0. 9 tJ-mol/kg/min) although a small but significant
decrease was seen after antithyroid therapy (12. 3 + 1. 2 pmol/kg/min,
14
p £ 0. 05). In hypothyroid subjects RT[ C] was decreased (6. 9 + 0. 4
vs 10. 2 + 0. 8 pmol/kg/min, p 2. 0. 01) and increased with thyroxine
therapy (8. 2 + 0. 8 pmol/kg/min).
3 14
The difference between RT[ H] and RT[ C] was increased
four fold in hyperthyroidism (4. 7 + 0. 6 vs 1. 3 + 0. 3 pmol/kg/min,
3
p 2. 0. 001) with a 2. 7 fold increase in the recycling index (RT[ H]-
14
RT[ C] x 100) (Table 9:3). Both returned to normal with therapy.
By contrast, apparent recycling was not significantly altered in
hypothyroidism (Table 9:4). Metabolic clearance rate for glucose was
TABLE9.3Glucoseturnoverates,"recycling','meanresidenceti ,po lspacandmetab liclear ncer t sinhyperthy oidsubj beforeandduringth rapyandicont ols. Subject No. Patient 1 2 3 4 5 6Absolute Glucose Turnover (RT3H) ^imolkg"min BeforeDuring 16.6 18.5 17.7 21.6 14.4 19.911.1 13.5 13.3 18.5 11.9Cderived glucose Turnover (r^o ,i |imolkgmin BeforeDuring 10.8 13.7 12.7 18.4 11.4 13.5rt3h-rt14ca Hmolkg^ minrt3h^.t!4cb rthx100 BeforeDuringf ruring
MeanResidence Time (min) BeforeDuring
10.5 13.4 11.8 16.5 9.4
5.8 4.8 5.0 3.2 3.0 6.4
0.6 0.1 1.5 2.0 2.5




60 83 81 71 79 69




































































































































































































































































































































































































































also increased (3. 5 _+ 0. 3 vs 2.4 + 0.2 ml/kg /min , p <, 0. 05)
and decreased(1.6jf0.1 vs 2.3 + 0.2 ml/kg /min , p^. 0.001) in
hyper- and hypothyroidism respectively. Glucose space was similar
in all groups and was unaffected by treatment. In hyperthyroid
subjects the glucose pool was not significantly different from control
values although a 15% decrease (p < 0. 01) was observed after
antithyroid therapy. Values for the glucose pool were normal in
hypothyroid subjects. Mean residence time was decreased in
hyperthyroid subjects (74 _+ 4 vs 97 + 5 mins, p 0. 01) and increased
in hypothyroid subjects (145 + 14 vs 107 + 7 mins, p <. 0. 05). Normal
values were restored with therapy.
Serum thyroxine and triiodothyronine concentrations did not
correlate within patient or control groups with any parameter of glucose
metabolism assessed. Similarly no correlations were observed for
body weight in the hypothyroid group and their controls where the




Turnover estimates made with the use of [ C]-l-glucose
are lower due to carbon recycling back to glucose at any level in the
glycolytic-gluconeogenic pathway (Streja et al. 1977; Reichard et al,
1963; Nosadini et al. 1982), although the bulk of this is considered to
occur from lactate and pyruvate (Streja et al. 19 63). The difference
between the turnover estimates with these two forms of labelled glucose
is therefore thought to provide an index of the amount of glucose cycled
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to 3-carbon intermediates and back.
Total glucose turnover was increased by 48% in hyperthyroidism
and decreased by 30% in hypothyroid subjects. Similar findings have
been obtained by other workers using isotopic methods in man
(Saunders et al. 1980) and animals (Okajima & Ui, 1979).
Sixty percent of the increase in glucose turnover noted in this study
could be accounted for by the increase in recycling and only 40% by an
increase in glucose metabolism by other routes. In contrast to these
findings a decrease in hepatic glucose production has recently been
observed in hyperthyroid man using catheterisation techniques to obtain
estimates of splanchnic glucose exchange (Wahren et al. 1981). The
reason for these disparate findings is unclear as the hyperthyroid
subjects studied appear similar in age, weight and severity of disease.
In other conditions, both techniques may be expected to produce
similar estimates of glucose production (Radzuik et al. 1978) and there
is no evidence for an increase in renal glucose output in hyperthyroidism.
A possible explanation may reside in the dietary preparation before
study. A carbohydrate intake in excess of 250 g daily for 48 hours
before investigation may have ensured greater glycogen stores in the
patients reported in the present study.
Increased glucose turnover may result from an increase in
either glycogenolysis or gluconeogenesis. After an overnight fast,
hepatic glycogen stores are diminished in hyperthyroidism (Pipher &
Paulsen, 1947) and increased gluconeogenesis is considered the major
factor (Wahren et al. 1981). Rat liver perfusion experiments have
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shown thyroid hormone dependent increases in glucose production
from lactate (Menahan & Weiland, 1969), alanine (Singh & Snyder, 1978)
and glycerol (Sestoft et al. 1977) and the activity of certain gluconeogenic
enzymes (Mennahan & Weiland, 1969; Szepesi & Freedland, 1969)
particularly pyruvate carboxylase ( Bottiger etal_. 1 970), is raised in
the livers of hyperthyroid animals. In the present study, fasting blood
glycerol concentrations were elevated in hyperthyroidism, as found by
other workers (Tibbling, 1969). Glycerol is metabolised largely to
glucose and its uptake is proportional to its concentration in blood
(Bortz et al. 1972). Circulating concentrations of the other
gluconeogenic precursors were normal in the present study but flux
was not measured. Others have, however, reported increased
splanchnic fractional uptake of these substrates in hyperthyroid man
with a return to normal with treatment (Wahren et al. 1981).
Absolute amounts of glucose recycled were increased 3. 6 fold
in hyperthyroidism and percentage recycling also rose (2. 7 fold). This
process is energetically wasteful but represents only a trivial amount of
energy lost: 10. 5 kcal/24 h, assuming ATP equivalent of 7. 5 kcal/mole
and wastage of 4 ATP molecules per molecule of glucose recycled as
the sole energy deficit. However isotopic estimation of recycling may
underestimate total chemical recycling because of interchange between
labelled and unlabelled carbon in substrate pools such as that for
oxaloacetate (Krebs et al. 1966). Furthermore the isotopes used in
the present study will not estimate glucose cycled in "futile" cycles
such as that between glucose and glucose-6-phosphate, activity of which
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may be increased by thyroid hormones (Okajima & Ui, 1979 ). The
mechanisms controlling such "futile" cycles are unclear but are
independent of catecholamine action in thyroid excess in animals
(Okajima & Ui, 1979b).
Increased hepatic glucose production has been attributed to
increased glucagon secretion (Kabadi & Eisenstein, 1980). Circulating
glucagon levels were however normal in the present and one other
study (Wahren et al. 1981). Alternatively increased secretion or
increased sensitivity to catecholamines has been postulated
(Landsberg & Young, 1978). Catecholamine levels were not measured
in the present study but glucose turnover in hyperthyroidism is not
restored to normal by (3-adrenergic blockade (Saunders et al. 1980).
Similarly, alterations in circulating insulin concentrations
can not be implicated being normal in this and other (Sieno et al. 1974),
studies although patterns of insulin secretion were not examined.
However changes in portal insulin and glucagon concentrations cannot
be excluded. It has been suggested that alterations in insulin
sensitivity may occur although the evidence is conflicting with enhanced
(Elrick et al. , 1961; Elgee & Williams, 1955) normal (Ambrosolini et al.
1956) and diminished (Doar et al. 1969; Holdsworth & Besser, 1968)
insulin sensitivity all having been reported in hyperthyroidism.
In the present study peripheral disposal of glucose, assessed
by glucose clearance, was diminished in hypothyroidism and elevated
in hyperthyroidism with both abnormalities reversed by treatment.
However, a major abnormality of insulin action is unlikely in view of
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the normal blood glucose concentrations in both hyperthyroid and
hypothyroid subjects.
Finally, body weight is a determinant of glucose turnover and
glucose turnover may be reduced in the grossly obese (Paul & Bortz,
1969). In the present study, with a smaller range of body weights,
no correlation between weight and glucose turnover was seen within
the control subjects. Patients were matched by weight to separate
control groups and differences in turnover are therefore more likely
to be related to thyroid status.
In conclusion, glucose turnover and recycling were markedly
enhanced in hyperthyroid subjects. The greater proportion of the
increase in turnover was due to the increase in recycling of 3-carbon
intermediates. These abnormalities could not be accounted for by
alterations in glucose space or changes in the two main glucoregulatory
hormones insulin and glucagon. In hypothyroid subjects glucose
turnover representing both production and utilisation were decreased.
In both groups of subjects values returned to normal with treatment.
The precise mechanisms of these changes remains to be elucidated.
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i°. GLUCONEOGENIC CAPACITY FROM GLYCEROL:
EFFECTS OF HYPER AND HYPOTHYROIDISM
10.1. INTRODUCTION
Total glucose production is increased in hyperthyroidism
(Chapter 9) (Saunders et al. 1980; Perez et al. 1980) and decreased
(Chapter 9) or normal (Saunders et al. 1980) in hypothyroid man and
blood glycerol concentrations may be elevated in the former state
(Chapter 7 ) (Tibbling, 1969). The relative contributions glycogenolysis
and gluconeogenesis to these changes in glucose production are not,
however known.
Animal and in vitro studies have suggested that thyroid
hormones may regulate gluconeogenesis from the major gluconeogenic
precursors lactate (Menahan & Weiland, 1969; Weinberg & Utter,
1979; Okajima & Ui, 1979) alanine (Ness et al. 1969) and glycerol
(Sestoft et al. 1977). In the rat, thyroid hormones cause the
induction of 1. glycerophosphate dehydrogenase in liver mitochondria
(Lee et al. 1959); the activity of this enzyme playing a central
role in the regulation of glycerol utilisation by determining the rate
of carbon transfer into gluconeogenesis (Schimassek et al. 1963).
In normal man and animals glycerol is highly gluconeogenic
(Nikkila & Ojala, 1964; Bortz et al. 1972) and is metabolised to
glucose in preference to the other gluconeogenic precursors
(Steele et al. 1971). In fasting man 80-100% of circulating glycerol
is converted to glucose (Bortz et al. 1972; Shaw et al. 1976),
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conversion increasing as blood concentrations rise (Winkler et al. 1970).
The liver is responsible for 70-90% of total glycerol uptake (Larsen, 1963;
Gidez & Karnowsky, 1954; Swick & Nakao, 1954; Schambye et al. 1954)
with the remainder metabolised by the kidneys (Borchgrevink & Havel,
1963; Swanson & Thompson, 1969), small intestine and other tissues
(Saunders & Dawson, 1967; Haessler & Isselbacher, 1963; Din, 1977).
Clearance of glycerol from blood following intravenous glycerol loading
may therefore provide an estimate of the gluconeogenic capacity of
the liver in normal man and in patients with thyroid dysfunction.
(See Chapter 4. 4b for discussion of clearance and tolerance tests).
Glycerol clearance has therefore been examined in patients with
thyrotoxicosis, primary thyroid failure and in normal controls using
a bolus intravenous technique with subsequent analysis of decay of
blood glycerol levels.
1 0. 2. MATERIADS AND METHODS
Seven hyperthyroid (6 female, 1 male) and six hypothyroid
(6 F) were compared with separate groups of matched controls (7 F
and 8 F) (Table 10:1). Hyperthyroidism was due to Graves' disease
in all cases (on the basis of clinical features and the absence of thyroid
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nodules on Tc scanning). Hypothyroidism was due to Hashimotos
thyroiditis in all patients (on the basis of clinical features and the
presence of circulating antibodies to thyroid tissue). No subject had
any evidence of hepatic or renal impairment and none was taking any
drug prior to the study.
Studies were performed on recumbent subjects after an
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overnight (10 h) fast. Subjects had abstained from alcohol for at least
48 h and had a daily carbohydrate intake in excess of 250 g for this
period. Bilateral indwelling intravenous cannulae (Venflon, Viggo
Helsinborg) were inserted using 1% lignocaine as local anaesthetic.
Cannula patency was maintained by flushing with 0. 154 mol/1 saline
after every sample.
Basal samples for hormones and metabolites were withdrawn
25 and 30 minutes after cannulation and assayed as in 6. 2. and 6. 3. .
An intravenous bolus injection of glycerol (0.1 mmol/kg body weight)
diluted with water to isotonicity was then administered over 15 seconds
and further blood samples were taken 1, 2, 3, 4, 5, 6, 8, 10, 12.5,
15, 20, 30, 40, 50 and 60 minutes after injection.
Results are expressed as mean + standard error of the mean
(SEM). Statistical analysis was performed using Student's unpaired
t-test. Correlations were sought by the least squares method.
3-Hydroxybutyrate concentrations were log normally distributed and
statistical analyses were performed on log transformed data.
Mathematical Analysis
The decay of blood glycerol following bolus intravenous injection
was closely approximated by a double exponential function of the form
*"■ 1c t — £
A 1 + B 2 where A, B, k ,and k„ are constants. Curve fitting
e e J- 2
was performed by computer to the points of the blood glycerol decay
curve, after subtraction of basal glycerol concentrations. The area
under the curve was calculated using a polyexponential equation.
Metabolic clearance is equal to the dose of glycerol injected divided
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by the area under the glycerol decay curve
M.C.R. (1/min) = mmol injected
mmol/l/min
Endogenous glycerol production (E. P. R. ) is equal to the product of
metabolic clearance and basal glycerol concentration
EPR (mmol/min) = MCR x Basal [glycerol]
It is assumed in these calculations that the endogenous production rate
of glycerol remains constant throughout the experimental period.
Volume of distribution of glycerol was calculated using the intercepts
and exponents for the a and p phases of the glycerol decay curve
(Gibaldi, 1969).
10.3. RESULTS
Serum thyroxine and triiodothyronine concentrations were
increased in hyperthyroid and decreased in hypothyroid patients when
compared to controls (Table 10; 1.). Serum thyroid stimulating
hormone concentrations were increased in hypothyroidism.
Peak blood glycerol concentrations following glycerol injection
ranged between 0. 35 and 1 . 20 mmol/1 and were not significantly
different in any group. Glycerol injection had no effect on any of the
other metabolite concentrations measured in any group nor on peripheral
insulin levels.
Hyperthyroid Subjects
Fasting blood glucose (5. 4 + 0. Z vs 4. 6 + 0. 1 mmol/1, p <. 0. 01)
(Table 10:2) and blood glycerol (0.12+0.01 vs 0.07 + 0.01 mmol/1,
p iC 0. 01) (Table 10:3) concentrations were increased in hyperthyroid
subjects but basal circulating lactate, pyruvate, alanine,
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TABLE 10:1. Clinical details of hyperthyroid, hypothyroid and































*** p <. 0. 001 versus appropriate controls.
** p c. 0. 01 versus appropriate controls.
TABLE10:2.Fastinghormonendetaboliteco centrations(m+SEM)ihyp rthyroid, hypothyroidandcontrolsubjects.F3-hydr xybutyratemean(ra g )isgiven. SubjectsBloodl GlucoseLactatPyruvate (mmol/l)( l/l) Hyperthyroid5.4HH0.2094^1 .159+ . Control4.6+0.1088+0.67 .1 Hypothyroid5.lJ^O.41.10 07■.+ . Control4.9+0.20.99150.08+0.04 **pC0.1hyperthyroidsubjectsvscontrol .Bloodl dSerum Alanine3-hydroxybutyrateIns lin (mmol/l)(mmol/l)mu/1 0.28+0.02. 8( .03- .18)71 0 0.30+0.04. 8( 03-0.18)8.1 5 0.31+0.02. 4( 01- .14)9.8 0.34+0.04.05(0 005- .14)8.1 3
TABLE10:3.Glycerolkineticdataihyperthyr idndcontrolsubje ts SubjectBasalblood glycerol (mmol/l)MetabolicVolume clearanceof ratedist ibution (ml/kg/min)l g)
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Controls(n=8) Mean0.0825.00.521 107692. 7 S.E.M.0.011.8917.01022.60 1 pNS60.12.0.054.0.01<-0.04 .01 NS,p>0.5.Half disappearance timefor1st component (min)
Half disappearance timefor2nd component (min)



























- FIGURE 10:1. Change in blood glycerol concentration from basal
levels following bolus intravenous glycerol
(0.1 mmol/kg) administration in
a) hyperthyroid (■ ) and control (O ) and
b) hypothyroid ( • ) and control ( O ) subjects.
Blood glycerol is shown on a logarithmic scale.
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3-hydroxybutyrate and insulin levels were similar to controls (Table 10:2).
The double exponential decay curve for injected glycerol is
clearly demonstrated in Figure 10:1 (r = 0. 98 + 0. 003). Values for
the second exponential constant (k^) were increased in hyperthyroidism
(0. 14 _+ 0. 02 vs 0. 07 _+ 0. 01, p 2. 0. 05) and as a result the second
component half time was shorter (5. 9 + 1 • 0 vs 11.9 + 0.3 mins,
p 2 0. 05). Glycerol clearance rate was also increased in hyperthyroidism
(48. 7 + 5. 7 vs 27. 2 _+ 2. 6 ml/kg/min, p 2. 0. 005) as was endogenous
glycerol production (5. 7 + 0. 8 vs 2. 1 + 0. 3 pmol/kg/min, p < 0. 01)
(Table 10:3).
Hypothyroid Subjects
In hypothyroidism, fasting circulating concentrations of glucose,
lactate, pyruvate, alanine, glycerol, 3 hydroxybutyrate and insulin
were similar to control values (Table 10:2). Both the first (p 2. 0. 05)
and second component (p .2.0. 01) half times were significantly
prolonged in hypothyroidism (Table 10:4). Glycerol clearance rate
was decreased (hypothyroid 17.1 +0.7 vs control 25. 0 + 1.8 ml/kg/min,
p < 0. 01) and endogenous glycerol production rate was diminished
(1.1 _+ 0. 2 vs 2.1 _+ 0. 2 pmol/ kg/min, p < 0. 01) in hypothyroid patients.
Correlations
Correlations between glycerol kinetic data, metabolic status and
thyroid hormone levels did not reach significance in either patient
or control groups.
10.4. DISCUSSION
These studies show that in man hyperthyroidism is associated
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with enhanced glycerol clearance after bolus injection of glycerol
which is strongly suggestive of increased gluconeogenic capacity.
No estimate of basal gluconeogenesis is possible from our data but
a 270% increase in endogenous production with only a 70% increase in
fasting levels implies enhanced basal glycerol clearance and hence,
perhaps, increased gluconeogenesis. Converse changes were noted
in hypothyroid subjects.
Fasting blood glucose concentrations were increased in
hyperthyroidism in this, as in other (Chapter 7, Ikejiri
et al. 1978) studies whilst lactate pyruvate and alanine concentrations
were normal. Alone amongst the gluconeogenic precursors,
glycerol levels were increased presumably secondary to enhanced
lipolysis (Chapter 7, Chapter 9,, Tibbling, 1969; Brodie et al. 1966;
Rich et al. 1959). In hypothyroidism blood glucose, lactate, pyruvate
and glycerol levels were normal, as has previously been reported
(Chapter 8, Chapter 9).
Hepatic glucose production measured isotopically has been
shown to be increased in hyperthyroidism (Chapter 9) (Saunders et al.
1980; Perez et al. 1980) and diminished (Chapter 9) or normal
(Saunders et al. 1980) in hypothyroidism. Such data does not
distinguish between glycogenolysis and gluconeogenesis nor does it
give information about the capacity of those two processes. In
fasting man, glycerol taken up by the liver enters the gluconeogenic
pathway (Fig. 10:2) and thus clearance of an intravenous glycerol load
provides an estimate of gluconeogenic capacity. Previous studies of
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gluconeogenesis in patients with thyroid disease are few. In
hyperthyroidism, splanchnic balance studies suggest that hepatic
uptake of all the major gluconeogenic precursors is increased
(Wahren et al. 1981). For lactate, pyruvate and alanine this is
achieved by an increase in fractional extraction whilst for glycerol
increased arterial concentrations combined with a 20% increase in
hepatic blood flow are responsible. Apart from a single study in
congenital hypothyroidism (Hayek, 1979) showing normal
gluconeogenesis from alanine, there have been no estimates of
gluconeogenesis in hypothyroid man.
The metabolic clearance rate for glycerol is the best index
of glycerol disappearance in the kind of study used here as its
r~
measurement (amount of glycerol administered divided by j delta
o
blood glycerol) is independant of any descriptive compartmental
model and its estimate is valid even if glycerol elimination occurs
outside the sampling compartment (Wilkinson & Shand, 1971). The
amount of glycerol used in this study was chosen to give peak blood
glycerol values between 0. 4 and 1. 5 mmol/1. This avoided the very
high blood glycerol levels which have been reported to cause renal
damage in man and animals (Hagnevick et al. 1974; Anderson et al.
1950). Much higher doses than those used in this study have been
used therapeutically in man without adverse effects (Senior &
Loridan, 1968).
Glycerol clearance rate was increased by 80% in hyperthyroidism
and decreased by 30% in hypothyroidism. The mechanism(s)
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underlying these changes are uncertain. Glycerol taken up by the
liver (Fig. 10:2) is first phosphorylated by glycerol kinase and enters
the gluconeogenic pathway after oxidation by glycerol kinase and
enters the gluconeogenic pathway after oxidation by glycerol-3-
phosphate dehydrogenase (G3PD). Glycerol kinase is subject to
feedback inhibition by glycerol 3 phosphate (Robinson & Newsholme,
1969; Sestoft & Fleron, 1975). In the rat, the activity of mitochondrial
G3PD is thyroid hormone dependent (Hoch, 1974) and has long been
considered an intracellular marker of thyroid hormone action.
Alteration of mitochondrial G3PD activity in our subjects is thus a
possible explanation of the observed changes in glycerol metabolic
clearance rates. However, Nolte et al. (1972) in an as yet
unconfirmed study, failed to demonstrate any increase in
mitochondrial G3PD activity in thyrotoxic man.
Altered hepatic blood flow may also contribute to the findings.
A 20% increase in hepatic blood has previously been directly
demonstrated in hyperthyroid patients (Wahren et al. 1981).
Circulating (albeit venous) glycerol concentrations of glycerol were
increased by 70% in our thyrotoxic subjects. Assuming a similar
20% increase in hepatic blood flow, this would provide a 100%
increase in hepatic glycerol delivery in hyperthyroidism. Fractional
glycerol extraction need not therefore be increased to account for
increased glycerol clearance rates of 80%. This is compatible with
the data of Tibbling (1969) who demonstrated that fractional glycerol
turnover was not significantly increased in thyrotoxic humans.









FIGURE 10:2. Gluconeogenesis from glycerol in the liver
Similarly, in hypothyroidism cardiac output, stroke volume
(Graetinger et al. 1958) and flow through many organs is diminished
(Scott et al. 1962; Stewart & Evans, 1942; Zondek, 1967) and may
contribute to the decreased glycerol clearance rates reported here.
In keeping with the changes in glycerol clearance rates, the
fractional rate constants (k^ and k^) were approximately doubled in
hyperthyroidism and halved in hypothyroidism with appropriate
reciprocal changes in the calculated first and second half
disappearance times. These changes may result from either
haemodynamic factors, primary changes in hepatic glycerol uptake
or a combination of these two factors.
Calculated endogenous glycerol production rates for normal
subjects (2. 1 pmol/kg/min) were similar to those quoted in other
studies using different methods (2. 2 pmol/kg/min; Johnston et al.
(In press), 1. 6 pmol/kg/min; Bortz et al. (1972) ). Endogenous
production rates were increased 3 fold in hyperthyroidism and
decreased by 50% in hypothyroidism. These results are entirely
consistent with previous studies showing lipolysis to be increased
in hyperthyroidism (Chapter 7, Chapter 9, Brodie et al. 1966;
Rich et al. 1959) and decreased in hypothyroidism (Hamburger et al.
1963; Goodman & Bray, 1966).
Volumes of distribution for glycerol, although variable, were
not significantly different in any group suggesting that the changes in
glycerol elimination were not secondary to altered distribution space.
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Given the findings described above, it is perhaps a little
surprising that blood glucose concentrations did not rise following
glycerol administration. No definite reasons can be given for this
although several factors may have been important. Firstly glycerol
normally contributes less than 10% of total glucose output in overnight
fasting man thus any changes in blood glucose concentrations may have
been small. Secondly, small changes in arterial blood glucose
concentrations may not have been reflected in venous sampling and
thirdly, although peripheral insulin concentrations were not increased
after glycerol administration, changes in portal insulin concentrations
cannot be ruled out and may have suppressed hepatic glucose output.
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11. INSULIN SENSITIVITY IN HYPERTHYROIDISM
i
11.1. INTRODUCTION
The blood glucose concentration of hyperthyroid man has been
reported to be elevated following the ingestion of glucose (Holdsworth &
Besser, 1968; Kreines et al. 1965) and mixed meals (Chapter 7)
in most, but not all (Macho, 1936; Gorowski & Wolanska, 1957) studies.
The cause of this hyperglycaemia remains uncertain. Insulin
sensitivity in hyperthyroidism has been assessed as normal
(Ambrosolini et al. 1956), diminished (Doar et al. 1969; Holdsworth
& Besser, 1968) or enhanced Elgee & Williams, 1955; Maracek &
Feldman 1973; Elrick et al. 1961). This probably reflects the variety
of techniques used to measure insulin sensitivity as well as species
differences between man (Holdsworth & Besser, 1968; Kreines et al.
1965; Chapter 7) rat (Ambrosolini et al. 1956; Elgee & Williams, 1955)
and rabbit (Maracek & Feldman, 1973). Where glucose tolerance is
impaired, the finding of normal (Holdsworth & Besser, 1968, Chapter 7)
or elevated (Doar et al. 1969) peripheral insulin levels has been taken
to indicate insulin resistance, even where the pattern of insulin secretion
has not been examined. Measurement of the rate of fall or nadir of
blood glucose concentrations after injection of exogenous insulin in man
has produced contradictory results, sometimes suggesting enhanced
(Elrick et al. 1961) and sometimes decreased (West et al. 1975)
sensitivity to insulin. Such studies are however complicated by the
counter-regulatory response to hypoglycaemia which is very variable
in both time and degree.
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The euglycaemic clamp technique allows assessment of
insulin sensitivity in the absence of stimulated counter regulatory
hormone secretion (Alberti et al. 1979; De Fronzo et al. 1979; Home
et al. 1982). The purpose of this study was to investigate with the aid
of a blood glucose controlled glucose infusion system (Biostator, Miles)
insulin sensitivity in matched normal and hyperthyroid subjects.
Insulin sensitivity is defined as the rate of glucose infusion required
to maintain the blood glucose level in the face of a constant infusion of
insulin. The response of intermediary metabolites to the insulin
infusion has also been examined to give a broader assessment of
insulin action.
11.2. MATERIALS AND METHODS
Subjects
Six female patients with hyperthyroidism due to Graves Disease
(diffusely enlarged hyperaemic thyroid glands with no nodules on
Technicium scanning) were compared with a matched group of seven
healthy female controls (Table 11:1). Patients and controls were all
within 10% of ideal body weight, and their ages ranged from 22 to 36 years.
They were asked to maintain their normal diet for three days before
the study and to fast from midnight on the evening beforehand.
No subject was taking oral contraceptive pills or any other drug
and none was known to be suffering from any disease other than
thyrotoxicosis.
Protocol
On the morning of the study, three PTFE cannulae (Venflon, Viggo,








Helsinborg) were inserted i. v. into each subject. One cannula, in
an antecubital fossa, was used for intermittant blood sampling for
hormones and metabolites and was flushed with 0. 15 mol/1 saline
after use. A second cannula, inserted retrogradely and more distally
on the same arm was used for continuous sampling of arterialised
blood by the biostator. Arterialisation of venous blood was achieved
using a heated hand warming system (Abumrad et al. 1981). The third
cannula, on the contralateral arm, was used for all infusions. A
period of one hour was allowed for equilibration following cannulation,
calibration of the machine and to achieve stability of the glucose
sensor response.
At the end of calibration (time 0 minutes) highly purified
porcine insulin (Actrapid, Novo) was infused i. v. at a rate of
0. 05 u/kg body weight. The biostator constants and clamping
technique were as described by Home et al. (1982). Blood glucose
was clamped 0. 28 mmol/1 (5 mg/dl) below fasting levels to avoid
stimulation of endogenous insulin during oscillation around the
intended clamp value. The insulin infusion continued for 120 minutes
and blood samples were taken at -30, 0 and every 15 minutes thereafter
for 2 hours. Blood for glucose, lactate, pyruvate, alanine, glycerol
and 3-hydroxybutyrate was assayed as described in 6.2 (Lloyd et al.
1978). Serum insulin was measured by double antibody
radioimmunoassay (Soeldner & Slone, 1965) (sensitivity 2 mU/1 :
intraassay coefficient of variation (CV) 7%) using human insulin as
standard. C-peptide was measured by radioimmunoassay with ethanol
precipitation (Heding, 1975) (sensitivity 0. 02 nmol/1, within assay
CV 3%). Serum triiodothyronine (T^) and serum thyroxine (T^) were
measured by radioimmunoassay.
Statistics
Results were analysed by standard parametric methods and
expressed as mean + standard error unless otherwise indicated. Blood
3-hydroxybutyrate concentrations were log normally distributed and
statistical analysis was performed on log transformed data. Students
independant t-test was employed to detect differences between groups.
Insulin sensitivity was calculated as the amount of glucose infused to
maintain euglycaemia in the second hour of insulin infusion (60-120 mm/
when the glucose infusion rate was relatively constant.
11.3. RESULTS
Serum thyroxine (hyperthyroid 276 + 33 vs control 107 _+
4 nmol/1, p 0. 001) and triiodothyronine (8. 5 _+ 1. 6 vs 2. 0 _+ 0. 1
nmol/1, p /L 0. 001) were increased in hyperthyroid subjects (Table 11:1]
Basal values for blood glucose, lactate, pyruvate and alanine
were similar in the two groups (Table 11:2), but glood glycerol
(hyperthyroid 0. 11 + 0. 02 vs control 0. 06 + 0. 01 mmol/1, p 2. 0. 01)
and blood 3-hydroxybutyrate (0. 28 [ 0. 03 - 0. 79 ] vs 0. 09 [ 0. 01 - 0. 29]
mmol/1 (mean and range), p 4 0. 05) were increased in hyperthyroidism
Basal serum insulin (hyperthyroid 7 + 1 vs control 6 _+ 2 mu/1 and
C-peptide (0. 32 + 0. 06 vs 0. 33 + 0. 03 nmol/1) were however identical.
During insulin infusion, plateau serum insulin values were similar in
the two groups (hyperthyroid 44+2 vs control 44 + 1 mU/l) (Fig. 11:1).
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FIGURE 11.1. Glucose delivery to maintain blood glucose levels,
blood glucose, serum insulin and C-peptide
concentrations (mean _+ SEM) during infusion of
highly purified porcine insulin (0-120 min) in
hyperthyroid ( • ) and control ( O ) subjects.
Values for glucose delivery are expressed as
mmol/kg/min and are shown as the mean of each


















FIGURE 11:2. Blood lactate, glycerol and 3-hydroxybutyrate
concentrations during insulin infusion with
maintainance of blood glucose by feedback
glucose infusion. For lactate and glycerol mean





A 0. 05 hyperthyroid vs control
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No significant difference was seen in the glucose required to maintain
the clamp value at any time.
Blood lactate levels rose to the same extent in both groups
(Fig. 11:2, Table 11:2) and blood pyruvate followed a similar pattern.
Blood alanine levels were unchanged in both groups during insulin
infusion. Blood glycerol concentrations fell in both groups (Fig. 11:2,
Table 11:2) although levels in the hyperthyroid patients remained
significantly higher than in the controls. Blood 3-hydroxybutyrate
levels decreased to similar values in both groups (Fig. 11:2, Table 11:2).
11.4. DISCUSSION
Glucose clamp techniques allow assessment of insulin activity
on glucose metabolism without the interference of countersegulatory
responses to hypoglycaemia (De Fronzo et al. 1979; Olefsky &
Kolterman 1981). As glucose production will be totally suppressed by
the insulin infusion, glucose turnover is equal to the glucose delivered
to maintain euglycaemia, which is thus a measure of peripheral
insulin activity. For ethical reasons repeated studies to obtain dose
response curves were not performed, but the single dose chosen
(0. 05 u/kg/h) lies on the straight part of the curve in normal subjects
(Massi-Benedetti et al. 1981). This infusion rate also gives circulating
insulin levels comparable to those seen during glucose tolerance tests
(Sestoft & Heding, 1981) and after normal meals (Chapter 7). The
highly purified porcine insulin used in this study is known to be identical
in activity to human insulin when assessed using the same technique
(Home et al. 1982).
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In the current study, fasting blood glucose, serum insulin and
C-peptide levels were identical in matched hyperthyroid and euthyroid
women. No suggestion could be found of any difference in the rate of
change or absolute level of glucose turnover during peripheral insulin
infusion. Explanations for the glucose intolerance reported by
previous studies must therefore be sought elsewhere.
The published evidence for a disturbance of insulin secretion
in human and experimental hyperthyroidism is contradictory with
enhanced (Doar et al. 1 969; Yallow & Berson, I960) diminished
(Daweke et al. 1965; Andreani et al. 1970) or normal (Hales & Hyams,
1964) all being reported. Secretion of biologically inactive insulin in
hyperthyroid patients may also be important. As described in 7. 4.
Sestoft & Heding (1981) have recently demonstrated that hyperthyroid
patients secrete a higher proportion of proinsulin to insulin.
Although proinsulin cross reacts in the standard insulin radioimmunoassay,
it has only 5% of the biological activity of insulin (Sonksen et al. 1973)
and hence could cause apparant insulin resistance. Enhanced
degradation of insulin has been reported in some (Elgee Williams,
1955; Maracek & Feldman, 1973) but not all (Wajchenberg et al. 1978)
studies, but it is clear from the present study that metabolic clearance
rates are unchanged. Increased clearance of insulin cannot in any
case explain glucose intolerance as both the action and degradation of
insulin are effected via its receptors (Terris &; Steiner, 1975).
Basal circulating lactate and pyruvate levels were also
similar and rose to the same extent during insulin infusion in patients
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and controls. These increases presumably reflect a combination of
insulin induced inhibition of hepatic gluconeogenesis and increased
hepatic and peripheral glycolysis. Blood alanine concentrations
were unchanged by insulin infusion in both groups reflecting a balance
of the hepatic and peripheral effects of insulin. 3-Hydroxybutyrate
levels were, however, increased in hyperthyroid subjects but
suppressed rapidly to control values during insulin infusion. Fasting
hyperketonaemia has previously been reported in these patients
(Beylot et al. 1980; Bartels et al. 1979) and ketone body levels are
known to fall to normal values after mixed meals (Chapter 7) as a
result of suppression of lipolysis and ketogenesis. Fasting blood
glycerol levels were increased in the hyperthyroid patients but, in
contrast to ketone bodies did not suppress to normal values during
insulin infusion, perhaps suggesting incomplete suppression of
lipolysis. This is consistent with recent studies using adipocytes from
hyperthyroid patients which demonstrated impairment of the normal
insulin mediated suppression of glycerol release (Wennlund et al. 1981).
In accord with this it has already been shown that blood glycerol levels
fail to return to normal after mixed meals (Chapter 7).
In summary insulin sensitivity in terms of overall glucose
metabolism is normal in hyperthyroidism. Lipolysis is however
enhanced at normal fasting insulin levels, and may not be totally
suppressed by insulin levels which in normal man profoundly
suppresses lipolysis.
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12. KETONE BODY KINETICS IN HYPER AND HYPOTHYROIDISM
12.1. INTRODUC TION
Ketone body concentrations in blood are known to rise more
rapidly during fasting in hyperthyroid man than in normal subjects
(Chapter 7, Beylot et al. 1980; Bartels et al. 1979) whilst in
hypothyroidism ketone body concentrations show prolonged suppression
following mixed meals (Chapter 8). Thyroid hormones may influence
ketone body production in the liver either by their effects on
peripheral lipolysis thereby altering NEFA release or by effects on
intrahepatic NEFA metabolism. Both lipolysis (Goodman & Bray, 19 66;
Wennlund et al. 1981; Rich et al. 1959) and NEFA turnover (Saunders
et al. 1980) are increased in hyperthyroidism. In hypothyroidism
lipolysis may be diminished (Chapter 8, Arner et al. 1976; Hamburger
et al. 1963) but NEFA turnover is purportedly normal (Saunders et al.
1980).
The effects of thyroid hormone excess and deficiency on ketone
body production and utilisation in vivo are unknown although experiments
using isolated perfused rat liver systems have suggested that hepatic
ketone body production from fixed NEFA concentrations in the
perfusate varies with thyroid status. Isotope dilution studies using
both 3-hydroxybutyrate and acetoacetate as tracers have therefore been
performed in patients with hyper- and hypothyroidism before and
during therapy and in normal subjects.
158.
12.2. PATIENTS AND METHODS
Five patients (4F, 1M) with hyperthyroidism were compared
with 6 (3M, 3F) age and weight matched controls (Table 12:1).
Hyperthyroidism was due to Graves' disease (on the basis of clinical
9 9m
features and the absence of thyroid nodules on Tc thyroid
scanning) in all patients. Six (4F, 2M) patients with Hashimotos
thyroiditis (on the basis of spontaneous hypothyroidism in subjects
with circulating antibodies to thyroid tissue) were also compared with
a separate group of appropriate controls (3M, 3F; Table 12:1). Three
subjects with hyperthyroidism were restudied after 6 months,
treatment with carbimazole (30-45 mg) and thyroxine (100-150 pgm
daily) to maintain normal circulating thyroid hormone and thyroid
stimulating hormone levels. Four subjects with hypothyroidism were
restudied after 6 months therapy with thyroxine, 100-150 pgm daily.
All patients were clinically euthyroid by the time of their second
study.
All studies were performed on overnight (10 h) fasted subjects.
Teflon cannulae (Venflon Viggo Helsinborg) were inserted intravenously
using 1% lignocaine as an anaesthetic. One cannulae was inserted into
an antecubital vein for injection of tracer. A second cannula was
inserted retrogradely into a dorsal hand vein and the hand was placed
in a warming chamber at 60°C (Keller et al. 1981; Abumrad et al. 1981)
to obtain arterialized blood. Arterialised blood was sampled at -15
and 0 minutes before bolus intravenous administration of 50pCi of
14 14
either 3-[ C] -acetoacetate or 3[ C]-hydroxybutyrate in random order
on separate occasions. Subsequent samples were withdrawn at 1, 2,3,4,
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5, 6, 8, 10, 12. 5, 15, 20, 30, 40, 50, 60, 75, 90 and 1 20 mins after tracer
administration. 1 The sampling cannula was flushed with 0. 1 54M saline
between each sample. Subjects remained recumbant during the study
and for at least one hour before.
Preparation of tracer infusate
14
Ethyl 3-[ C] acetoacetate (250 H-Ci, specific activity 8.9 mCi/
mmol, Radiochemical Centre, Amersham, U.K.) was hydrolysed to
14
sodium 3-[ C] -acetoacetate in the presence of freshly redistilled
carrier ethylacetoacetate. Hydrolysis was performed as described
by Nosadini et al. (1980). Radioactive and carrier ethyl acetoacetate
were incubated with 0. 5 ml. 2M NaOH at 45°C for lh. After
neutralisation with 0. 5 M HC1 and addition of 5 ml distilled sterile
the solution was washed six times with 15 ml diethyl ether to remove
any impurities and unsaponified ethylacetoacetate then blown with a
stream of nitrogen for 45 mins to remove any radioactive acetone.
14
Radiochemical purity of sodium 3-[ C]-acetoacetate was ascertained
using the method of Mayes and Felts (1967) by boiling in 4N HC1 and
subsequent blowing with a stream of nitrogen. Any radioactivity left
following this treatment is taken to be impurity. The radioactive purity
14
of sodium 3- C acetoacetate was determined in each experiment and
14
was between 90-96%. 250 pCi of 3-[ C] -hydroxybutyrate (specific
activity 56 mCi/mmol, Radiochemical Centre, Amersham, U.K.)
were diluted with 10 ml distilled sterile saline. Both tracer solutions
were sterilised by filtration stored at -20° C in 50 pCi aliquots in
sterile ampoules, and used within 14 days.
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Analytical Procedures (Fig. 12:1)
Blood for both radioactive and cold acetoacetate and
3-hydroxybutyrate determinations were taken into chilled 20%
perchloric acid and kept on crushed ice until assayed. Samples were
then neutralised with 20% and 5% (w/v) KOH. The radioactive
concentrations of acetoacetate and 3-hydroxybutyrate were determined
as described previously (Nosadini et al. 1982; Bates, 1972)
(Fig. 12:1). Duplicate 2 ml aliquots of neutralised supernatant were
boiled for 45 min. in 1 2 ml of mercuric sulphate/sulphuric acid
solution (6 ml 10% w/v) HgSO in 4NH SO , 3 ml 50% (w/v) H SO ,
t: L, rt L, rr
3 ml distilled H O) containing 3 0 pmol carrier lithium acetoacetate
L*
(Sigma Chemical Company). The resulting precipitate (Denige ppt. )
was washed twice with distilled water, dissolved in 0. 5 ml 4N HC1,
suspended in 1 0 ml liquid scintillation fluid (Cocktail T, Hopkins
and Williams) and counted in a liquid scintillation counter
(Intertechnique, Middlesex, England). Efficiency of liquid scintillation
14
counting was determined using C-toluene as an external standard
and each sample count was corrected for quenching. This procedure
gave the counts associated with acetoacetate. Parallel 2 ml aliquots
of neutralised supernatant were incubated for 1 h. at room temperature
in 1 ml 1. 5 M tris buffer containing 10 pmol carrier 3-hydroxybutyrate
(Boehringer Corp. Ltd. ), 30 pmol NAD (Boehringer Corp. Ltd. ) and
37 pi 3-hydroxybutyrate dehydrogenase (specific activity 3 ku/gm;
prepared from Rhodopseudomonas spheroides, Boehringer Corp. Ltd.).
Subsequent boiling in mercuric sulphate/sulphuric acid mixture
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FIGURE 12:1. Pathway for determination of radioactive and
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Counts associated with 3-hydroxybutyrate = (b) - (a)
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and liquid scintillation counting (see above) yielded the counts
associated with 3-hydroxybutyrate plus acetoacetate. The counts
associated with 3-hydroxybutyrate could thus be calculated by
14
subtraction. Neither C-acetone nor acetone were measured.
14
Recoveries of C-acetoacetate were 87 4% when corrected for
14
radiochemical purity and 83 + 6% for C-hydroxybutyrate.
The specific activity of acetoacetate and 3-hydroxybutyrate
in urine was measured in the same manner as in blood. All analyses
were performed in duplicate within 8 h of sample collection.
Concentrations of acetoacetate and 3-hydroxybutyrate were
also determined in the neutralised supernatant by manual methods.
For acetoacetate 0. 5 ml of neutral supernatant was incubated for
60 minutes with 1. 0 ml of "cocktail" containing 0. 1 M phosphate buffer
(pH 7. 0) and 0. 36 mg NADH together with 0. 5 ml deionised water and
10 pi of 3-hydroxybutyrate dehydrogenase. The change in optical
density was measured at 340 nm using a Zeiss spectrophotometer.
For 3-hydroxybutyrate 0. 5 ml of neutral supernatant was incubated
for 60 minutes with 1 ml 0. 1 M tris buffer (pH 8. 5) containing EDTA
1. 25 g/1, 0. 5 ml deionised water, 3 mg NAD and 10 pi 3-hydroxybutyrate
dehydrogenase. The change in optical density was measured at 340 nm.
Hormone and metabolite concentrations were assayed as described
in 6:2 and 6:3.
Mathematical Analysis
1
Ketone body turnover was calculated for each experiment
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assuming steady state blood ketone body concentrations using the
sum of ketone body specific activities (SA) (Keller et al. , 1981;
Bates, 1972; Reichard et al. 1974; Ballasse, 1979; Bates et al. 1968).
_ . dpm in Acac + dpm in BOHKetone body SA = [Acac] + [BOH]
(For a review of this method see Introduction 4:4d).
The decay in ketone body specific activity approximated
closely to a double exponential function (r = 0.96). The area under
the ketone body SA decay curve was calculated using polyexponential
regression on a mini (Apple II) computer. Kinetic parameters
were calculated for each tracer using the formulae:
Ketone body turnover - Dose of radioactivity administered
(KBRT)([imol / kg/min ) y*TKSA dt
O
C
Mean residence time = 0 J (t x TKSA) dt
(MRT) (min ) fTKSA dt
o
Ketone Body Pool Size = MRT x RT
(pmoles)
Volume of distribution = Pool Size x 100
of ketone bodies (V. D. ) Body wt x [TK]
(% body wt)
according to Shipley & Clark (1972).
Statistical Analysis
Comparisons between groups were sought using Student's
paired and unpaired t-tests as appropriate. Certain measurements
(insulin, glucagon) were log normally distributed and statistical
analysis was performed on log transformed data. Correlations
were sought using the least squares method or the Spearman
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Ranking method as appropriate. Values in the text are given as
mean + standard error of the mean (SEM) or mean (range).
12.3. RESULTS
Thyroid Hormone Concentrations (Table 12:1)
Serum thyroxine and triiodothyronine concentrations were,
as expected, increased in hyperthyroid subjects (T^ 249 + 28 vs.
86 _+ 5 nmol/1, p 21 0. 001) and decreased in hypothyroidism
(T^ 17 + 3 vs. 91 +; 5 nmol/1, p 2 0. 001). Serum thyroid stimulating
hormone (TSH) concentrations were elevated in hypothyroid patients
(41.3 + 3.1 vs. 1. 6 _+ 0. 3 mU/1, p 2 0, 001). Normal circulating
thyroid hormone and thyroid stimulating hormone concentrations
were restored in those patients restudied during therapy (Table 12:1).
Hormone and Metabolite Concentrations (Table 12:2)
Basal hormone and metabolite concentrations are expressed
as the mean of the values obtained from the two experiments. Blood
glucose, lactate, pyruvate and alanine concentrations were similar
in all groups. Blood 3-hydroxybutyrate (0. 1 3 0. 04 vs. 0. 05 _+
0. 003 mmol/1, p X 0. 05) and blood acetoacetate levels (0. 11 _+ 0. 03
vs. 0. 04 _+ 0. 01 mmol/1, p X 0. 05) were increased in hyperthyroid
patients as were blood glycerol (0. 09 _+ 0. 005 vs. 0. 05 Hb 0. 01 mmol/1,
p ^0. 01) and plasma NEFA concentrations (0. 8 6 _+ 0. 07 vs. 0. 59 +;
0.05 mmol/1, p <0.01). Blood glycerol, acetoacetate,
3-hydroxybutyrate and plasma NEFA levels were similar in hypothyroid
patients and controls whilst serum insulin and plasma glucagon levels
were similar in all groups.
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Kinetic Data
Hyperthyroidism : Acetoacetate tracer (Tables 12:3, 12:4)
Total ketone body (KB) concentrations were increased in
hyperthyroidism (0. 24 + 0. 06 vs 0. 09 + 0. 01 mmol/1, p £ 0. 05)
and ketone body turnover (KB. RT) was increased (6.3 + 1.2 vs 1.9
+ 0.3 (J.mol/kg/min..) when assessed with the acetoacetate tracer
(p 2. 0. 005). Metabolic clearance rates (MCR) were normal but KB
pool size was increased (1 04 + 36 vs 28 + 4 pmol/kg, p ^ 0. 05) as
was the volume of distribution (KB . VD) (66. 2 _+ 7. 6 vs 30. 2 + 7. 4%,
p 4 0. 01). Mean residence time (MRT) was similar in both groups.
Following treatment KBRT, pool size and KBVD fell to normal whilst
MCR and MRT were unchanged.
Hyperthyroidism : 3-hydroxybutyrate tracer (Tables 12:3, 12:4)
Total KB levels were increased (0. 25 _+ 0. 08 vs 0. 08 _+
0.01 mmol/1, p ^ 0. 05) as were KB. RT (6.8 + 1.0 vs 1.6 + 0. 2 pmol/
kg/min, p < 0.001), KB. MCR (36.1 _+ 7. 4 vs 1 8. 3 _+ 1. 6 ml/kg/min,
p < 0. 05), KB pool size (81. 4 _+ 25. 7 vs 18.5 + 2.6 |o.mol/kg, p < 0. 05)
and KB. VD (53. 2 + 5. 2 vs 24. 3 _+ 3. 3%, p 4. 0. 001) in hyperthyroidism.
KB. MRT was normal. Following antithyroid therapy KB concentrations
KB.RT, KB. MCR and KB pool size returned to normal although
KB. VD and KB. MRT were unchanged.
Hypothyroidism : acetoacetate tracer (Tables 12. 5, 12. 6)
Total KB concentrations, KB.RT, KB. MCR, pool size,
KB. MRT and KB. VD were similar in hypothyroid and control
subjects and were not affected by thyroxine therapy.
TABLE12:1.Clinicaldetailsofhyp rthyroida dhypothyro dsubjectsbef(andduring)treatmen andofcontrols.Resultsfo"b f retreatment"ren+SEM.Fo"duringtreatment' onlymeanvaluesargiveinbrackets. Age(yrs) Sex %Ideal bodyweight Serum thyroxine (nmol/l) Serum triiodothyronine (nmol/l) Serumthy oid stimulating hormone (mU/1)HyperthyroidCont ol 53+3( 5)48+6 4F1M(3F)3 100+3( 5)103 249+8(106)86 6.5+1 3( 7)1.50.1Hypothyroid 56+2( 4) 4F2M( ) 119+5( 6) ***,17+3( 07) 0.7+.1(1 9)
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[KB] [KB] MCR MCR RT RT POOL POOL MRT MRT VD VD T„ %IBW NEFA
A B A B A B A B A B A B
NS NS NS NS NS NS NS NS NS NS
NS
0.63
2.0.05 NS NS NS NS NS NS NS
NS NS
NS NS
NS NS NS NS NS
NS NS NS NS NS NS
NS NS NS NS NS NS
NS NS
NS NS
NS NS NS NS NS NS NS
NS
0.75
20,1 0.57 =0.5 NS NS NS NS
0.73
20.01 0.75 2.0.005 NS NS NS NS
NS NS NS NS NS NS
0.74
20.01 NS NS NS NS
0.54 =0.6 NS NS NS NS







TABLE [KB] [KB] MCR MCR RT RT POOL POOL MRT MRT VD VD T3 X4 %IBW NEFA
12:10.Correlationsb tweenkin ticparametersdmetabolicind esllsubje ts(hype hypothyroidancontrols).F rsymbolsseeTabl12:7. A B A B A B A B A B A
rthyroid,
0.93
k.o.o i 0.83 ko.o i 0.92 k0.0 1"X NS
0.77
ko.001 0.83 ko.o il
NS
0.53
ko.oi 0.59 ko.oi 0.42 to.05 NS 0.46 kO.05
NS
0.78 ko.001 0.48 ML05
NS NS
0.54









ko.05 0.50 k0.05 0.64 ko.01 0.48 k0.05 NS
0.93







k-o.001 0.77 £0.001 0.43 K0.05 0.47 £0.05
0.71





£0.1 0.47 £0.5 NS NS
0.41
£0.5 NS NS NS NS NS
0.56
£0.005 NS NS NS NS
0.62
£0.0 5! 0.63 £0.01 0.53 £0.01 NS NS
0.47










Hypothyroidism : 3-hydroxybutyrate tracer (Tables 12:5, 12:6)
Kinetic parameters, as above, were similar in patients
and controls and were unaffected by treatment of hypothyroidism.
Correlations (see Tables 12:7, 12:8, 12:9 and 12:10)
Considering data from both experiments significant
correlations emerged between KB concentrations (r = 0.83, p c 0. 001
for acetoacetate and r - 0. 77, p 4 0. 001 for 3-hydroxybutyrate),
KB. RT (r = 0. 93, p £ 0. 001), pool size (r = 0. 83, p^ 0.001),
KB. VD (r = 0.62, p £ 0. 005) and KB. MRT (r = 0. 41, p ^ 0. 05).
For hyperthyroid, hypothyroid and control subjects together circulating
thyroid hormone levels in blood correlated with KB.RT (p 4 0. 001
all comparisons) and these correlations held within the hyperthyroid
group but not within either control group or in hypothyroid patients.
12:4. DISCUSSION
In the post absorptive state, ketone bodies play a minor role
in supplying the energy needs in mammals (Robinson & Williamson,
1980) but in other metabolic conditions ketone bodies are major metabolic
substrates (Owen et al, 1969). Isotopic techniques provide relatively
non invasive methods for measuring rates of production and utilisation
of ketone bodies in vivo (Bates et al. 1968) and infusion of either
14 14
3-[ C] -acetoacetate or 3-[ C]-hydroxybutyrate has been widely
used in animals and humans (Ballase, 1979; Barton, 1973; Bates et al.
1968; Keller et al. 1978; Keller et al. 1981). However, this approach
is not without potential problems. Acetoacetate and 3-hydroxybutyrate
are interconverted too rapidly to be considered independent substrates
177.
but too slowly for their specific activities in blood to become equal
(Barton, 1980). Most investigators therefore attempt to circumvent
this problem by using the combined specific activities of acetoacetate
and 3-hydroxybutyrate to quantify total ketone body turnover although
this compromise may not be valid (Barton, 1980; Cobelli et al. 1982).
It was therefore decided to investigate ketone body kinetics
14
in overnight fasted subjects using both 3-[ C] -acetoacetate and
14
3-[ C]-hydroxybutyrate as tracers on separate occasions in random
order. This approach allowed a direct comparison of kinetic data
obtained with the two tracers and calculations have been performed
by conventional means. The estimations obtained have also provided
the basis of a new modelling approach to ketone body kinetics
(Cobelli et al. 1982). These modelling studies of the data have been
performed entirely by others and the results will not therefore be used
in this thesis .
.
In the normal subjects mean KB. RT was similar by either
tracer although individual differences of up to 80% were apparant. These
differences were not consistent in direction and the most likely
explanation is that KB.RT varies from day to day. Further studies
using the same isotope repeatedly in the same subject are required
but should await the development of stable isotope techniques.
Similar explanations pertain for the variability in KB. MCR, pool,
KB. MRT and KB. VD despite the close agreement in their mean values.
Mean KB.RT for normals reported here are similar to those found
in previous studies where fasting KB concentrations were comparable
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(1. 2 pmol/kg/min, Bradley et al. 1981; 1. 8 pmol/kg/min,
Miles et al. 1980).
In hyperthyroidism, circulating KB concentrations were
increased as in previous studies (Chapter 7; Beylot et al. 1980;
Bartels et al. 1979), whilst ketone body turnover rates were 3-4 fold
increased. Circulating glycerol and NEFA levels were increased
consistent with increased lipolysis noted in several other studies
(Chapter 7; Rich et al. 1959; Tibbling, 1969). Since, in addition,
hepatic blood flow may be 20-35% increased in hyperthyroidism (Wahren
et al. 1981), hepatic NEFA supply is likely to be 3-4 fold increased.
This derived figure is in accord with the data of Hagenfeldt et al.
(1981) who showed a 3-fold increase in hepatic NEFA uptake in fasting
hyperthyroid patients during splanchnic balance studies. These
authors also showed a 400% increase in KB production, similar to the
findings reported in the present study. Thus a potent effect of thyroid
hormones to increase hepatic NEFA supply is likely to be a major
determinant of the increased KB production demonstrated. Perfused
rat liver studies have also suggested that thyroid hormones may also
alter the ketogenic "set" of the liver, diverting fatty acids
preferentially away from the triglyceride synthetic pathway and
towards (3 oxidation and ketone body formation (Keyes & Heimberg,
1979; Laker & Mayes, 1981). Precise mechanisms at a cellular level
remain to be elucidated.
The 3-4 fold increase in ketone body production demonstrated
here compares with only a 50% increase in glucose production
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(Chapter 9; Saunders et al. 1980; Perez et al. 1980). This increase
in glucose production and utilisation can largely be accounted for by
increased Cori cycle activity with no significant increase in
irreversible glucose disposal (Chapter 9). These findings indicate
that a significant portion of the increased energy demands of
hyperthyroidism are met by increased lipid metabolism.
Peripheral disposal of ketone bodies (KB.MCR) was
increased in hyperthyroidism (although this was statistically significant
only when 3-hydroxybutyrate was used as tracer) suggesting that thyroid
hormones stimulate the ability of peripheral tissues to extract ketone
bodies from blood.
Following antithyroid therapy KB concentrations, KBRT,
KBMCR, pool size and KBVD returned towards normal.
In hypothyroidism, fasting KB concentrations and all kinetic
parameters were normal irrespective of the isotope used. No previous
studies concerning in vivo ketone body production in hypothyroidism
have appeared in the literature although normal fasting ketone body
concentrations (Saunders et al. 1980; Chapter 8) normal NEFA levels
(Chapter 8; Saunders et al. 1980) and NEFA turnover (Saunders et al. 1980)
have all been described. Perfused hypothyroid rat liver studies have
produced contradictory results with normal (Baker & Mayes, 1981)
and decreased (Keyes & Heimberg, 1979) KB production being reported.
Treatment with B-thyroxine had no effect on any parameter
of ketone body metabolism measured in this study.
Ketone body turnover rates correlated positively with
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circulating ketone body levels in this as in previous studies in man
(Bates et al. 1968; Nelson et al. 1941). Thyroid hormone levels did
not correlate with KBRT within individual groups although when all
subjects were considered together a highly significant correlation emerged
even on non parametric testing. Surprisingly there was no correlation
between NEFA and KBRT overall or within individual groups.
Thus ketone body turnover was significantly increased in
hyperthyroidism. This may be the result of increased hepatic NEFA
supply due to increased lipolysis. A direct effect of thyroid hormones
on intrahepatic metabolism may also be important but further
experiments are required to investigate this point. The data also
suggests that thyroid hormones are unnecessary for ketogenesis to
progress normally in man.
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1 3. KETONE BODY PRODUCTION BY ISOLATED RAT
HEPATOCYTES; EFFECTS OF EXPERIMENTAL
HYPERTHYROIDISM
13.1. INTRODUCTION
Previous studies in thyrotoxic man have demonstrated
elevated blood ketone body concentrations during fasting (Chapters 11, 12;
Beylot et al. 1980; Bartels et al. 1980) with increased hepatic ketone
body production (Hagenfeldt, 1981; Chapter 12). Enhanced ketogenesis
may be due either to an increase in the supply of precursor fatty
acids to the liver, to alteration of hepatic ketogenic capacity or to a
combination of these two processes. Lipolysis is increased in
hyperthyroidism (Chapter 7; Arner et al. 1981; Goodman & Bray, 19 66;
Tibbling, 1969) with increases in both blood concentrations
(Chapter 7; Goodman & Bray, 1966; Tibbling, I969) and turnover
(Saunders, Hall & Sonksen, 1980) of non-esterified fatty acids.
Hepatic blood flow is also increased in thyrotoxic man (Wahren et al.
1981) further contributing to increased hepatic fatty acid supply.
Whether thyroid hormones have any direct effect on intrahepatic fatty
acid metabolism is however uncertain. Isolated rat hepatocyte
preparations allow the effects of hormones on hepatic metabolism to
be studied in a controlled and manipulable environment. Using this
technique effects of insulin (Barker, 1980), glucagon (Christiansen,
1977; McGarry et al. 1978) and catecholamines (Burrin et al. 1982)
on intrahepatic fatty acid metabolism have been examined by others
but the effects of thyroid hormones are unknown. Acute effects of
thyroid hormones on ketogenesis have therefore been examined by
1 82.
incubating hepatocytes from fed and fasted normal rats with
- 8
triiodothyronine in a concentration (10 M) exceeding normal free
circulating levels in the rat. Chronic effects of thyroid hormones
on ketogenesis have been examined by measuring ketone body
14
production in the presence and absence of added (ImM U- C
palmitate) fatty acid substrate by hepatocytes from fed and fasting
normal rats and from rats pretreated with triiodothyronine for 7 days.
Circulating hormone and metabolite concentrations have also been
determined in rats prepared in the same way (Table 13:1).
13:2. MATERIALS AND METHODS
1 • Preparation of solutions
Stock (conc. ) Krebs Hensleight Buffer
NaCl 34.7g
Dissolved in distilled water
and made up to 1 Litre
KC1 1. 77g
KH2P04 0. 81 g
MgS04:7H20 1. 46g
CaCl2:2H20 1.87g
NaHCOs 1 2. 94g
Fatty acid free albumin
lOOg Fraction V bovine albumin (BSA) (Sigma, Poole, Dorset)
were dissolved in 500ml distilled water at 4°C. The solution was
dialysed against distilled water for 4h and then for four lh periods.
The solution was removed from the dialysis tubing and brought to
pH 3. 5. Activated charcoal (20g/l) was added and the solution stirred
for lh at 4°C and centrifuged at 7000 rpm for 30 mins to remove
larger particles. The supernatant was separated and filtered through
as artorius filter. The albumin was brought to pH 7.4 and the
concentration determined gravimetrically. The solution was adjusted
to give a final concentration of 10% (w/v) and stored at -20°C in
20 ml aliquots.
Solution A (10 x conc. Hepes [N^ hydroxy ethyl piperazine-
N-2-ethane sulphuric acid] solution)




















Soln. A 50 ml )
)
Distilled H20 450 ml )
Solution C
Soln. A 50 ml )
)
Distilled H20 450 ml )
Solution C
Soln. A 50 ml )
)
Distilled H20 450 ml )
Solution D




II; 135 units/mg) )
Made up to 1 litre at pH 7. 6.
Kept at 4°C.
pH 7. 6. Made up on the day of
experiment. Oxygenated at 3 7°C
pH 7. 6. Made up on the day of
experiment. Oxygenated at 3 7°C
pH 7. 6. Made up on the day of
experiment. Oxygenated at 37°C
)
)
Ca.Cl2:2H20 73. 5 mg )
Distilled H2q 90 ml j
Kept in deep freeze (-20°C) until




Cone. Krebs solution 20 ml Made up to 100ml with
distilled water. Stored at
1. 3% NaHCO 1 6 ml -20°C until day of use.
J
Oxygenated for 3 0 min
3. 4% Hepes 1 6 ml before adjusting to pH





Cone. Krebs solution 20 ml
1.3% NaHCO 1 6 ml Made up to 100ml with
distilled water. Stored at
3. 4% Hepes 1 6 ml -20°C until day of use.
Oxygenated for 30 min at
1 0% BSA 20 ml 37°C and adjusted to
pH 7. 6.
Bacitracin 1 00 mg
Trasylol 100,000 kiu
L-Carnitine
E-carnitine (Sigma Chemicals) 6. 5 mg was added to 40 ml.
hepatocyte suspension before preincubation to yield a final
concentration of 1 mmol/1.
Trypan blue
67 mg Trypan blue ) dissolved in 25 ml distilled water,
) filtered through a 0. 2 millipore
120 mg NaCl ) filter. Solution was stored until use
at -20 °C in 3. 0 ml aliquots.
Radioactive Palmitic Acid (Radioactive Substrate)
104 nig Palmitic acid (sodium salt; Sigma Chemical Co. Ltd. )
•were dissolved in 25ml distilled water at 50°C to give a 15 mM
solution. 90 pi uniformly labelled palmitic acid (403 mCi/
mmol,. Radiochemical_Centrey Amersham, Bucks.).
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was added to 9 nil 15 mM palmitic acid and 7. 24 ml of this solution
was added to 70 ml Soln. F. 1.5 ml of this final solution was added
to each culture flask to which 0. 5 ml hepatocyte suspension was
subsequently added. This yielded a final concentration of 1 mM
palmitic acid.
2. Preparation of rats
Male Wistar rats (200-220 g) were used in all experiments.
Previous studies in this department have shown that rats of this weight
eat 20 g diet pellets/day (small animal diet No. 1. , Special Diet Services,
Essex). To induce hyperthyroidism 1. 6 mg of L-triiodothyronine
were dissolved in distilled water made slightly alkaline by addition of 1-2
drops of ImM NaOH and sprayed evenly over 1 kg of diet pellets.
20 g diet prepared in this way were fed daily. The dose of
L-triiodothyronine administered was therefore 32 pg/day (Laker &
Mayes, 1981). Control rats were fed with 20 g of standard pellets
daily. In 48 h starved rats, 32 pg T^ were administered
intraperitoneally for the last 2 days of preparation. Circulating
insulin and metabolite concentrations were determined in separate groups
of fed and fasting normal and thyrotoxic rats prepared as above
(n = 6 all groups). Ketone body production from endogenous and
exogenous substrate was assessed in fed normal (n = 6), fed
thyrotoxic (n = 6), fasted normal (n = 5) and fasted thyrotoxic rats
(n = 5). Acute effects of thyroid hormones were studied by incubating
hepatocytes from fed normal (n = 4) fasted normal (n = 4) fed
- 8
thyrotoxic (n = 4) and fasted normal rats (n = 4) with 10 M
triiodothyronine (Table 13:1).
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Rats were anaesthetised using pentabarbitone (55mg/kg )
intraperitoneal!/. The abdomen was incised and the viscera displaced
to expose the portal vein. Sutures were placed round the portal
vein which was cannulated using a 20G Medicut cannula. Sutures were
tightened to hold the cannula in place. The inferior vena cava (i. v. c. )
was cut at the level of the renal veins and solution B was perfused
through the liver at a rate of 40 ml/min after also cutting the i. v. c.
above the liver. The rate was reduced to 30 ml/min after 1 min and
perfusion with solution B continued for a further 3 minutes. Perfusion
was changed to solution C at 40 mls/min for 1 minute and 30 ml/min
for 3 minutes. Solution D (collagenase) was then perfused and
recirculated at 40 ml/min for 1 minute and 30 ml/min for 9 minutes.
The perfusion was then stopped and the liver placed in a petri-dish
containing solution E at 4°C. The liver was gently teased/apart with
forceps and dispersed in the solution which was subsequently filtered
through nylon mesh (pore size 100 pm and made up to 40 ml with
solution E.
Preincubation of hepatocytes
The crude cell suspension was oxygenated and incubated with
1 mM carnitine at 37 °C for 20 minutes in an airtight culture flask in a
water bath with an automatic shaker. Previous studies in the laboratory
had suggested that this concentration of carnitine was optimal for
ketone body production.
Purification of hepatocytes
The cells were centrifuged at 200 r. p. m. for two minutes
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at 4°C and the supernatant discarded. The cells were washed twice
with solution E and resuspended in a known volume of solution F.
Viability of hepatocytes
100 pi of cells suspended in F were diluted in 300 pi
trypan blue. The solution was mixed by inversion and introduced into
an improved Neubauer counting chamber (McFarlane Robson Ltd. ).
The total number of cells present was calculated by counting
(25 squares = 1/10,000 ml) and the number of dead cells (those
taking up trypan blue) subtracted to yield the number of live cells.
Viability was expressed as the percentage of live cells present, and
was determined in the fresh preparation and after 60 minutes incubation.
Incubation of hepatocytes v
0. 5 ml hepatocyte suspension were incubated at 37°C in
airtight culture flasks as follows
a) with 1. 5 ml solution F + 1 mM radioactive palmitate
b) with 1. 5 ml solution F.
In those experiments where thyroid hormone was added directly to
the incubation medium 0. 34 pg T^ was added to 40 ml solution F
(with or without radioactive palmitate) to a final concentration of
- 8
10 M. Ketone body production was assessed at 60 minutes only.
4. Preparation of hepatocyte samples for metabolic estimations
Samples (0. 5 ml)were taken from incubation flasks at times
0 (in quadruplicate) 30 mins (triplicate) and 60 mins (triplicate)."
Samples were added to 2. 0 ml 3% perchloric acid (w/v) at 4°C.
The P. C. A. extract was centrifuged for 20 min at 2000 r. p. m. at
4°C and the supernatant transferred to preweighed tubes. The acid
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weight was recorded and the extract neutralised with 20% and 2% KOH.
Extracts were centrifuged again and the neutral weight recorded.
The sample extracts were then assayed for 3 -hydroxybutyrate and
acetoacetate concentrations as shown below.
Acetoacetate assay
Acetoacetate assays were performed spectrophotometrically
on a Zeiss Spectrophotometer. Cuvettes for the assay were prepared
as below




Sample 0.5 1.0 0.5
The cocktail consisted of the following;
Potassium phosphate buffer(0. 1 M) pH 7. 0
(K HPO 10.3 g/1 20 ml ) Sufficient4
)
K2H2P04 5. 3 g/1) ) for
NADH 6 mg ) 20 samples
Cuvettes were agitated and the optical density (OD)
read at 340 nm. 10 pi 3-hydroxybutyrate dehydrogenase
were added to each cuvette (except the blank) and mixed. The OD
was again determined at 340 nm after 30 minutes and reading repeated
until a steady value was obtained.
3-Hydroxybutyrate assay










In this case the cocktail consisted of



















Cuvettes were agitated and the OD read at 340 nm. 10 pi of
Hydroxybutyrate dehydrogenase (HBDH) was added to each cuvette
except the blank and the OD read again at 340 nm after 60 minutes.
Calculation of results
The 3-hydroxybutyrate and acetoacetate assays depend on the
change in absorption of light at 340 nm due to the conversion of NAD^
to NADH or vice versa. Results can therefore be calculated using the
same general formula.
OD, sample - OD control . .
340 340 x vol. PCA extract








OD control x 2. 5 x 2. 0 x neutral wt.
6. 22 0.5 0. 5 acid wt.
This gives the concentration of the metabolite in pmol/ml (or mM).
190.
14 14
5. Measurement of C ketone body production from U-C
palmitic acid
Radioactively lab eL led 1 mmol/1 palmitic acid was
prepared as described above, and incubations carried out as before.
Radioactivity in ketone bodies was determined by a modification of
the method of Bates, Krebs and Williamson (1965). 0. 25 ml of neutral
PCA extract was boiled for 45 min in 1 2 ml mercuric sulphate/
sulphuric acid/distilled water mixture as described previously
(Chapter 12). Radioactivity in palmitic acid was calculated by
counting aliquots of Solution F to which radioactive substrate had
been added (total palmitate d. p. m. ).
Counts were corrected for background and quenching and
recoveries of radioactive acetoacetate and 3-hydroxybutyrate were
calculated by passing known amounts of each through the assay
procedure. Radioactivity associated with acetoacetate and total
ketone bodies was calculated as shown below.
x PCA vol. x Cuvette vol. x Neutral wt. x 100
c. p. m. ——;
Sample vol. Sample vol. Acid wt. % recovery
= x dpm/ml.
x _ y pmol/ml
(total palmitate dpm/4)
y/cells/ml - pmol/10^ cells.
Radioactivity associated with 3-hydroxybutyrate was determined by
subtraction of the counts for acetoacetate from those of total ketone
bodies. It was assumed in these calculations that each mole of
palmitate gave rise to 4 moles of ketone bodies.
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6. Calculation of circulating insulin and intermediary *
metabolite concentrations
Circulating insulin and intermediary metabolite
concentrations were measured in normal and thyrotoxic fed and
fasted rats (n = 6 for each group). For glucose, lactate, pyruvate,
\
alanine, glycerol and 3-hydroxybutyrate 0.2 ml of blood was added
to 2 ml 3% (w/v) perchloric acid and measured by automated
fluorimetric methods (Lloyd et al. 1978). Acetoacetate from the
same extract was measured as in 13. 2 (3). Serum insulin was
measured by double antibody radioimmunoassay using rat serum as
standard (Soeldner & Stone, 1965).
7. Statistics
Comparisons between groups were made using Student's
paired and unpaired t-tests as appropriate.
Precision
Within rat coefficient of variation of labelled ketone body
production production was 6. 3% whilst between rat variation was 27. 6%.
Recovery
14
The recovery of added C-labelled acetoacetate in the assay
1 4
of C-acetoacetate and total ketone body production was 81 j_ 8%
14
whilst the recovery of added C-3-hydroxybutyrate in the assay for
total ketone body production was 73 _+ 9%.
Cell Viability (Trypan blue exclusion)
Mean SEM viability of hepatocytes from all groups was
94 + 3% at 0 time and 89 + 4% at 60 minutes.
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TABLE 13:1. Outline of Experiments Performed
A. Chronically Thyrotoxic Animals (32 pg T^ daily for 7 days)
1. Ketone Body Production in the Absence of added
Fatty Acid Substrate
(a) Thyrotoxic Fed Rats (n 6)
(b) Normal Fed Rats (n = 6)
(c) Thyrotoxic Starved Rats (n = 5)
(d) Normal Starved Rats (n = 5)
2. Ketone Body Production from ImM Palmitate
(a) Thyrotoxic Fed Rats (n s 6)
(b) Normal Fed Rats (n = 6)
(c) Thyrotoxic Starved Rats (n = 5)
(d) Normal Starved Rats (n = 5)
3. Circulating Hormone and Metabolite Concentrations
(a) Thyrotoxic Fed Rats (n = 6)
(b) Normal Fed Rats (n = 6)
(c) Thyrotoxic Starved Rats (n = 6)
(d) Normal Starved Rats (n = 6)
- 8
B. Acute Effects of Triiodothyronine (10 M) on Ketone Body
Production by Hepatocytes from Normal Rats
(a) Fed Rats (n » 4)
(b) Starved Rats (n = 4)
13.3. RESULTS
Circulating Insulin and Metabolite Concentrations (Table 13:2)
Peripheral insulin concentrations were significantly diminished
in fed thyrotoxic rats compared to controls (16. 2 _+ 3. 5 vs 33. 0 _+ 5. 2 mU/
p < 0. 05. . Insulin concentrations fell with starvation in both groups
and were not significantly different. Blood glucose concentrations were
similar in fed and 48 h fasted normal and thyrotoxic rats as were
blood alanine concentrations. Blood lactate was increased in
thyrotoxic rats in both the fed (thyrotoxic 2. 29 + 0. 13 vs normal
1. 64 _+ 0. 13 mmol/1, p 4 0. 01) and fasted state (2. 18 _+ 0. 1 5 vs 1. 87
j_ 0. 27 mmol/1, p 4 0. 01) whilst blood pyruvate was increased in fed
thyrotoxic rats only (0. 1 5 _+ 0. 01 vs 0. 07 _+ 0. 01 mmol/1, p 4 0. 01).
Blood glycerol was as expected, increased in normal fasted
rats compared with fed normal rats (0. 06 + 0. 01 vs 0. 50 _+ 0. 03
mmol/1, p 4 0. 001) and was increased further in thyrotoxic rats
compared to normals (fed 0. 42 + 0. 04 mmol/1, p 4 0. 001; fasted
0. 84 + 0. 08 mmol/1, p 4 0.001). A similar pattern was observed for
blood acetoacetate concentrations (fed normal 0. 11 + 0. 04 vs fasted
normal 0. 91 ,+ 0. 21 mmol/1, p 4 o. 001 ; fed thyrotoxic 0. 63 + 0. 19
mmol/1, p 4 0. 001; fasted thyrotoxic 1. 39 ,+ 0. 27 mmol/1, p 4 0. 05).
Blood 3-hydroxybutyrate concentrations were increased in fed
thyrotoxic rats (1. 64 _+ 0. 1 7 vs control 0.26 _+ 0. 01 ml/1, p 4 0. 001)
but were similar to control values during fasting. Blood ratios of
3-hydroxybutyrate to acetoacetate were similar in fed normal and
thyrotoxic rats but this ratio was diminished in fasted thyrotoxic
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rats (fasted normal 2.11 + 0. 42 vs fasted toxic 1 . 1 8 + 0. 49, p < 0.05).
Ketone body production by isolated rat hepatocytes in the absence
of added substrate (endogenous production) (Table 13:3)
Basal. Total ketone body production was similar in fed
normal and thyrotoxic rats (normal 0. 028 + 0. 004 vs thyrotoxic
0. 027 + 0. 010 pmol/10^ cells) and increased significantly in fasted
normal (p <. 0. 01) but not in fasted thyrotoxic rats (p 2 0. 05 v
fasted normals). The ratio of 3-OHB:Acac produced was decreased
in thyrotoxic rats both during feeding (normal 0. 85 + 0. 07 vs thyrotoxic
0.35 + 0. 07 pmol/ 1 0^ cells, p 2 0. 001) and fasting (normal 0.30 + 0. 05
vs 0. 07 + 0. 02 pmol/10^ cells, p 2 0. 001).
30 mins. Endogenous total ketone production was diminished
in thyrotoxic rats both when fed (normal 0. 099 +_ 0. 004 vs thyrotoxic
0. 055 _+ 0. 014 pmol/10^ cells, p ^ 0. 01) and fasted (0. 269 + 0. 025 vs
0. 039 + 0. 009 pmol/106 cells, p < 0.001) and this was associated with
a decrease in both acetoacetate and 3-hydroxybutyrate production.
The 3-OHB:Acac ratio was decreased in fed (p 2 0. 001) and fasted
(p 2. 0. 001) thyrotoxic rat hepatocytes. Acetoacetate and 3-hydroxybutyrate
production were increased in fed and starved normal rats compared to
0 minute values but no increases were seen in hepatocytes from
thyrotoxic rats.
60 mins. Total ketone body production was again diminished
in fed (normal 0.150 + 0.001 vs thyrotoxic 0. 089 + 0- 028 pmol/10^
cells; p 2. 0. 05) and fasted (0. 407 + 0. 034 v 0. 059 + 0. 011 pmol/10^
p 2 0. 001) thyrotoxic rats and the 3-OHB:Acac ratio was also decreased
(fed and fasted, p 2 0. 001). Ketone body production was also increased
in both fed and fasted normal rats compared with the 0 min and
30 min values but no increase was seen in thyrotoxic rats.
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Ketone body production from 1 mmol U- C-palmitate (Table 13:4)
30 mins. Total ketone body production was increased
in hepatocytes from fed thyrotoxic rats compared to fed controls
(0. 532 + 0. 079 v. 0. 294 + 0. 048 (J.mol/10^ cells, p4 0. 05). No
further increase was seen with starvation in hyperthyroidism. The
3-OHB Acac ratio was decreased in both fed (p Z_0. 001) and fasted
(p 0. 001) thyrotoxic rats. A significant increase in ketone body
production was apparent in starved normal rats compared to fed
normals (0. 435 + 0. 059 iJ-mol/10 cells, p C 0. 05).
60 mins. Hyperthyroidism was again associated with
increased ketone body production in the fed state (0. 940 _+ 0. 139 vs
0. 471 _+ 0. 050 pmol/ 1 0^ cells, p ^ 0. 05), no further increase
occurring with fasting. Ketone body production was however
increased in starved normal rats (0. 783 _+ 0. 090 ^moles/10^ cells,
p 0. 01 vs fed normals) to levels similar to those found in fasted
thyrotoxic rat. The 3-OHB Acac ratio vas significantly diminished in
both fed (p ^ 0. 001) and fasted (p A 0. 001) thyrotoxic rats compared
to controls.
Ketone body production by normal rat hepatocytes : Effects of
incubation with 10 M triiodothyronine (Table 13:5)
- 8
No effect of 1 0 M triiodothyronine incubated with normal
fed and fasted rat hepatocytes on acetoacetate, 3-hydroxybutyrate or
on the ratio of their production was apparent in this study.
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TABLE 13:2. Blood intermediary metabolite and insulin levels in
fed and 48h starved normal and thyrotoxic rats
(Mean + SEM)
FED FED STARVED STARVED
NORMAL THYROTOXIC NORMAL THYROTOXIC
(n =■ 6) (n = 6) (n - 6) (n — 6)
Blood
glucose
mmol/1 4.0 +0.4 3.9+0.13" 3.9+0.3 3.8+0.2
Blood
lactate





0.07 +0.01 0.15+0.01 0.07+0.02 0.08+0.01
Blood
alanine





0.50 +0.03 0. 84+0. 08••
Blood
acetoacetate















0.37 +0.04 2.55 +0.21 1.94+0.28 3.03 +0.41
Serum insulin
mu/1 33.0 +5.2 16.2+3.5* 6. 7+1. 0WW" 5.2+0.2
* p < 0. 05 thyrotoxic vs control (** p 2 0.01, *** p 2. 0. 001)
p 2 0. 05 starved vs fed ( «• p 4 0. 01, ••• p 2 0. 001)
TABLE13:3.








(n-6) 0.39+0.03 0.192+0.042*** 0.289+0.034***
48hSTARVED THYROTOXIC













0.28+0.04 0.99+04 0.150+0.1 0.85+0.7 0.46+0.4 0.62+0.7
0.27+0.1 0.55+0.14 0.89+028s 0.35+0.7 0.15+0.5 0.19+.7







*pc0.5Normalv.thyrotoxic(**£ 0.1,**001) •p^.0.05Fedvfasting( •<,0.1,• •1)
TABLE13:4.
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Totalketone30' bodies60' pmol/10ce ls 3-hydroxy-0' butyrate:60' acetoacetate ratio
0.294+0.048 0.471+0.50 2.18+0.49 1.70+0 40
0.532+0.079' 0.940+0.139: 0.60+0.16*** 0.45+0.12***
0.435+0.9 0.783+0.901 2.45+0.7 2.09+0.39




TABLE 13:5. Ketone body production from 1 mM U 1 4C palmitate
by isolated normal rat hepatocytes : effects of addition
of 10~^M triiodothyronine to incubation medium























cells 0.46+0.13 0.52+0.11 1.05+0.27 1.14+0.28
3.0HB:AcAc
ratio 1.19 +0.42 0.90 +0.17 1.88+0.63 1.19 +0.42
All comparisons control vs T^ addition NS.
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13.4.' DISCUSSION
Blood glycerol concentrations in fed and fasted thyrotoxic
rats were elevated compared to controls. These findings are
consistent with previous studies showing an effect of thyroid hormones
to increase lipolysis in the rat (Deykin & Vaughan, 19 63; Vaughan,
1967) and to impair insulin mediated suppression of glycerol
release from isolated rat adipocytes (Fisher & Ball, 1967). Blood
ketone body concentrations were also increased in fed thyrotoxic
rats with a less striking increase after 48 h starvation compared to
controls.
Circulating insulin levels were markedly decreased in
fed thyrotoxic rats compared to controls in the absence of any change
in blood glucose levels. Insulin secretion has previously been
reported to be diminished (Levy et al. 1969; Andreani et al. 1970),
normal (Hales & Hyans, 1964; Holdsworth & Besser, 1968) or
increased (Doar et al. 1969; Aranda et al. 1972) using a variety of
species and experimental techniques even though the pattern of insulin
secretion has not been examined. In hyperthyroid man true insulin
hyposecretion may indeed also occur but is marked by concommitant
hypersecretion of proinsulin (Sestoft & Heding, 1981) which cross-
reacts with insulin on standard double antibody radioimmunoassay.
Ketone body formation by hepatocytes from fed thyrotoxic
rats in the absence of added palmitate was diminished at both 30 and
60 min. and unlike the situation in normal rat hepatocytes, failed to
increase with subsequent starvation. Decreased hepatic triglyceride
stores in thyrotoxic rats could explain such a situation and evidence
2 01.
in favour of this hypothesis is provided by isolated perfused rat 1
liver studies (Keyes & Heirrbeig, 1 979; Laker & Mayes, 1981).
Ketone body production from added palmitate substrate
was increased in fed thyrotoxic rat hepatocytes at both 30 and 60
min. compared to fed controls demonstrating that ketogenesis is
already primed in these animals. In control rats, ketone body
production increased by 70% with starvation whilst in thyrotoxic rats
no such increase was apparant and production rates during starvation
were similar in both groups. The reasons for this are uncertain.
It is possible that production rates from 1 mM palmitate using the
system described were already maximal in fed thyrotoxic animals
(60 min. value — 1. 0 ^iM/lO^ cells). Previous studies in this
laboratory have shown similar rates of ketone body production at
60 mins in starved diabetic rats where extremely high rates of
ketogenesis would be expected (J. M. Burrin, personal communication).
Further studies using varying concentrations of substrate and
varying durations of incubation will be necessary to resolve this
question.
Increased ketone body production from fixed substrate
concentrations in hyperthyroidism have previously been demonstrated
in isolated perfused rat liver preparations (Keyes &: Heimbeig, 1979;
Laker & Mayes, 1981; Bartels & Sestoft, 1981) but the mechanisms
by which these changes occur are uncertain. Involvement of hepatic
cyclic nucleotides appears likely. Cyclic AMP (cAMP) and
dibutyryl cAMP both diminish output of triglycerides and VLDL
and increase ketogenesis in perfused livers from normal fed rats.
(Heimberg et al. 1969; Klausner et al. 1978) whilst treatment is
known to increase hepatic cAMP (Singh & Snyder, 1978) and hepatic
protein kinase activity (Rogues et al. 1977). Precise knowledge of
the effect of thyroid hormones on other known regulators of intra¬
hepatic fatty acid metabolism (malonyl CoA and the acyl carnitine
transferase system) remains to be determined. Ketogenesis from
octanoic acid (which does not require the acyl carnitine transferase
system to enter mitochondria) is unaffected by thyroid status suggesting
that thyroid hormones may act at this level (Bartels & Sestoft, 1981).
An alternative explanation to a direct hepatic effect of thyroid
hormones lies in the fact that peripheral insulin levels were
significantly diminished in fed thyrotoxic rats who demonstrated
enhanced lipolytic activity, increased circulating ketone body
concentrations and increased ketone body production. Insulin
deficiency, however mediated, may prime the liver for ketogenesis
(McGarry et al. 1978) before removal from the intact animal.
Previous studies have neglected to consider this aspect.
Thus during feeding lipolytic activity is increased in
hyperthyroid rats as witnessed by increased blood glycerol levels.
Ketone body production by the liver is also increased and as a result
ketone body concentrations in blood are elevated. During fasting,
blood glycerol levels increase by a further 100% but ketone body
production from fixed substrate is not increased. Ketone body
concentrations in blood rise only modestly. These findings suggest
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that in fasting hyperthyroid rats the pathways for ketone body
production may be saturated and this is supported by the production
rates by hepatocytes. However, in the intact animal substrate
supply may vary considerably allowing for higher rates than
predicted from the fixed substrate studies. Under these circumstances,
increased peripheral ketone body utilisation could explain the changes
in circulating metabolites.
The situation in the rat is however not directly
comparable to that in thyrotoxic man in whom ketone body
concentrations during feeding are normal. The degree of
circulating hypoinsulinaemia may be an important aspect in this
respect. During fasting however, ketone body concentrations rise
and ketone body production increases as previously described
(Chapter 12). Splanchnic balance studies have suggested that the
bulk of this increase can be accounted for by increased presentation
of NEFA to the liver but a direct effect of thyroid hormones on
intrahepatic NEFA metabolism could not be excluded (Hagenfeldt et al,
1981). Evidence that a {3 adrenergic mechanism could underlie such
a change was suggested by Beylot et al. (1980) who demonstrated that
ketone body concentrations in blood decreased in hyperthyroid
subjects treated with propranolol in the absence of any significant
changes in blood glycerol or plasma NEFA concentrations. Relative
hypoinsulinaemia (Sestoft & Heding, 1981) together with normal
(Chapter 7) or increased (Kabadi & Eisenstein, 1980) plasma glucagon
levels may also be important factors.
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A striking decrease in the ratio of 3-hydroxybutyrate :
acetoacetate (30HB:Acac .) production by hyperthyroid rat
hepatocytes was demonstrated in this as in one previous study
(Bartels & Sestoft, 1981). This suggests a more oxidised cytosolic
and mitochondrial redox state. Consistent with this an effect of
thyroid hormones to increase the rate of transfer of reducing
equivalents from the cytosol to the mitochondria in hepatocytes has
previously been described (Hoch, 1974; Sestoft, 1980). However,
a decrease in the ratio of 3CHB. to AcAc produced has not been a
universal finding (Keyes & Heimberg, 1979; Laker & Mayes, 1981)
although Laker and Mayes (1981) did demonstrate a decreased
lactate : pyruvate production again suggestive of a more oxidised
redox potential in thyrotoxic rat livers.
Direct addition of supraphysiological concentrations of
triiodothyronine to incubated normal rat hepatocytes had no effect
on ketone body production in the fed or starved state. This is
consistent with observations suggesting that thyroid hormones act on
nuclear receptors to induce protein, probably enzyme synthesis
with subsequent expression of thyroid hormone action (see Chapter 4).
Such effects would not be expected to be manifest before 60 minutes,
the earliest detectable changes being reported after 2 hours
(Hoch, 1974). Longer incubations are required to investigate this
aspect of thyroid hormone effects on ketogenesis and would clearly be
decisive in determining a 'direct' role for thyroid hormones on




14. 1. CARBOHYDRATE METABOLISM
i) Post absorptive man
As in many previous studies, hyperthyroidism was
characterised by an elevation of the fasting blood glucose
concentration (Chapters 7, 9, 10, 11) (for review, see Chapter 4).
This represents a balance between glucose production and glucose
utilisation. Further studies were required to determine whether
over-production or under utilisation of glucose was responsible.
Isotope dilution studies were therefore performed in overnight fasted
thyrotoxic and control subjects (Chapter 9)- Two isotopes of glucose
were used as tracers and were administered by bolus injection.
3
[ H]-3-glucose behaves as an "irreversible" tracer in that the tritium
label is lost as tritiated water at the triose phosphate level of the
glycolytic pathway and recycling of label back to glucose does not
occur. Turnover estimates using this isotope represent the amount
of glucose metabolised to this point and beyond. In normal man this
isotope provides the best estimate of "absolute" glucose turnover in
the post-absorptive state (Saunders et al. 1979). A theoretical criticism
does arise in thyrotoxicosis in that this isotope will not take account
of potential substrate cycle activity at the fructose-6-phosphate :
fructose-1 -6-diphosphate level which has been shown to be increased
in thyrotoxic rats (Okajima & Ui, 1979)- Similarly cycling at the
glucose:glucose-6-phosphate level will not have been recognised so that
absolute glucose turnover may have been overestimated.
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Simultaneous administration of [ C]-l. glucose allowed
assessment of glucose recycling from more distant sites. Glycolytic
metabolites of this isotope (3-carbon derivatives) have the potential
to recycle to form new radioactive glucose molecules thereby
lowering the apparant glucose turnover rates. The difference between
the two derived turnover rates is due to such recycling. The bulk of
this recycling is considered to occur from lactate (Streja et_al. 1963).
Absolute glucose turnover, assessed as above, was increased
by 50% in hyperthyroid patients. This finding is in agreement with
other studies using the same isotope of glucose in man (Perez et al.
1980; Saunders et al. 1979) and rats (Okajima & Ui, 1979).
Contradictory data has recently been produced from splanchnic
balance studies demonstrating a decrease in hepatic glucose output
in byperthyroid subjects of similar age and severity of disease.
(Wahren et al. 1981). The reason for this discrepancy is unclear.
In normal man, after an overnight fast, over 90% of glucose production
comes from the liver. Increased glucose production from the kidney,
well recognised in prolonged fasting in normal subjects, could occur
more rapidly in hyperthyroidism. An increase in total glucose
production, assessed isotopically, could thus be compatible with a
decrease in hepatic glucose output. Increased renal glucose
production has not however been demonstrated in hyperthyroidism.
Alternatively, dietary preparation may be an important factor. The
subjects reported in this thesis had a daily carbohydrate intake of
at least 250g/day whereas in the splanchnic balance study details of
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dietary preparation are not given.
Glucose recycling was increased 3. 6 fold in hyperthyroid
patients. In normal man, such cycling serves to preserve glucose
not required in a particular tissue for utilisation elsewhere.
However, attention has recently been directed towards substrate
and Cori cycles as potential sites of energy consumption or heat
production in hyperthyroidism (Okajima & Ui, 1979, Sestoft, 1980).
The finding of increased glucose-lactate (Cori) cycling reported here
is consistant with data from hyperthyroid rats (Okajima & Ui, 19 79)
and is the first direct assessment of recycling in hyperthyroid man.
The excess energy consumption in this process is however minimal
although the concept is important.
Assuming a wastage of 4ATP molecules per molecule of
glucose recycled as the sole energy deficit, the amount of energy
involved would be only 10. 5 kcal per 24h. However, as will be
discussed later, fuel economy in hyperthyroidism may be more
heavily based on lipid metabolism. Given also that the body has
greater stores of fat than carbohydrate and that substrate cycles may
operate within the adipocyte (NEFA:triglyceride), the potential for
energy consumption in adipose tissue may be considerably greater.
The demonstration that lipolysis and lipogenesis both proceed at
accelerated rates in isolated rat adipocytes (Sestoft, 1980) lends
weight to this hypothesis. Energy derived from the hydrolysis of ATP
during operation of such cycles cannot be harnessed to any
metabolically useful purpose, and is dissipated as heat. Many of the
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clinical features of hyperthyroidism (such as heat intolerance, sweating
and tachycardia .) could be explained on this basis.
14
Turnover rates determined using [ C]-l-glucose represent
'irreversible' glucose disposal and were not significantly increased
in hyperthyroidism. The greater part of the increase in total glucose
turnover could thus be accounted for by increased recycling. This is in
contrast, to the findings in hyperthyroid rats where irreversible
glucose disposal was also increased (Okajima & Ui, 1979)-
Isotopic studies therefore suggest that glucose production
is increased in hyperthyroid but they do not differentiate between
changes in glycogenolysis and gluconeogenesis nor do they indicate
the total capacity of either process.
An attempt was therefore made to investigate gluconeogenesis
in vivo in man. Blood concentrations of the gluconeogenic precursors
lactate, pyruvate and alanine were similar in hyperthyroid and control
subjects whilst blood glycerol concentrations were increased in
hyperthyroidism. Circulating levels of gluconeogenic precursors do
not however give sufficient information to extrapolate results to changes
in gluconeogenesis.
Administration of a radioactively labelled gluconeogenic
precursor and measurement c£ its appearance in glucose is an
attractive means for increasing gluconeogenesis. However, fairly
large amounts of radioactivity may have to be given to achieve satisfactory
increases in glucose specific activity for subsequent analysis. This
would be particularly true should isotopes of lactate or pyruvate be
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used because of the numerous and diverse metabolic pathways in
which there intermediates participate (Okajima et al. 1981; Katz et al.
1981). Exchange of isotope between these various metabolites also
hampers interpretation of the results. In addition the majority of
patients suitable for study were young and female to whom
radioisotopes could not be administered ethically.
Alternatively, splanchic balance studies would have permitted
estimation of uptake of gluconeogenic precursors by the liver. Such
studies have been performed (Wahren et al. 1981) and have shown
that uptake of all the major gluconeogenic precursors by the liver is
increased in hyperthyroidism. For lactate, pyruvate and alanine this
is achieved by increased fractional splanchnic extraction whilst for
glycerol increased arterial concentrations leading to increased hepatic
supply is responsible. These data are consistent with isolated
perfused rat liver studies which have also demonstrated increased
hepatic uptake of all the major gluconeogenic precursors
(see Chapter 4:3). Splanchnic balance studies are however invasive
and involve catheterisation of the hepatic vein and a peripheral
artery andthus pose serious ethical problems. Also, the assumption
from these studies is that hepatic uptake of a gluconeogenic precursor,
during fasting is equivalent to its incorporation into glucose, which
may not be true in normal or diseased man (Cherrington, 1981).
The other principal method involves administration of a
substrate load and measurement of its clearance from blood. For
lactate, pyruvate and alanine the assumption that clearance from blood
could be equivalent to incorporation into glucose is untenable because
of their diverse metabolic fates (see above). However, in the fasting
state, glycerol has no major metabolic fate other than hepatic uptake
for gluconeogenesis (Shaw et al. , 1976) and indeed is metabolised
to glucose in preference to other precursors (Sestoft et al. 1977).
The underlying principal of the study undertaken was therefore to
"flood" the metabolic pathway for glycerol clearance with a bolus i. v.
glycerol injection so that the subsequent clearance rate of glycerol
could be equated to the capacity for gluconeogenesis (see Chapter 4:4).
Using this technique glycerol clearance was increased by
80% in hyperthyroidism compared to controls of similar age and weight
suggesting a considerable increase in gluconeogenic capacity.
Assuming that glycerol clearance is independent of its concentration
within the range employed, the finding of a 3 fold rise in endogenous
glycerol production with only a 70% increase in fasting blood glycerol
levels suggests that basal rates of gluconeogenesis from glycerol
are also increased in hyperthyroidism. It should however be stressed
again that the assumption that clearance can be equated directly with
gluconeogenesis remains to be firmly established.
The contribution of glycogenolysis to hepatic glucose
production has not been assessed in this thesis but previous studies
have shown that hepatic glycogen stores are diminished in overnight
fasted thyrotoxic man (Pipher and Paulsen, 1947) and animals
(Battarbee, 1974). In addition splanchnic balance studies have shown
that glycogen breakdown contributed less to hepatic glucose production
in thyrotoxic subjects compared to normals after an overnight fast
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(Wahren et al. 1981).
Thus in hyperthyroidism blood glucose concentrations are
increased after an overnight fast as a result of increased hepatic
glucose production. The bulk of this increase is probably the
result of enhanced gluconeogenesis. Irreversible glucose disposal
is normal but recycling of glucose derived 3-carbon intermediates
is greatly increased.
In hypothyroidism fasting blood glucose concentrations were
normal. This is in agreement with previous reports (Saunders et al.
1980) although some studies have shown a small decrease (Lamberg
1965; Levy et al. 1970). Despite these findings a small, but highly
significant decrease in glucose turnover was apparent together with
a significant reduction in irreversible glucose disposal. Whilst
similar results have been demonstrated in hypothyroid rats (Okajima
& Ui, 1979) Saunders et al. (1980) found glucose turnover values in
hypothyroid man to be within the normal range although a significant
increase was demonstrable following thyroxine replacement therapy.
Glucose recycling, not previously investigated in hypothyroid man, was
normal in contrast to rat studies where recycling was diminished
(Okajima & Ui, 1979)-
Circulating concentrations of lactate, pyruvate and alanine
were normal in fasted hypothyroid subjects whilst glycerol concentrations
were diminished (Chapter 8) or normal (Chapters 9, 10, 11). The
reason for the variable fasting blood glycerol concentrations is
uncertain because dietary preparation was similar in all studies.
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These results are comparable with those of Saunders et al. (1980)
but other studies have shown diminished lactate (McDaniel et al.
1977), and alanine ( Bondy, P.K. 1949; Ness, et al. 1969)
concentrations.
Diminished gluconeogenesis from all the major precursors
has previously been reported from studies using hypothyroid
perfused rat liver preparations (Chapter 4:4). Evidence concerning
gluconeogenesis in hypothyroid man is however scanty. The finding
of normal glucose recycling suggests that gluconeogenesis from lactate
and pyruvate is normal. Glycerol clearance rates were however
decreased by 33% indicated that gluconeogenic capacity from this
substrate is diminished in hypothyroidism. In addition a 50%
1
decrease in endogenous glycerol production in the absence of any
decrease in basal glycerol concentrations in the subjects studies
suggests that basal glycerol clearance (and hence basal gluconeogenesis)
is also diminished. Gluconeogenesis from alanine has previously been
investigated only in infants with congenital hypothyroidism (Hayek, 1979)
and was reported to be normal.
No estimates of glycogenolysis in hypothyroidism has been
made here but previous reports have shown that whilst hepatic glycogen
stores are normal in hypothyroid rats, glycogenoly sis is impaired
(Battarbee, 1974).
Thus in hypothyroidism fasting blood glucose concentrations
are normal but hepatic glucose production is diminished as is
irreversible glucose disposal. Glucose recycling is normal but
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gluconeogenesis from glycerol may be diminished,
ii) Fed man
Impaired tolerance to oral glucose has frequently been
described in hyperthyroidism (Hales & Hyams, 1964; Holdsworth &
Besser, 1968; Marks et al. , I960), but the mechanisms of its
production remain uncertain. Rapid absorption of glucose from the
gastrointestinal tract may be a factor (Holdsworth & Besser, 1968)
but the glucose tolerance test is to some extent an unphysiological
one in that a meal consisting of 50-100 g of pure glucose is rarely,
if ever, encountered in everyday life. For this reason the blood
glucose and intermediary metabolite response to mixed meals was
examined (Chapter 7).
Post-prandial hyperglycaemia was readily demonstrable and
in addition blood glucose concentrations remained elevated
throughout a 1 2h period of normal meals and activity. Peak post¬
prandial blood glucose concentrations occurred at the same time in
patients and controls suggesting that absorption from the gut was not
the major factor. Peripheral insulin concentrations, measured by
standard double antibody radioimmunoassay were similar in hyperthyroid
and control subjects despite prevailing hyperglycaemia in the patient
group. A defect in insulin secretion and/or action was therefore
apparent (for review see Chapter 4:4).
Previous studies of insulin sensitivity in hyperthyroid man and
animals have yielded conflicting results largely due to the variety of
experimental techniques employed. Thus increased, (Elgee &
Williams, 1955; Maracek et al. 1973), decreased (Ikejiri et al. 1977)
or normal (Elrick et al. 1961) insulin sensitivity, have all been
described. In these studies the index of insulin sensitivity has been
the rate of fall of blood glucose concentrations following oral glucose
or intravenous insulin administration. Factors other than true
insulin sensitivity may therefore be involved particularly if
hypoglycaemia is induced and counter-regulatory hormone secretion
is stimulated. The euglycaemic hyperinsulinaemic clamp technique
allows assessment of insulin sensitivity at physiological (usually fasting)
blood glucose concentrations and in the absence of stimulated
counterregulatory hormone secretion (DeFronzo et al. 1979)
(see Chapter 11).
No difference in insulin sensitivity could be found between
hyperthyroid and control subjects. Also, very similar steady state
circulating insulin concentrations were achieved suggesting that insulin
metabolic clearance rates were identical in the two groups.
Explanations for hyperglycaemia after mixed meals or oral glucose
in hyperthyroidism must therefore be sought elsewhere.
Diminished insulin secretion by isolated rat pancreatic tissue
(Milcu et al. 197 5) and, more recently, hypersecretion of proinsulin
in response to oral and intravenous glucose in man (Sestoft & Heding,
1981) have suggested that hyperthyroidism may be associated with
impairment of normal pancreatic insulin secretory mechanisms.
Thus, in man high circulating proinsulin levels may cross react with
insulin when measured by standard double antibody radioimmunoassay
and mask true "hypoinsulinaemia" in thyrotoxicosis. This hypothesis
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could be investigated further using the hyperglycaemic clamp
technique in which insulin secretory pattern and capacity can be
determined in response to a glucose infusion designed to maintain
blood glucose concentrations at a desired hyperglycaemic value
(usually 10 mmol/l) (Ponchner et al. 1982).
Hyperlactataemia and hyperpyruvicaemia were apparant in
hyperthyroid subjects after mixed meals. Since neither production
nor utilisation of these metabolites were measured changes in either
could have been responsible. Evidence suggests that increased
production is the major factor as after oral glucose loading there is
an increase in both peripheral glucose utilisation (Elgee & Williams,
1955; Maracek & Feldman, 1973) and in lactate production measured
directly by forearm balance studies (Araki et al. 1968).
Hyperglycaemia per se may also be important as recent evidence
suggests that the circulating glucose level may be critical in the
regulation of blood lactate concentrations (Cherrington, 1981).
These studies have shown that in the presence of peripheral insulin
levels similar to those reported here after meals, lactate released
by insulin sensitive tissues varies positively with ambient blood
glucose concentrations (Blackshear et al. , 1974; Dietz, 1978).
During the hyperinsulinaemic euglycaemic clamp experiments
(which mimic a pure glucose meal) incremental rises in lactate and
pyruvate were identical in thyrotoxic and control subjects. The
reason for the difference between this finding and the response to mixed
meals despite similar peripheral insulin concentrations is uncertain.
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Several factors may be involved. The total amount of glucose
infused during clamping was 28-30g (whereas a mean oral
carbohydrate load with mixed meals was 45-50g) thereby limiting
the potential for lactate production. Also, blood glucose concentrations
were maintained at fasting levels during clamping and this may
directly affect peripheral lactate production (vide supra).
In hypothyroid subjects blood glucose concentrations were
mildly elevated after breakfast and the peak blood glucose level was
delayed. Meal tolerance thereafter was normal. Impaired tolerance
to oral glucose has previously been reported (Gutman et al. 1972)
and attributed to impaired absorption of glucose from the gastro¬
intestinal tract (Holdsworth & Besser, 1968; Althausen & Stockholm,
1980). Whilst this may explain a delay in peak post prandial blood
glucose levels it would be expected to produce a "flattening" of the blood
glucose profile. The exaggerated blood glucose response reported
here suggests impaired peripheral glucose utilisation in
hypothyroidism. Sensitivity to exogenous insulin was not assessed in
hypothyroid subjects, nor was the pattern of insulin secretion. Thyroid
hormones are however required for normal insulin secretion by
isolated rat pancreatic cells (Milcu et al. 197 5).
Hyperlactataemia and hyperpyruvicaemia were apparent after
meals in hypothyroidism (as in hyperthyroidism) and the bulk of the
available evidence suggests that this is due to diminished clearance
(Shamer et al. 1971; McDaniel et al. 1977). An effect of ambient
hyperglycaemia (Cherrington et al. 1981) may also be important.
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iii) Effects of Therapy
Antithyroid therapy for 6 months (Chapter 7) had no
effect on fasting blood glucose concentrations or on the response of
blood glucose, lactate and pyruvate to mixed meals. Similarly
Kreines et al. (1965) and Cavagnini et al, (1974) reported persisting
intolerance to oral glucose in subjects whose hyperthyroidism had
apparently been successfully treated. The reasons for persistance
of these abnormalities are uncertain particularly because some aspects
of glucose metabolism (e. g. glucose turnover and recycling) do
return to normal within this period.
Serum insulin levels were unaltered by antithyroid treatment.
In animals, thyroid hormone excess is associated with damage to
pancreatic beta cells (Hoist, 1921). In dogs, although short term
exposure to thyroid hormone excess produces reversible damage,
permanent pancreatic damage may be caused by more prolonged
exposure (Houssay, 1946), resulting in persisting insulin hyposecretion.
The presence of hyperglycaemia with normal serum insulin levels in
our patients suggests that insulin hyposecretion persisted despite
treatment. The pattern of insulin secretion with regard to insulin :
proinsulin ratio in hyperthyroid patients following treatment is unknown.
Persisting hyperlactataemia and hyperpyruvicaemia after meals
is difficult to explain but may again relate to ambient blood glucose
concentrations (Cherrington, 1981). Further studies are required to
determine whether glucose metabolism ever returns entirely to normal
in treated thyrotoxic patients.
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In hypothyroidism, thyroxine therapy over a six month period
had no effect on fasting or post-prandial blood glucose, lactate or
pyruvate concentrations. Circulating insulin levels increased
significantly and were higher than in controls. Untreated
hypothyroidism may thus be associated with both insulin hyposecretion
and insulin resistance. Thyroxine therapy may restore insulin
secretory capacity but have no effect on insulin resistance. No ready
explanation for the failure of post-prandial hyperlactataemia to respond
to treatment can be proposed, particularly as glucose turnover and
recycling return to normal within 6 months (Chapter 9; Saunders et al.
1980; Okajima & Ui, 1979).
14.2. LIPID METABOLISM
i) Post-absorptive man
The finding of increased levels of NEFA and glycerol
in hyperthyroid subjects both after an overnight fast and immediately
prior to each meal suggests increased lipolysis. This has previously
been demonstrated in hyperthyroidism both in vivo (Rich et al. 19 59;
Harlan et al. 1963) and in isolated adipose tissue (Arnereit al. 1979;
Wennlund et al. 1981). These latter authors have suggested that the
increase in lipolysis may be due to increased p adrenergic sensitivity
perhaps coupled with diminished responsiveness of the adipocyte to
circulating insulin. A direct effect of thyroid hormones cannot be
confirmed or excluded on available data. The turnover of both glycerol
(Tibbling, 1969) and NEFA (Saunders et al. 1980) is also increased
in hyperthyroid man confirming that both production and utilisation of
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these substrates are enhanced. Data from the glycerol clearance
study reported here showing enhancement of glycerol clearance and
production (Chapter 10) is in agreement with these findings.
Blood ketone body concentrations were also increased in
hyperthyroid patients (Chapter 7, 10, 11, 12) and, as in normal
subjects, this was related to an increase in ketone body production.
The 3-fold increase in ketone body production reported in
hyperthyroidism agrees well with the splanchnic balance studies of
Hagenfeldt et_al. (1981). Because of this increased production,
several authors (Hagenfeldt et al. 1981; Bartels et al. 1979) have
postulated that hyperthyroidism is characterised by a state of
"accelerated starvation". Contrary to this view studies reported
here have demonstrated fasting hyperglycaemia with increased glucose
production features not associated with prolonged starvation. The
increase in glucose production was however modest (50%) and most
was used for recycling. Compared to the increase in ketone body
production this suggests that whilst overall energy demands are
increased in hyperthyroidism a significant proportion of this increase
is met by increased fat metabolism.
The reason for the increased ketone body production is
uncertain. Increased supply of substrate NEFA due to increased
lipolysis and increased hepatic blood flow are clearly important
factors but whether thyroid hormones alter the metabolic "set" of the
liver such that fatty acid oxidation and ketone body production are
favoured is unclear. Hagenfeld et al. (1981) believed that the
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major part of the increase in ketone body production in hyperthyroidism
could be accounted for by the increase in precursor supply although an
effect on hepatic metabolism could not be excluded by their data.
Effects on intrahepatic NEFA metabolism in hyperthyroidism
have previously been investigated using isolated perfused livers
from hyperthyroid rats (Keyes & Heimberg, 1979; Laker & Mayes, 1981;
Bartels & Sestoft, 1980). These studies have universally demonstrated
that hyperthyroidism is associated with increased ketone body
production from exogenous substrate. Ketone body production rates
in the absence of added substrate (endogenous production) had not
previously been examined nor had the hormonal environment
prevailing in the donor rats.
Using isolated hepatocytes from recently fed rats
(Chapter 13) thyroid hormone pretreatment was associated with a
significant increase in ketone body production from 1 mM palmitate.
After 48h starvation however there was no apparent difference in
ketone body production by hepatocytes from hyperthyroid compared to
control or indeed fed hyperthyroid rats. These observations have
previously been described in studies using perfused rat livers
(Bartels & Sestoft, 1980) and may be related to experimental design.
Possibly ketone body production from ImM palmitate was already
maximal in fed thyrotoxic rat hepatocyte preparations with no
possibility for an increase with subsequent starvation. This maximal
production rate could also be achieved by normal rat hepatocytes
after 48 h starvation. Further studies using different substrate
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concentrations and varying fasting periods are required to resolve
the question.
The intrahepatic events which regulate these processes are
largely unknown but it is likely that the acyl-carnitine transport
(ACT) system is an important regulatory step. Bartels and
Sestoft (1981) have shown that whilst ketone body production from
long chain fatty acids (which enter mitochondria via the ACT system)
is increased in hepatocytes from recently fed thyrotoxic rats,
production rates from octanoic acid (a medium chain fatty acid which
does not use the ACT system to enter mitochondria ) are similar to
control values. This is also consistent with data from Van Tol (1971)
showing an effect of thyroid hormones to increase the activity of the
carnitine shuttle.
Of the postulated regulators of the ACT system activity,
malonyl CoA has received most attention (McGarry et al. 1977 & 1978).
This compound, the first committed intermediate of the fatty acid
synthesis sequence is a potent inhibitor of the ACT system. Malonyl
CoA levels in the liver are increased in the fed state when conversion
of glucose to fat is enhanced resulting in inhibition of the ACT system
and hence fatty acid oxidation. Conversely, during fasting, little
glucose is available for conversion to fat, malonyl CoA levels are
low, ACT is activated and ketone body production accelerated. Insulin
I
is a potent inhibitor of ketogenesis in the intact animal firstly by its
action to suppress lipolysis but secondly by its capacity to greatly
increase the activity of acetyl CoA carboxylase (which catalyses
the reaction acetyl CoA—> MalQnyl CoA) (Lee et al. 1973, Klain et al.
1974). Glucagon on the other hand has been shown to markedly and
rapidly decrease hepatic fatty acid synthesis and to simultaneously
diminish by 70% the activity of acetyl CoA carboxylase (Klain &
Weber, 1973; McGarry et al. 1978). These observations lead
McGarry and Foster to hypothesize a bihormonal control of the ACT
system. The finding of decreased peripheral insulin concentrations
in fed thyrotoxic rats may therefore be of crucial importance in
that the livers may have been primed for ketogenesis before
removal. The findings reported here would be compatible with an
effect of hyperthyroidism to inhibit pancreatic insulin secretion in the
rat without necessarily implicating a direct effect of thyroid hormones
on rat liver metabolism.
In the absence of added palmitic acid substrate ketone body
production was diminished in hepatocytes from hyperthyroid rats
implying that endogenous substrate stores were also diminished.
Intrahepatic triglyceride levels were not determined here but
previous studies (Bartels & Sestoft, 1981; Laker & Mayes, 1981;
Keyes &Heimberg, 1979) have shown them to be decreased.
Metabolic clearance rates for ketone bodies, measured
isotopically were increased in hyperthyroid man suggesting
adaptation of peripheral tissues to ketone body utilisation as a source
of calories. The reason for this is uncertain but the oxidation of
ketone bodies by peripheral tissues produces an immediate sparing
of glucose (for cerebral use) by inhibiting glycolysis (as in heart
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and kidney) and/or pyruvate oxidation (in all tissues) (Fenselau, 1981).
The products of the limited degradation of glucose, pyruvate and
lactate, can be returned to the liver for gluconeogenesis. This
sequence of events may explain why irreversible glucose
is normal in hyperthyroidism whilst Cori cycle activity and total
glucose turnover are increased. As the brain adapts to ketone body
utilisation (mechanism unknown) the obligatory requirement of
nervous tissue for glucose will fall, the requirement for gluconeogenesis
will be diminished so that protein can be conserved. Ketone bodies
also have a direct inhibitory effect on proteolysis (Felig, 1973) in
skeletal muscle thus further reducing the demand on protein stores/
I
muscle bulk which would otherwise become severely depleted in
hyperthyroidism.
Initial studies in fasting hypothyroid men reported here
suggested, on the basis of diminished blood glycerol concentrations,
that lipolysis was decreased (Chapter 8). In subsequent studies
(Chapters 9, H> 12) hypothyroidism was associated with normal
fasting blood glycerol concentrations. The reason for these
discrepant findings is not readily apparant as dietary preparation
was identical. Normal fasting NEFA concentrations were also found
and NEFA turnover has been shown by others (Saunders et al. 1980)
to be normal in hypothyroid man. Previous studies have however
suggested diminished lipolysis in hypothyroidism both in vitro
(Arner et al. 1981) and in vivo (Goodman & Bray, 1966) with
diminished responsiveness to circulating catecholamines as the
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likely mechanism (Arner et al. 1981). The finding of decreased
endogenous glycerol production rates (Chapter 10) is again suggestive
of diminished lipolysis in hypothyroidism despite the presence of
normal fasting glycerol levels.
Fasting blood ketone body concentrations were normal as
were ketone body production and clearance rates suggesting that
not only is hepatic substrate supply normal but intrahepatic NEFA
metabolism is also normal. Studies using isolated perfused rat
liver preparations have yielded conflicting results with both normal
(Laker & Mayes, 1981) and diminished (Keyes &: Heimberg, 1979)
ketone body production from fixed amounts of substrate being reported.
The balance of the evidence reported in this thesis therefore
suggests that thyroid hormone deficiency is associated with diminished
lipolysis with normal blood glycerol levels the result of diminished
glycerol clearance. Ketone body metabolism is however normal,
ii) Fed man
Although the normal diurnal patternsfor plasma NEFA
and blood glycerol concentrations were maintained in hyperthyroid
subjects (rising before and falling after meals), post prandial
concentrations of both remained elevated compared to controls.
These findings suggest that meal induced suppression of lipolysis
may be impaired in hyperthyroidism. Circulating levels of both these
metabolites also fail to suppress following oral glucose administration
in hyperthyroidism (Ortigosa et al. 197 6) whilst studies using isolated
fat tissue have shown impaired insulin mediated suppression of glycerol
release (Wennlund et al. 1981). These findings suggest that
resistance to insulin action may be present in thyrotoxic human
adipose tissue. Further evidence in support of this view comes
from the hyperinsulinaemic euglycaemic clamp studies (Chapter 11).
These showed that blood glycerol concentrations in hyperthyroid
subjects failed to suppress to control values during insulin infusion.
The mechanism(s) underlying these changes are uncertain but
alteration of insulin receptor number or affinity has been postulated
(Wennlund et al. 1981). Further studies are underway to investigate
these possibilities in more detail.
In contrast to glycerol and NEFA levels, circulating ketone
body concentrations returned to normal following mixed meals and
during insulin infusion (Chapter 7, 11). This suggests that
suppression of ketogenesis is normal in hyperthyroidism despite
increased precursor supply from the periphery.
In hypothyroidism the normal diurnal profiles for blood
glycerol, plasma NEFA and blood ketone body concentrations were
lost, concentrations neither increasing before nor falling after
meals. Since blood ketone body production is normal in hypothyroidism
(Chapter 12) loss of the diurnal profile may simply reflect changes in
blood glycerol and plasma NEFA. Plasma NEFA levels reflect the
balance between lipolysis and reesterification with the adipocyte as
well as hepatic uptake and utilisation by peripheral tissues. Following
oral glucose hypothyroid subjects show impaired suppression of plasma
NEFA concentrations (Gutman et al. 1972). The reason for this is
unclear but in the presence of diminished peripheral glucose utilisation
226.
reesterification of NEFA by adipocytes may be impaired
(Chapters 8, 9; Okajima & Ui, 1979). Although there is discrepant
data concerning fasting concentrations, the loss of normal diurnal
blood glycerol concentrations does suggest that there may be prolonged
post-meal suppression of lipolysis compared to the situation in
normal subjects.
iii) Effects of therapy
In hyperthyroid subjects fasting blood glycerol, plasma
NEFA and blood ketone body concentrations returned to control values
following 6 months of antithyroid therapy (Chapters 7, 12) suggesting
that normal rates of lipolysis and ketogenesis were restored.
Normal responsiveness of isolated human adipocytes to both
catecholamines (Arner et al. 1979) and insulin (Wennlund et al. 1981)
is also restored by adequate treatment of hyperthyroidism. Ketone
body production and clearance (Chapter 12) are also normal after
treatment as are glycerol (Tibbling, 1969) and NEFA (Saunders et al.
1980) turnover. Normal ketone body production may reflect normal
hepatic substrate NEFA but splanchnic balance studies (Hagenfeldt
et al. 1981) have shown that the ratio of ketone body production to
hepatic fatty acid uptake is also decreased suggesting an additional
effect on intrahepatic fatty acid metabolism.
Diurnal profiles of glycerol, NEFA and ketone body
concentrations retained a normal pattern in treated hyperthyroid
subjects and were similar to or even lower than values found in
I
controls following mixed meals (Chapter 7). These results are in
contrast to the profiles for glucose and the gluconeogenic precursors
which were unaltered by treatment. The reasons for these
discrepant results are uncertain (vide supra).
In hypothyroidism the initially decreased fasting blood
glycerol concentrations observed in the metabolic profile
experiments (Chapter 8) were increased towards normal by thyroxine
therapy. In other studies (Chapters 11, 12) normal fasting
glycerol concentrations were unaltered by treatment. Plasma NEFA
and blood ketone body concentrations were normal after overnight
fasting before and after replacement therapy as were ketone body
production and metabolic clearance. Diurnal profiles for blood glycerol,
ketone bodies and plasma NEFA were restored towards a more
normal pattern.
14:3. EFFECTS OF THYROID HORMONES ON CYTOSOLIC AND
MITOCHONDRIAL REDOX STATE AND HYDROGEN
SHUTTLE ACTIVITY
Although none of the studies reported here were specifically,
designed to look at this question, several observations suggest that
thyroid hormones may have important effects on the intracellular
redox state. Thyroid hormones not only determine the amount of
pyridine nucleotides (NAD NADp', NADH, NADPH) in the tissues
of experimental animals but also the balance between the oxidised
and reduced forms (Hoch, 1974). In the cytosol and mitochondria
hyperthyroidism favours the oxidised form and hypothyroidism the
reduced. Changes in mitochondrial and cytosolic redox state maybe
reflected in blood as alterations in the ratio of lactate to pyruvate (l:p)
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or in the ratio of 3 hydroxybutyrate to acetoacetate (3-OHB:Acac).
The finding therefore of a paradoxical increase in L:P ratio
following meals in hypothyroid subjects suggests a more reduced
cytosolic redox state implying a failure of transfer of reducing
equivalents from the cytosol to the mitochondria.
Thyroid hormones may exert their influence on redox
states partly by their effects on H-shuttle activity. The activity of
mitochondrial a;-glycerophosphate dehydrogenase (aGPD) has special
metabolic significance. The enzyme converts a -glycerophosphate
(aGP) to dihydroxyacetone phosphate (DHAP) with generation of the
reducing equivalent, FADH. DHAP is transferred to the cytoplasm
where it is converted to a GP by a cytosolic a-glycerophosphate
dehydrogenase. The latter reaction converts NADH to NAD and
regenerates sGP for mitochondrial use. Since the mitochondria are
impermeable to NADH the system provides a mechanism for the
transfer of reducing equivalents from the cytosol to the mitochondrial
with the regeneration of NAD . Malic enzyme adopts a similar role
in another H-shuttle mechanism and the activity of this enzyme and
ffGPD are known to be dependant on thyroid hormones in the rat both
by increasing synthesis of the enzymes themselves (Lee &: Lardy,
1965; Lee et al. 1959; Lardy et al. I960) and also the coenzyme FAD
(Wolf & Rivlin, 1970) (see Figure 10:2).
The rather surprising finding of a marked decrease in the
ratio of production of 3-hydroxybutyrate to acetoacetate by isolated
hepatocytes from hyperthyroid rats (Chapter 13) could also be
explained on the basis of changes in the cellular redox potential if
the balance within the mitochondria was towards a more oxidised
state as shown by Hoch (1974). Decreased 3-hydroxybutyrate to
acetoacetate production has been described by some (Bartels &
Sestoft, 1981) but not all (Laker & Mayes, 1981) workers using
isolated perfused hyperthyroid rat liver preparations. In hyperthyroid
man (3-OHB : Acac) production was normal as judged by splanchnic
balance studies although effects due to recycling of ketone bodies from
the periphery to the liver cannot be excluded. The observation that
a decreased 3-hydroxybutyrate to acetoacetate production by
hyperthyroid rat hepatocytes was not reflected by a decreased 3-OHB :
Acac ratio, in blood suggests either preferential peripheral utilisation
of acetoacetate or substantial interconversion of the two ketone bodies
peripherally. Freeze-clamp studies of rat peripheral tissues are
planned to investigate this in more detail.
Further evidence suggesting an important role for
mitochondrial a GPD in the metabolic sequelae of thyroid over and
underactivity comes from the glycerol infusion data described in
Chapter 10 showing thyroid hormone dependent changes in glycerol
I
clearance in man. Glycerol taken up by the liver is first
phosphorylated. In the rat, the activity of glycerol kinase is
unaffected by thyroid state but gluconeogenesis from glycerol in
isolated perfused livers is greatly increased in hyperthyroidism as
feedback inhibition by glycerol-3-phosphate on glycerol kinase is
lacking (Sestoft et al. 1977). Accumulation of glycerol-3-phosphate
does not occur because of the extraordinarily large induction of
mitochondrial arGPD by thyroid hormones (Lee et al. 1959). The
activity of mitochondrial a GPD could play a role in the calorigenic
action of thyroid hormones by at least two different mechanisms
(1) by allowing a higher rate of glycerol phosphorylation (Sestoft
et al. 1977) and of glycerol conversion to glucose (Schimasseck
et al. 1963; Werner & Berry, 1944; Sestoft et al. 1977; Lin, 1977)
and (2) by reducing the phosphorylation : oxidation ratio for oxidation
of cytosolic reducing equivalents from three to two (NAD linked
shuttles versus FAD linked shuttles respectively). It is therefore of
interest that Nolte et al. (1972) did not find any increase in the
activity of mitochondrial a GPD in the liver of hyperthyroid man.
Although this observation remains to be confirmed it is indirectly
supported by the finding that fractional glycerol turnover is not
increased in hyperthyroid man (Tibbling, 1969)- Haemodynamic factor
may thus be as or more important in determining glycerol clearance
in man than changes in mitochondrial a GPD activity.
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SUMMARY
To investigate the influence of thyroid hormones on intermediary metabolism in
man, hormone and metabolite profiles were obtained over a 12-h period of
normal meals and activity in eight hypothyroid subjects before and during
thyroxine replacement therapy, and in sixteen matched controls.
The fasting blood glucose concentration and the mean 12-h blood glucose
concentration were normal in hypothyroid subjects but the blood glucose
response to breakfast was exaggerated. Fasting blood lactate and pyruvate
levels were normal but post-prandial hyperlactataemia and hyperpyruvicaemia
were found and mean 12 h values for lactate (hypothyroid 1 08 + 0-06 v. control
0-77 + 0-03 mmol/1, RcOOl) and pyruvate (0-10 + 0-01 v. 0-08 + 0 003 mmol/1,
P < 0-01) were elevated. Blood alanine concentrations were elevated only in the
evening. Although plasma non-esterified fatty acid levels were normal, fasting
blood glycerol levels were decreased (0 06 + 0-01 v. 0-08 + 0-01 mmol/1,
P< 0-001) and this decrease persisted throughout the 12-h period. Blood total
ketone body concentrations did not differ from controls, but, as for plasma
NEFA and blood glycerol, the normal preprandial rise in concentration was
absent. Serum insulin, glucagon and growth hormone concentrations did not
differ from control values at any time.
Six months of thyroxine (T4) treatment produced a rise in blood glycerol
concentrations (mean 12 h value during T4 therapy, 0-06 + 0-01; before T4
therapy, 0-04 + 0-005 mmol/1; EcO-Ol) but not to control values (0-08 + 0-01
mmol/1). Concentrations of glucose and other gluconeogenic precursors were
unaltered by therapy but the insulin response to meals and the mean 12 h serum
insulin concentration were increased.
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Hypothyroidism is therefore associated with mild postprandial hyperglycae-
mia which is not normalized by thyroxine therapy, despite an increased insulin
response to food. The elevated concentrations of gluconeogenic precursors
could result from diminished hepatic uptake. Lipolysis in hypothyroidism is
diminished and only partially normalized by conventional replacement therapy.
The clinical features of thyroid hormone deficiency are well recognized and many
abnormalities of carbohydrate, lipid and protein metabolism in both animals and man
have been described.
Animal studies have shown that hypothyroidism is associated with decreases in
gluconeogenesis (Freedland & Krebs, 1967), glycogenolysis (Battarbee, 1974), peripheral
glucose utilization (Scow & Cornfield, 1954), lipolysis (Bray & Goodman, 1968),
lipogenesis (Bates et al., 1955; Bray & Goodman, 1968) and protein turnover (Hoberman
& Graff, 1951).
In man fasting hypoglycaemia (Lamberg, 1965), impaired tolerance to oral glucose
(Crawford, 1940) with normal (Holdsworth & Besser, 1968) or impaired (Shah & Cerchio,
1973) peripheral insulin responses have all been reported. Decreased lipolysis, both in vivo
(Hamburger et a!., 1963) and in isolated human adipocytes (Rosenqvist, 1972) has been
demonstrated, but little is known about the effects of hypothyroidism on ketone body
metabolism.
The effects of these changes on circulating hormone and metabolite concentrations in
hypothyroid man under normal circumstances are unknown and the effects of subsequent
thyroid hormone replacement have not previously been described. We have therefore
examined hormone and metabolite profiles during normal meals and activity in
hypothyroid subjects before and during thyroxine replacement therapy and in euthyroid
controls.
PATIENTS AND METHODS
Eight (six female and two male) patients with hypothyroidism were compared with
sixteen control subjects of similar age, sex and ideal body weights (Table 1). No subject
had a personal or family history of diabetes and none were on any medication at the time
of initial study. Liver function tests were normal. Hypothyroidism was secondary to
Hashimoto's thyroiditis in six subjects (on the basis of spontaneous hypothyroidism
occurring in subjects with circulating antibodies to thyroid tissue), partial thyroidectomy
for colloid goitre in one subject and radioiodine therapy in one subject.
An intravenous teflon cannula was inserted into an antecubital vein at 0800 h after an
overnight (10 h) fast, and subjects remained recumbent until 0830 h. The cannula was
maintained patent with 0-15 mmol/1 saline. Blood samples for hormones and metabolites
were withdrawn at 0825 h and 0830 h. Breakfast was eaten at 0830 h and further blood
samples were withdrawn at half-hour intervals until 2000 h. Meals were standard hospital
meals containing approximately 2000 calories with 45% carbohydrate, 40% fat and 15%
protein by weight. Lunch was eaten at 12 noon and the evening meal at 1800 h. All
subjects consumed a dietary intake of 300 g of carbohydrate for at least 48 h prior to the
study. After breakfast subjects were mobile and encouraged to take gentle exercise
throughout the test although remaining at rest for at least 10min before each sample time.
Hypothyroid subjects were restudied when clinically euthyroid and conventional thyroid
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function tests were normal. Treatment consisted of L-thyroxine 100-200 pg daily to
maintain normal circulating serum thyroxine and serum thyroid stimulating hormone
concentrations. The mean interval between studies was 5-9 months.
Blood for glucose, lactate, pyruvate, alanine, glycerol and 3-hydroxybutyrate was
taken in 5% (V/V) chilled perchloric acid and assayed by automated fluorimetric
enzymatic methods (Lloyd et al., 1978). Acetoacetate was assayed by a kinetic
spectrophotometric method (Price et al., 1977). All metabolite samples were separated
immediately, frozen at —20°C and assayed within 24 h. Total ketone bodies refers to the
sum of acetoacetate and 3-hydroxybutyrate concentrations. Serum insulin (Soeldner &
Slone, 1965) thyroid stimulating hormone (Hall et al., 1971), triiodothyronine (Hesch &
Evered, 1973) and growth hormone (Hartog et al., 1964) were assayed by double antibody
radioimmunoassay and serum thyroxine by radioimmunoassay (Malinkrodt, RIA-
MAT® T4). Samples for glucagon were taken into chilled tubes containing 1 mmol EDTA
in 1250 Kiu trasylol and assayed by wick chromatography (0rskov et al., 1978). Plasma
non-esterified fatty acids NEFA were assayed by a radiochemical method (Ho & Meng,
1969).
Statistical analyses were performed using Student's paired and unpaired t tests as
appropriate. Certain measurements (ketone bodies, glucagon and insulin) were log-nor¬
mally distributed and statistical analysis was performed on log-transformed data.
Correlations were sought by the method of least squares or the Spearman ranking
method where appropriate. Values in the text are given as the mean + the standard error
of the mean or as mean+ range.
Informed consent was obtained from all subjects and the study was approved by the
Ethical Committee of Newcastle Area Health Authority (Teaching).
RESULTS
Thyroidfunction tests
Results for serum thyroxine (T4) serum triiodothyronine (T3) serum thyroid stimulat¬
ing hormone (TSH) and percent ideal body weight (% IBW) are shown in Table 1. Serum
T4 and T3 concentrations were lower in hypothyroidism (P < 0 001) than in controls and
increased to normal with thyroid hormone replacement. Serum TSH levels were higher in
hypothyroidism (P< 0 001) and fell, with treatment, to normal values. Although there
was a significant fall with thyroxine therapy (P < 0-05), percentage of ideal body weight in
hypothyroid subjects before and after therapy was similar to controls.
Fasting metabolites and hormones
Metabolite concentrations Fasting concentrations of blood glucose and the gluconeo¬
genic precursors, lactate, pyruvate, and alanine, blood ketone bodies and plasma NEFA
were similar in hypothyroid patients and controls (Table 2). Blood glycerol concentra¬
tions were however decreased in hypothyroidism (patients, 0 06 ±001; controls,
0 08 + 0 01 mmol/1; RcOOOl).
Hormone concentrations There were no significant differences between fasting serum
insulin, growth hormone and plasma glucagon concentrations in hypothyroid and
control subjects.
Effect of thyroxine therapy Fasting blood concentrations of glucose, lactate, pyruvate,
alanine and 3-hydroxybutyrate were unchanged by thyroxine replacement therapy. Blood
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acetoacetate levels rose significantly [during treatment 0 08 (0 03-0-16), untreated 0 04
(0 02-0 07) mmol/1; /><0-05], Blood glycerol levels also rose (during treatment
0 08 + 0 01, untreated 0 06 + 0 01 mmol/1; P < 0 05). Serum insulin, growth hormone and
plasma glucagon levels were unchanged by thyroxine replacement.
Diurnal profiles
Metabolite concentrations Mild hyperglycaemia was apparent after breakfast in
hypothyroid subjects (Fig. 1) although the glycaemic response to lunch and evening meal
was normal. As a result the mean 12-h blood glucose value was unaltered by
hypothyroidism. Blood lactate and pyruvate responses to meals were exaggerated and
mean 12 h values for blood lactate (hypothyroid 1 08 + 0 08; control 0-77+ 0 03 mmol/1;
F<0-001) and blood pyruvate (hypothyroid 0-10 + 0-01; control 0-08 + 0-003 mmol/1;
P < 0-01) were elevated in hypothyroidism (Fig. 2) (Table 2). The ratio of blood lactate to
blood pyruvate in control subjects fell after each main meal (Table 3). In hypothyroid
subjects, lactate:pyruvate ratios rose with meals and were significantly higher than in
control subjects.
* * * *
i I I I
200 1500 1800 2000
h
Fig. 1. Blood glucose and serum insulin profiles in hypothyroid subjects before (• •) and
during (• •) thyroxine therapy and in controls (■ ■). The first sample was taken after
an overnight fast. Thereafter meals were taken at 0830, 1200 and 1800 h with snacks at 1030 and
1530 h. * /><0-05 hypothyroid subjects before therapy v. hypothyroid subjects during therapy.
(**P<0-01). +P<0-05 hypothyroid subjects before therapy v. controls (+ + = + <0-01).







0830 1200 1500 1800 2000
Fig. 2. Blood alanine, lactate and pyruvate profiles in hypothyroid subjects before and during
thyroxine therapy and in controls. See legend to Fig. 1 for key and conditions.
Table 3. Blood lactate: pyruvate ratios before and 2 h after the three main meals in
hypothyroid subjects before and during therapy and in controls. (For symbols and







therapy Controls Pi Pi Pi
Before breakfast 10-3 + 0-7 10-1 + 0-6 10-2 + 0-3 ns ns ns
2 h after breakfast 11 -7 ± 0-6 10-6 + 0-4 9-7 + 0-4 ns <0-05 ns
Before lunch 10-3 + 0-4 10-2 + 0-6 10-5 + 0-4 ns ns ns
2 h after lunch 11-5 + 0-5 10-9 + 0-6 10-2 + 0-4 ns <0-05 ns
Before supper 10-6 + 0-3 10-5 + 0-7 11-2 + 0-3 ns ns ns
2 h after supper 12-1 ±0-8 11-6 + 0-3 10-1+0-4 ns <0-05 <0-05
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Blood alanine concentrations were similar in hypothyroid and control subjects in the
morning and early afternoon but were significantly higher in hypothyroidism over the last
4 h of the study (Fig. 2). As a result mean 12 h blood alanine levels (Table 2) were
significantly higher in hypothyroidism (0-40 + 0 02 v. 0-33 + 0-02 mmol/1, Z' < 0-05). In
control subjects, blood total ketone body, glycerol and plasma non-esterified fatty acid
(NEFA) showed a characteristic diurnal pattern with rises in circulating levels of each
metabolite before meals (Fig. 3). In hypothyroidism, this diurnal pattern for blood
glycerol and blood ketone bodies was lost. Blood glycerol levels were decreased
throughout the study period (0 04 + 0-01 v. 0-08 + 0-01 mmol/1, P< 0-001). A similar,
though less striking decrease was also evident for blood ketone bodies before the evening
meal. The rise in ketone body concentrations between lunch and the evening meal,
assessed as the area under the ketone body curve, was decreased in hypothyroidism













** * * * ****** * * ** ** * * * * *
++-H-++-H- + ++-H-I+-H--H- + + + -H-H--I+-H--H--H-++-H + -H- -H-
, j..r-
0830 1200 1500 1800 2000
Fig. 3. Diurnal profiles for plasma non-esterified fatty acids, blood ketone bodies and blood
glycerol in hypothyroid subjects before and during therapy and in controls. For conditions and
symbols see Fig. 1.
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Hormone concentrations Serum insulin, growth hormone and plasma glucagon levels
did not differ in hypothyroid and control subjects at any time.
Effects of thyroxine therapy Thyroxine therapy did not restore the blood glucose
response to breakfast to normal but serum insulin levels after meals were increased
particularly in the evening, and the mean 12-h serum insulin concentration was elevated
(Table 2). Plasma glucagon concentrations were not affected.
Mean 12 h values for blood lactate, pyruvate or alanine concentrations (Table 2) were
also unaltered by thyroxine therapy, but blood glycerol concentration rose significantly
(untreated 004 + 001, during treatment 006 + 001 mmol/1, .PcO-01) although they
remained lower than in controls (0-08 ±0 01 mmol/1, PcO-05). Total ketone body
concentrations were unaltered by replacement therapy although a normal diurnal pattern
was restored.
Serum T4, T3 and TSH concentrations did not correlate with blood levels of any of the
hormones or metabolites measured in hypothyroid subjects before or during therapy or in
controls.
DISCUSSION
Previous studies in hypothyroid subjects have shown either a normal (Saunders et al.,
1980) or decreased (Lamberg, 1965; Levy et al., 1970; Shah et al., 1972) fasting blood
glucose concentration. The decrease in blood glucose has been attributed to both
impaired hepatic glycogenolysis (Battarbee, 1974) and impaired gluconeogenesis (Bondy,
1949; Freedland & Krebs, 1967; Menahan & Weiland, 1969; Sestoft et al., 1977). In the
present study, fasting blood glucose concentration was normal. Glucose turnover is
decreased in hypothyroid rats (Okajima & Ui, 1979) but in hypothyroid man, glucose
turnover may be decreased (McCulloch et al., 1980) or normal (Saunders et al., 1980).
The blood glucose response to breakfast was mildly elevated and the peak blood
glucose value delayed in hypothyroidism. Absorption ofglucose from the gastrointestinal
tract is delayed both in man (Holdsworth & Besser, 1968) and experimental animals
(Althausen & Stockholm, 1980). This may explain the delay in blood glucose peak but
does not explain the exaggerated glycaemic response. This suggests impaired peripheral
utilization of glucose. A similar intolerance to oral glucose has previously been noted
(Gutman et al., 1978).
Fasting blood concentrations of the gluconeogenic precursors, lactate, pyruvate and
alanine were normal in the present and previous (Saunders et al., 1980) but not all
(McDaniel et al., 1977) studies. Peripheral release of lactate (McDaniel et al., 1977) and
alanine (Bondy, 1949; Ness et al., 1969)may be reduced in hypothyroidism but the normal
circulating levels suggest that any impairment of gluconeogenesis is not secondary to a
reduction in precursor supply. The total amount of 3-carbon substrates of glucose origin
recycled to glucose in hypothyroid man is decreased although the proportion recycled is
normal (McCulloch et al., 1980). This suggests that lactate, pyruvate and alanine uptake
by the liver is decreased in hypothyroidism in proportion to the decrease in hepatic
glucose output.
The exaggerated lactate and pyruvate responses to meals may be secondary to
increased peripheral production or diminished clearance. Most studies in hypothyroidism
suggest diminished peripheral glucose utilization and diminished lactate (Shamer et al.,
1971; Okajima & Ui, 1979) and pyruvate output (McDaniel et al., 1977) from peripheral
tissues. Increased production of lactate and pyruvate after meals is therefore unlikely as
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the cause of the hyperlactataemia and hyperpyruvicaemia, making a defect in hepatic
uptake more likely.
The ratio of blood lactate to blood pyruvate was elevated after meals. This ratio may
reflect the prevailing cytosolic redox state which is in turn dependent on the transfer of
reducing equivalents across the mitochondrial membrane (Krebs et al., 1975; Alberti &
Nattrass, 1977). Thyroid hormones are important in this transfer process (Miillhoffer &
Loy, 1974; Rognstadt, 1977; Sestoft, 1980), which may therefore be deficient in
hypothyroidism.
Fasting blood alanine concentrations were normal in hypothyroidism and were only
significantly greater than control values during the last 4 h of the study. Hyperalaninae-
mia may be due either to diminished alanine uptake for gluconeogenesis or alternatively
to a loss of the normal protein sparing effects of ketone bodies. Ketone bodies are known
to inhibit protein degradation and peripheral alanine output (Sherwin et al., 1976). The
lower ketone body concentrations, particularly during the afternoon period, could
possibly be responsible for the elevated blood alanine concentrations observed.
Alone among the gluconeogenic precursors, circulating blood glycerol levels were
diminished in hypothyroidism. This finding, and the findings of other studies (Goodman
& Bray, 1966; Fisher & Ball, 1967) suggests decreased lipolysis. Thyroid hormones have
lipolytic actions in vitro (Vaughan, 1967), and a permissive effect for the lipolytic actions
of other hormones, particularly the catecholamines both in vitro (Arner et al., 1979;
Debons & Schwartz, 1961) and in vivo (Flamburger et al., 1963). In hypothyroidism
plasma catecholamine levels may be increased (Christensen, 1972) and sensitivity to their
peripheral effects reduced (Goodman & Bray, 1966; Rosenqvist, 1972; Reckless et al.,
1976). These changes may be mediated by altered phosphodiesterase activity (Armstrong
et al., 1974). The presence of normal rather than low plasma non-esterified fatty acid
levels is not readily explained but has previously been reported (Saunders et al., 1980). It is
possible that despite diminished lipolysis, decreased NEFA uptake by the hypothyroid
liver balances the diminished release.
The hypoketonaemia observed may be secondary to diminished lipolysis although
substrate supply as judged by plasma NEFA measurements appears adequate. Recent
studies have suggested that intrahepatic fatty acid oxidation and ketone body production
may be thyroid hormone dependent (Keyes & Heimberg, 1979; Bartels & Sestoft, 1980).
Serum insulin levels in hypothyroidism have been reported to be decreased (Okajima &
Ui, 1979; John et al., 1970; Shah & Cerchio, 1973), normal (Holdsworth & Besser, 1968),
or increased (Andreaniet al., 1968; Renauld etal., 1979), with a marked species variation.
Thyroxine is necessary for normal insulin secretion by isolated pancreatic cells in vitro
(Milcu et al., 1975). In the present study serum insulin concentrations were similar to
control values in the presence of elevated ambient blood glucose concentrations
suggesting insulin hyposecretion. The mechanism of this is uncertain. Elevated blood
glucose levels with insulin concentrations similar to controls also suggest insulin
resistance in hypothyroidism. Alternatively the insulin measured by radioimmunoassay
may be inactive. In human hyperthyroidism a high proportion of circulating 'insulin'
measured by radioimmunoassay may be proinsulin (Sestoft & Heding, 1980) which is
biologically inactive. This finding may account for the apparent insulin resistance in
hyperthyroidism. Sensitivity to exogenous insulin at physiological blood glucose
concentrations has previously been reported to be either normal (Iwatsubo et al., 1967;
Brauman & Corvilain, 1968), or reduced (West et al., 1975) in hypothyroid man.
Hormone-metabolite profiles in hypothyroidism 617
Some of the abnormalities described in hypothyroidism, in particular the mild
elevation in blood glucose and gluconeogenic precursor concentrations have previously
been described in obese subjects (Doar & Wynn, 1970). The patients outlined in the
present study were within 10% ideal body weight with one exception. Abnormalities in
intermediary metabolite concentrations are not noted in patients with such mild obesity
(Johnston et al., 1981). Similarly weight change with thyroxine therapy was small and
could not explain any metabolic changes noted.
Thyroxine therapy had no effect on circulating blood glucose concentrations but did
cause a significant elevation in the serum insulin response to meals. This may reflect a
permissive effect of thyroid hormones on pancreatic insulin secretion. Blood lactate and
pyruvate responses to meals were not normalized by thyroxine therapy and it is difficult to
explain the persistent abnormality of glucose or gluconeogenic precursor concentrations
with treatment.
Thyroxine therapy did cause a significant elevation in blood glycerol concentrations
although levels remained lower than those obtained in control subjects. This change
presumably reflects a thyroid-hormone-induced effect on peripheral lipolysis.
Plasma glucagon levels were unaltered in hypothyroidism and no effect of thyroid
hormone therapy was seen. Plasma glucagon response to protein meals has been shown to
be impaired in hyperthyroid subjects but no previous information on plasma glucagon
levels in hypothyroidism has been published. Growth hormone deficiency has previously
been demonstrated in hypothyroidism (Eisenberg et al., 1972; Peake et al., 1973) but in the
present study growth hormone levels were normal. Thyroxine therapy had no effect on
circulating growth hormone levels.
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Abstract. Hormone and metabolite profiles during a
12 h period of normal meals and activity were
examined in nine hyperthyroid subjects with Graves'
disease and sixteen matched controls. Six hyperthyroid
subjects were restudied when euthyroid on carbima-
zole and thyroxine. Thyrotoxic patients had mild
fasting hyperglycaemia (mean + SEM blood glucose,
5-5 + 0-2 v. 4-8 + 0-1 mmol/1, PcOOl), elevated blood
glycerol (015 + 0-02 v. 0-08 + 0-01 mmol/1, PcO-OOl)
and elevated plasma non-esterified fatty acid (NEFA)
concentrations (0-91+0-06 v. 0-58 + 0-03 mmol/1,
P < 0-001) when compared to controls. Fasting blood
concentrations of the gluconeogenic precursors lac¬
tate, pyruvate and alanine, blood ketone body concen¬
trations and circulating insulin and growth hormone
levels were similar in hyperthyroid and control sub¬
jects. Blood glucose responses to meals were exagger¬
ated and the mean 12 h blood glucose was increased
(6-1+0-1 v. 5-5 + 01 mmol/1, PcO-Ol) in hyperthyr¬
oidism. Similarly, hyperlactataemia and hyperpyruvi-
caemia were observed after meals. Blood ketone body,
blood glycerol and plasma NEFA levels showed
exaggerated pre-prandial peaks and the mean 12 h
values for blood glycerol (0-12 + 0-01 v. 0-08 + 0-01
mmol/1, PcO-Ol) and plasma NEFA (0-71+0-03 v.
0-53 + 0-04 mmol/1, F><0-01) were increased. Concen¬
trations of insulin and growth hormone remained
similar to control values throughout the study period.
Blocking therapy with carbimazole and thyroid hor¬
mone replacement with thyroxine for 5-10 months
suppressed blood glycerol, plasma NEFA and blood
ketone body levels to normal or subnormal values but
had no effect on the elevated blood glucose, blood
lactate or blood pyruvate profiles.
Graves' disease with hyperthyroidism is thus asso¬
ciated with abnormalities ofcarbohydrate metabolism
which are not restored to normal by 5-10 months oral
antithyroid therapy. The changes in lipid metabolism
in hyperthyroidism are normalized by this treatment.
Correspondence: Dr A. J. McCulloch, Department of Clinical
Biochemistry and Metabolic Medicine, Royal Victoria Infirmary,
Newcastle upon Tyne, NEI 4LP.
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Introduction
Although the clinical features ofhyperthyroidism have
been recognized for many years, mechanisms of their
production remain uncertain. In addition numerous,
and often conflicting, metabolic abnormalities have
been described in hyperthyroid man. Fasting blood
glucose concentrations have been reported to be
normal [1, 2] or elevated [3, 4] with normal [5] or
abnormal tolerance to oral [6, 7] or intravenous
glucose [3]. Peripheral insulin responses to oral glucose
have also been described as normal [8], enhanced [3] or
impaired [9]. Plasma nonesterified fatty acid (NEFA)
concentrations [3, 10] and turnover [2] may be in¬
creased with enhanced ketosis during starvation [11],
Data concerning the response of these abnormalities to
restoration of euthyroidism is also conflicting and
poorly documented.
The purpose of the present study was to investigate
hormone and intermediary metabolite concentrations
both after an overnight fast and during normal meals
and activity in hyperthyroid subjects before and after
treatment and in euthyroid controls.
Subjects and Methods
Subjects
Nine (eight female, one male) patients with hyper¬
thyroidism were compared with sixteen (thirteen
female, three male) normal controls (Table 1). No
subject had a personal or family history ofdiabetes and
none was on any medication at the time of the initial
study. Patients had Graves' disease on the basis of
clinical features, such as ophthalmopathy, and an
absence of thyroid nodules on "Tc scanning.
Hyperthyroid subjects were restudied when clini¬
cally euthyroid and when thyroid function tests had
been normal for at least 2 months (Table 1). Treatment
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Table 1. Clinical details of patients before and during therapy and of controls
Before therapy During therapy
Serum % Serum % Interval
Serum triiodo- Serum ideal Serum triiodo- Serum ideal between
thyroxine thyronine TSH body thyroxine thyronine TSH body studies
Patient Age Sex (nmol/1) (nmol/1) (mU/1) weight (nmol/1) (nmol/1) (mU/1) weight (months)
1 38 F 283 11-2 0-1 114 94 1-4 1-6 119 5
2 63 F 347 12-3 0-1 110 84 1-4 2-8 115 10
3 61 F 189 3-9 0-1 138 89 1-2 3-1 136 6
4 33 F 327 12-1 0-1 105 87 1-7 3-2 110 5
5 57 F 222 3-8 1-8 121 106 1-4 8-0 122 9
6 30 F 312 12-4 1-2 100 95 2-1 4-2 105 5
7 58 F 172 5-3 1-4 98
8 43 M 225 6-6 1-6 102
9 43 F 164 30 1-4 110
Controls 41 13F 98 1-6 (<7) 109
(23-61) 3M (77-112) (1-2-2-3) (94-122)
For controls mean (range) is given and for serum thyroid stimulating hormone (TSH) the normal range is quoted.
consisted of carbimazole 30-45 mg daily with sub¬
sequent addition of thyroxine to maintain a normal
circulating serum thyroxine and serum thyroid stimu¬
lating hormone concentration. Antithyroid therapy
was taken on the day of repeat study. The mean
interval between studies was 7 months (range 5-10).
Protocol
Intravenous teflon cannulae were inserted at 08.00
hours after an overnight (10 h) fast and subjects
remained recumbent until 08.30 hours. Basal samples
for hormone and metabolite estimations were with¬
drawn at 08.25 and 08.30 hours when breakfast was
taken. Lunch was at 12.00 hours and dinner at 18.00
hours with snacks at 10.00 and 15.30 hours. Blood
samples were withdrawn at 30 min intervals until
20.00 hours. Meals were standard hospital meals
containing approximately 2500 calories with 45%
carbohydrate 40% fat and 15% protein by weight. All
subjects consumed a daily intake of 300 g of carbo¬
hydrate for at least 48 h before study. After breakfast,
subjects were mobile and encouraged to take gentle
exercise throughout the test but remained at rest for at
least 10 min before each sample time. All subjects gave
informed consent before the study which was
approved by the Newcastle Hospitals Ethical Com¬
mittee.
Methods
Blood for glucose, lactate, pyruvate, alanine, gly¬
cerol and 3-hydroxybutyrate was taken into 5% (v/v)
chilled perchloric acid and assayed by automated
fluorimetric enzymatic methods [ 12]. Acetoacetate was
assayed by a kinetic spectrophotometric method [13]
on perchlorate samples. Possible interference in meta¬
bolite assays by carbimazole was excluded by addition
of this drug in a concentration of 10 mg/1, far in excess
of expected plasma values, to paired blood samples.
Serum insulin [14], thyroid stimulating hormone [15],
triiodothyronine [16] and growth hormone [17] were
assayed by double antibody radioimmunoassay and
serum thyroxine by radioimmunoassay (Mallinckrodt,
RIA-MAT® T4). Plasma non-esterified fatty acids
(NEFA) were assayed by a radiochemical method [18],
Statistical analyses were performed using Student's
paired and unpaired /-tests as appropriate. Certain
measurements (ketone bodies, insulin and growth
hormone) were log-normally distributed and statistical
analysis was performed on log transformed data.
Correlations were sought by the least squares method
or the Spearman ranking method where appropriate.
Values in the text are given as the mean + standard
error of the mean (SEM) or mean (range).
Results
1. Fasting metabolite and hormone levels in untreated
hyperthyroidism
(a) Metabolite concentrations. Fasting blood glucose
concentrations were elevated in untreated hyper¬
thyroidism (5-5 + 0-1 mmol/1, hyperthyroid subjects;
4-8 + 0-1 mmol/1, controls; PcO-Ol). Concentrations
of the gluconeogenic precursors, lactate, pyruvate and
alanine were similar in hyperthyroid and control
subjects (Table 2).
Fasting blood glycerol concentrations were elevated
in hyperthyroidism (0-15 + 0-02 v. 0-08 + 0-01 mmol/1,
,P< 0-001) as were plasma non-esterified fatty acid
levels (0-91+0-06 v. 0-58 + 0-03 mmol/1, RcO-OOl).
Blood ketone body concentrations were variable and
did not differ between hyperthyroid and control
subjects.
(b) Hormone concentrations. Fasting serum insulin
and growth hormone concentrations were similar in
hyperthyroid subjects and controls (Table 2).
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Figure 1. Blood glucose and serum insulin profiles in hyperthyroid subjects before (•—•) and during (• •) therapy and in
controls (■—■) The first sample was taken after an overnight fast. Thereafter meals were taken at 08.30. 12.00 and 18.00 hours
with snacks at 10.00 and 15.30 hours. *+<0-05 hyperthyroid subjects before therapy v. hyperthyroid subjects during therapy
(**/><0-01). +P<005 hyperthyroid subjects before therapy v. controls (+ -t-PcO-Ol). •P<005 hyperthyroid subjects during




2. Diurnal hormone andmetabolite profiles in untreated
hyperthyroidism
(a) Metabolite concentrations. Blood glucose profiles
over 12 h are shown in Fig. 1. The peak blood glucose
responses to breakfast (7-3 + 0-4 v. 6-0 + 0-2 mmol/l,'
PcO-Ol) and lunch (8-0 + 0-4 v. 6-1+0-3 mmol/l,
P< 0 001) although synchronous in both groups were
exaggerated in hyperthyroidism. The mean blood
glucose concentration over the 12 h was also increased
(Table 2). Similarly, blood lactate and pyruvate con¬
centrations after breakfast and lunch were increased in
untreated hyperthyroidism (Fig. 2) as were the 12 h
mean values for lactate and pyruvate (Table 2). Blood
alanine concentrations were similar in hyperthyroid
subjects and controls (Fig. 2, Table 2).
In control subjects, blood total ketone body, plasma
NEFA and blood glycerol concentrations fell with
feeding and rose with fasting before meals (Fig. 3).
This diurnal pattern was preserved in hyperthyroidism
but the premeal peaks for blood ketone body, plasma
NEFA and blood glycerol levels were exaggerated. As
a result, the 12 h mean values for blood glycerol and
plasma NEFA were elevated in hyperthyroidism
(Table 2).
(b) Hormone concentrations. Serum insulin and
growth hormone concentrations were similar in hyper¬
thyroid and control subjects over the 12 h (Fig. 1 and
Table 2).
3. Effects of antithyroid therapy
(a) Fasting hormones and metabolites. Blocking-
replacement treatment had no effect on fasting blood
glucose concentrations (Table 2). Blood glycerol and
plasma NEFA levels decreased to normal, however,
with therapy. Concentrations of other metabolites,
insulin and growth hormone were not influenced by
treatment.
(b) Diurnal hormone and metabolite profiles. Blood
glucose concentrations remained elevated in hyper¬
thyroid subjects after treatment (Fig. 1), with 12 h
mean values higher than in controls (6-0 + 0-1 v.
5-5 + 0-2 mmol/l, /><0-05) (Table 2). Similarly, hyper-
lactataemia and hyperpyruvicaemia persisted during
antithyroid therapy (Fig. 2 and Table 2). Treatment
also resulted in a significant increase in blood alanine
concentrations, not evident in the untreated state
(Fig. 2).
Circulating ketone body, NEFA and glycerol con¬
centrations decreased with antithyroid therapy (Fig. 3)
although the meal related fluctuations were preserved.
Plasma NEFA and blood glycerol levels were sup-
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Figure 2. Blood alanine, lactate and pyruvate profiles in hyperthyroid subjects before and during therapy and in controls. See
legend to Fig. 1 for symbols and conditions.
pressed to values below those found in controls (Fig. 3
and Table 2).
Insulin and growth hormone concentrations were
unaffected by therapy. In untreated hyperthyroidism
neither serum thyroxine nor triiodothyronine levels
correlated with fasting, peak or mean 12 h glucose or
gluconeogenic precursor levels. However, serum triio¬
dothyronine levels correlated positively with peak
prelunch blood glycerol (r = 0-63, P < 0 05) and plasma
NEFA levels (r= 0-62, R<0 05).
In treated hyperthyroid and control subjects thyroid
hormone concentrations did not correlate with fasting,
peak or mean 12 h values for any of the hormones or
metabolites measured.
Discussion
The present study showed fasting hyperglycaemia in
hyperthyroid subjects. This could be a consequence of
diminished utilization or increased hepatic glucose
production. The latter has been noted by some [2, 19],
but not all [20] workers. Increased glucose production
may result from increased gluconeogenesis and/or
increased glycogenolysis. Hepatic glycogen stores are











Figure 3. Diurnal profiles of blood ketone bodies, plasma non-esterified fatty acids and blood glycerol in hyperthyroid subjects
before and during therapy and in controls. See legend to Fig. 1 for symbols and conditions.
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decreased in hypothyroid man [21] although whether
this is because of increased utilization or decreased
synthesis is uncertain. Recently, studies in overnight
fasted hyperthyroid man have shown increased
splanchnic uptake of the gluconeogenic precursors,
lactate, pyruvate, glycerol and alanine, largely due to
increased fractional extraction of these precursors but
also, to a smaller extent, to increased hepatic blood
flow [20]. Similarly, the finding of increased glucose
production from glucose derived 3-carbon interme¬
diates in both man [22] and animals [19] suggests an
increase in gluconeogenesis. Confirmatory evidence
has been obtained from studies with perfused rat livers
at high concentrations of gluconeogenic precursors
[23, 24] although not at physiological levels [25].
In the present study, postprandial as well as fasting
hyperglycaemia was noted. Peak blood glucose con¬
centrations occurred at the same time as in controls
indicating that rapid absorption of carbohydrate was
not the major factor; a suggestion made by others on
the basis of glucose tolerance tests [26].
Normal serum immunoreactive insulin levels were
also found. The combination of fasting hyperglycae¬
mia, meal intolerance and normal circulating insulin
levels suggests insulin resistance. Studies of insulin
sensitivity in hyperthyroid man have been equivocal
showing a normal [27], increased [5] or decreased [28]
blood glucose response to exogenous insulin.
Enhanced insulin degradation in hyperthyroidism,
noted by some [29] but not all workers [30], may not
explain the coexistence of normal insulin and elevated
blood glucose concentrations as insulin degradation
and biological effect are inextricably linked [31].
The important recent demonstration of elevated
circulating proinsulin concentrations with low C-pep-
tide levels suggests that true insulin secretion may be
diminished in hyperthyroid man [32], Proinsulin cross
reacts with insulin in the assay used in our radioim¬
munoassay and many other studies. Thus 'true' insulin
levels may have been decreased in our patients.
However, even if proinsulin secretion were normal, the
fact that insulin levels were not raised in the presence of
hyperglycaemia suggests undersecretion of insulin.
The mechanism of insulin hyposecretion is uncertain
but has been attributed to increased adrenergic tone
[33].
Recent work has suggested a role for glucagon in
glucose intolerance of hyperthyroidism [1], some hy¬
perthyroid subjects showing elevated basal plasma
glucagon levels with impaired glucagon suppression
following oral glucose challenge. In addition, in¬
creased sensitivity to the cyclic AMP mediated effects
of glucagon has been proposed [34], This may be
important in decreasing glycogen stores in the liver of
hyperthyroid man and animals.
The elevated blood lactate and pyruvate responses to
meals is not readily explained. Blood lactate levels are
also increased in response to exercise in hyperthyroid
man [35]. This hyperlactataemia is abolished by
/(-adrenergic blockade and increased adrenergic tone
has been suggested as a mechanism [36]. Our subjects
were resting and a thyroid hormone mediated increase
in peripheral glycolysis is a more likely mechanism.
Such an effect has been demonstrated in vivo [37],
The elevated circulating concentrations of glycerol
and NEFA after an overnight fast and before lunch
and dinner reflect increased adipose tissue lipolysis.
Increased lipolysis in hyperthyroidism has long been
recognized [7, 16] and NEFA [2] and glycerol turnover
[38] are elevated in fasting hyperthyroid man. The
correlations observed between thyroid hormone con¬
centrations and the premeal peaks for NEFA and
blood glycerol in this suggest a direct effect of thyroid
hormones or potentiation of the lipolytic action of
other hormones, particularly the catecholamines.
Although plasma catecholamine levels are not in¬
creased in hyperthyroidism [39] increased lipolysismay
be due to increased /? adrenergic responsiveness [40],
Enhanced ketogenesis with fasting has been recog¬
nized in hyperthyroidism for many years [11], In¬
creased NEFA supply combined with relative insulin
deficiency are important and an additional direct
ketogenic effect of thyroid hormone excess on the liver
has recently been described [41],
Antithyroid treatment with carbimazole and thy¬
roxine replacement therapy did not restore blood
glucose or gluconeogenic precursor concentrations to
normal. Similarly Kreines et al. [42] and Cavagnini [43]
reported persistent intolerance to oral glucose after
antithyroid therapy while Saunders et al. [2] reported
normalization of fasting glucose turnover by carbima¬
zole but blood lactate levels remained elevated. The
reasons for the persisting abnormalities are not appar¬
ent. All patients were clinically and biochemically
euthyroid and the decline in blood glycerol, ketone
body and plasma NEFA levels (to subnormal levels in
the case of glycerol) suggests that therapy adequately
suppressed lipolysis and ketogenesis. No direct effects
of carbimazole on intermediary metabolism, indepen¬
dent of its effect on thyroid function have been
reported and the effects of methimazole, a related
drug, on glucose turnover in the rat are restored to
normal by thyroxine [19]. Insulin secretion, assessed by
peripheral insulin concentrations did not alter
although the proportion of'true' insulin to proinsulin
may have increased. It is still possible, however, that
there may have been residual pancreatic hyposecretion
or, particularly had 'true' insulin secretion increased,
persistent insulin resistance. These may have contri¬
buted to the persistent carbohydrate intolerance but
does not explain the elevated post-prandial lactate and
pyruvate concentrations during antithyroid therapy.
Finally, the duration of therapy (6-7 months) may have
been inadequate. Studies in the rat, however, suggest
that normalization of glucose metabolism occurs after
5 weeks [19]. Longer-term follow-up studies will be
necessary to resolve this question.
Acknowledgments
Financial support from the Scientific and Research
276 A. J. McCULLOCH et al.
Committee of Newcastle Area Health Authority and
from the British Diabetic Association is gratefully
acknowledged. We also thank Mrs M. Brown and Mrs
L. Ashworth for their technical assistance. Dr McCul-
loch is in receipt of an MRC Research Training
Fellowship. Dr Johnston is a Wellcome Senior
Research Fellow.
References
1 Kabadi U, Eisenstein A. Glucose intolerance in hyperthy¬
roidism, role of glucagon. J Clin Endocrinol Metab 1980;
50:392-6.
2 Saunders J, Hall SM, Sonksen P. Glucose and free fatty acid
turnover in thyrotoxicosis and hypothyroidism before and after
treatment. Clin Endocrinol 1980;13:33-44.
3 Doar JWH, Stamp TCB, Wynn V, Audhya TK. Effects of oral
and intravenous glucose loading in thyrotoxicosis studies of
plasma glucose, free fatty acid, plasma insulin and blood
pyruvate levels. Diabetes 1969;18:633-9.
4 Levy LJ. Adesmann JJ, Spergel G. Studies on carbohydrate and
lipid metabolism in thyroid disease: effects of glucagon. J Clin
Endocrinol Metab 1970;30:372-9.
5 Macho L. The influence of endocrine glands on carbohydrate
metabolism. II. Glucose tolerance and clearance of glucose in
healthy subjects and in patients with hypo- and hyperthyroidism.
Acta Med Scand 1958;160:485-90.
6 Hales CN, Hyams DE. Plasma concentrations of glucose,
non-esterified fatty acids and insulin during oral glucose toler¬
ance tests in thyrotoxicosis. Lancet 1964;ii:69-72.
7 Marks BH, Keim I, Hills AG. Endocrine influences on fat and
carbohydrate metabolism in man. 1. Effect of hyperthyroidism
on fasting serum non-esterified fatty acid concentrations and on
its response to glucose ingestion. Metabolism 1960:9:1 133-9.
8 Andreani D, Mensinger F, Fulluca G, Aliberti G, Tamburrano
G, Cassano C. Insulin levels in thyrotoxicosis and primary
myxoedema: response to intravenous glucose and glucagon.
Diabetologia 1970;6:1-7.
9 Malaisse WJ, Malaisse-Lague F. McCraw EF. Effects of thyroid
function upon insulin secretion. Diabetes 1967;16:643-6.
10 Harlan WR, Lazlo J, Bogdonoff MD, Estes EH. Alterations in
free fatty acidmetabolism in endocrine disorders. Part I. Effect of
thyroid hormone. J Clin Endocrinol Metab 1963;23:33-40.
11 Beylot M, Rioux J. Increase in ketogenesis in hyperthyroidism.
Evidence for a beta adrenergic mechanism. Diabetologia
1980;19:505-10.
12 Lloyd B, Burrin J, Smythe P. Simple automated fluorimetric
assays for blood glucose, lactate, pyruvate, alanine, glycerol and
3-hydroxybutyrate. Clin Chem 1978;24:1724-9.
13 Price CP, Lloyd B, Alberti KGMM. A kinetic spectrophoto¬
metry assay for rapid determination of acetoacetate in blood.
Clin Chem 1977;23:1893-7.
14 Soeldner J, Stone D. Critical variables in the radioimmunoassay
of serum insulin using the double antibody technic. Diabetes
1965;14:771-9.
15 Hall R, Amos J. Ormston BJ. Radioimmunoassay of human
serum thyrotrophin. Brit Med J 1971 ;i:582-5.
16 Hesch RD, Evered DC. Radioimmunoassay of triiodothyronine
in unextracted human serum. Brit Med J 1973;i:645-8.
17 Hartog M, Gaafar MA, Meisser B. Fraser TR. Immunoassay of
serum growth hormone in acromegalic patients. Brit Med J
1964;ii: 1229-32.
18 Ho RT. Meng HC. A simple and ultrasensitive method for
determination of free fatty acids by radiochemical methods. Ann
Biochem 1969;31:426-36.
19 Okajima F, Ui M. Metabolism of glucose in hyper and
hypothyroid rats in vivo. Glucose turnover values and futile
cycle activity obtained with 3H and 14C labelled glucose.
Biochem J 1979;182:565-75.
20 Wahren J, Wennlund A, Nilson L, Felig P. Influence of
hyperthyroidism on splanchnic exchange of glucose and glu¬
coneogenic precursors. J Clin Invest 1981;67:1056-63.
21 Piphcr J, Paulsen E. Liver biopsy in thyrotoxicosis. Acta Med
Scand 1947;127:439-47.
22 McCulloch A, Pernet A, Nosadini R. Glucose turnover and
recycling effect of thyroid hormones. Diabetologia 1980:19:298.
23 Menahan LA, Weiland O. The role of thyroid function on the
rate of gluconeogenesis in the perfused rat liver. Eur J Biochem
1969;10:188-93.
24 Freedland RA, Krebs HA. The effect of thyroxine treatment on
the rate of gluconeogenesis in the perfused rat liver. Biochem J
1967;104:45p.
25 Bartels PD, Sestoft L. Thyroid hormone induced changes in
gluconeogenesis and ketogenesis in perfused rat liver. Biochim
Biophys Acta 1980;633:56-67.
26 Holdsworth CD, Besser GM. Influence of gastric emptying rate
and insulin response on oral glucose tolerance and insulin
secretion in thyroid disease. Lancet 1968;ii:700-2.
27 Elrich H. Hlad CJ, Arai Y. Influence of thyroid function on
carbohydrate metabolism and a new method for assaying
response to insulin. J Clin Endocrinol 1961;21:387-93.
28 West T, Owens D, Sonksen P, Srivistava M, Thompkins C,
Nabarro J. Metabolic responses to monocomponent human
insulin infusions in normal subjects and patients with liver and
endocrine disease. Clin Endocrinol 1975;4:573-84.
29 Elgee NJ, Williams RH. Effects of thyroid function on Insulin
I13' degradation. Am J Physiol 1955;180:13-21.
30 Wajchenberg BL, Cesar FP, Leme CE, Didio R, Kieffer J.
Plasma insulin disappearance curve after intravenous insulin
injection in human hyperthyroidism. Clin Endocrinol
1978;8:233-6.
31 Terris S, Steiner DF. Binding and degradation of 125I insulin by
rat hepatocytes. J Biol Chem 1975;250(21):8389-98.
32 Sestoft L, Heding LC. Hypersecretion ofproinsulin in thyrotoxi¬
cosis. Diabetologia 1981;21:103-7.
33 Wajchenberg BL, Cesar GP, Leme CE, Sauja ITT, Pieroni RR,
Mattar G. Effects of adrenergic stimulating and blocking agents
on glucose induced insulin responses in human thyrotoxicosis.
Metabolism 1978;27:1715-20.
34 Lamberg BA. In Current Topics in Thyroid Research: Proc 5th
International Thyroid Conference, Rome. Cassano C; Andreoli
M (eds). New York: Academic Press, 1965:1074-8.
35 Nazar K, Chwalbinska-Moneta J, Machalla J, Kaciuba-Uscilko
H. Metabolic and body temperature changes during exercise in
hyperthyroid patients. Clin Sci Mol Med 1978;54:323-7.
36 Kaciuba-Uscilko H, Brzezinska Z. Interaction between catecho¬
lamines and thyroid hormones in regulation of exercising
metabolism in dogs. In Catecholamines and stress. Usdin E,
Kvetnarsky R, Kopin IJ (eds) New York; Pergamon Press, 1975:
179-85.
37 Araki S, Terao A. Matsumoto I. Muscle cramps in chronic
thyrotoxic myopathy. Arch Neurol 1968;19:315-20.
38 Tibbling G. Glycerol turnover in hyperthyroidism. Clin Chem
Acta 1969;24:121-30.
39 Christensen NJ. Plasma noradrenaline and adrenaline in patients
with thyrotoxicosis and myxoedema. Clin Sci Mol Med
1973;45:163-71.
40 Arner P, Wennlund A, Ostman J. Regulation of lipolysis by
human adipose tissue in hyperthyroidism. J Clin Endocrinol
Metab 1980;48:415-9.
41 Keyes WG, Heimberg M. Influence of thyroid status on lipid
metabolism in the perfused rat liver. J Clin Invest 1979;
64:182-90.
42 Kreines K, Jett M, Knowles HC. Observations in hyperthyr¬
oidism ofabnormal glucose tolerance in thyrotoxicosis. Diabetes
1965;14:740-5.
43 Cavagnini F, Peracchi M, Raggi U, Bana A, Pontiroli E,
Malinverni A, Pinto M. Impairment of growth hormone and
insulin secretion in hyperthyroidism. Eur J Clin Invest
1974;4:71-7.
Clinical Science (1983) 64,41-47
6-M.c.
Glucose turnover and indices of recycling in thyrotoxicosis and
primary thyroid failure
A. J. McCULLOCH*. R. NOSADINI*, A. PERNET*, M. PINIEWSKA*,
D. B. COOK*, F. CLARKt, D. G. JOHNSTON^ and
K. G. M. M. ALBERTI*
*Department ofClinical Biochemistry and Metabolic Medicine, Royal Victoria Infirmary, Newcastle upon Tyne,
tDepartment ofMedicine, Freeman Hospital, Newcastle upon Tyne, and tDepartment ofMedicine, Royal Victoria Infirmary,
Newcastle upon Tyne, U.K.
{Received 7 January 1982/7May 1982; accepted 29 July 1982)
Summary
1. Glucose turnover was examined by using
simultaneous bolus intravenous tracer adminis¬
tration of both [3-3H]glucose and [l-14Clglucose
in hyperthyroid and hypothyroid subjects before
and during appropriate therapy and in matched
controls.
2. In hyperthyroid subjects, total glucose
turnover (as indicated by analysis of decay
of [3-3H]glucose specific radioactivity) was
increased (18-1 + 1-0 vs 12-4 + 0-9 ,umol kg-1
min-1, P < 0-01), as was the metabolic clearance
rate for glucose (3-5 ± 0-3 vs 2-4 ± 0-2 ml kg-1
min-1, P <0-01).
3. Glucose turnover rates determined with
[l-14C]glucose as tracer were lower than total
glucose turnover rates in all subjects. This
difference represents an index of recycling of the
14C label between glucose and glucose-derived C3
intermediates.
4. The recycling index was increased in
hyperthyroidism both in amount (4-7 ±0-6 vs
1-3 ± 0-3 //mol kg-1 min-1, P < 0-001) and when
expressed as a percentage of total glucose
turnover (27 ± 3 vs 10 + 2%, P < 0-001).
5. Turnover rates determined by |1-
14C]glucose represent irreversible glucose dis¬
posal and were similar in hyperthyroid and
control subjects (hyperthyroid 13-4+1-1 vs
control 11-2 + 0-9 /rmol kg-1 min-1). The major
fraction of the increase in total glucose turnover
Correspondence: Dr A. J. McCulloch, Depart¬
ment of Clinical Biochemistry and Metabolic
Medicine, Royal Victoria Infirmary, Newcastle upon
Tyne NE1 4LP, U.K.
could thus be accounted for by increased cycling
of glucose.
6. Total glucose turnover, metabolic clear¬
ance and indices of recycling returned to normal
with treatment of hyperthyroidism.
7. In hypothyroidism, total glucose turnover
(hypothyroid 8-2 ± 0-3 vs control 11-7 ±1-2
,umol kg-1 min-1, P<0-01) and metabolic
clearance (hypothyroid 1-6 ± 0-1 vs control
2-3 ± 0-2 ml kg-1 min-1, P< 0-001) were
decreased and returned to normal with thyroxine
therapy. Indices of glucose recycling were
normal.
Key words: glucose turnover, hyperthyroidism,
hypothyroidism, recycling.
Introduction
Thyroid hormones have long been known to
influence carbohydrate metabolism. Fasting
blood glucose concentrations may be elevated in
hyperthyroidism [1, 2] and decreased in hypo¬
thyroidism [3, 4], although reports are con¬
flicting. Intolerance to orally [5-8] or intra¬
venously [2] administered glucose may also be
present.
Administration of pharmacological amounts of
thyroid hormones to animals has produced more
clear-cut results. Thus increases in glycogeno¬
sis [9], gluconeogenesis [ 10] and glucose
turnover 111] have all been reported. Such
experiments have also demonstrated increased
activity of certain substrate cycles, such as those
between glucose and glucose 6-phosphate [11]
and between triacylglycerols and non-esterified
014J-5221/83/OI0041-07$2.00 © 1983 The Biochemical Society and the Medical Research Society
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fatty acids [12]. In man increased glucose
turnover has been reported in hyperthyroidism
and normal turnover in hypothyroidism with the
use of [3-3H|glucose as tracer [131, and para¬
doxically decreased splanchnic glucose output in
hyperthyroidism with the use of catheterization
techniques [14], but substrate cycling between
glucose and glucose-derived C3 intermediates has
not been examined.
In the present study we have investigated
glucose turnover in fasting hyperthyroid and
hypothyroid man before and during treatment
with [3-3H|glucose as tracer to indicate total
glucose turnover. In addition, the possibility of
cycling of glucose-derived C3 intermediates was
investigated by simultaneous analysis of decay of
[l-14Clglucose specific radioactivity.
Subjects and methods
Six hyperthyroid subjects [90 ± 3% of ideal body
wt. before therapy, 99 ± 1% of ideal body wt.
after therapy (means ± sem, five subjects only),
were compared with six age-matched normal
controls (95 ± 2% of ideal body wt.) (Table 1).
Hyperthyroidism was caused by Graves' disease
in all subjects, on the basis of clinical features and
antibodies to thyroid tissue components. No
subject had a thyroid nodule on "Tc scanning.
Hyperthyroid subjects were re-studied after 5-8
months (mean 5-9 months) of antithyroid
therapy (carbimazole 30-40 mg daily from
diagnosis, with l-thyroxine 100-150 jug daily
added after 4-6 weeks). Circulating thyroxine,
tri-iodothyronine and thyrotrophin concentra¬
tions were normal at the time of re-investigation.
Seven hypothyroid patients [121 ± 3% of ideal
body wt. before therapy and 110 ± 2% of ideal
body wt. after therapy (six subjects only)] were
compared with six normal controls (111 ± 4% of
ideal body wt.) (Table 1). Hypothyroid subjects
were older than the controls, although the
difference was not significant. Hypothyroidism
was secondary to Hashimoto's thyroiditis in all
cases. Patients were re-studied after 6 months'
therapy with L-thyroxine, 100-200 /ug daily,
when circulating thyroxine, tri-iodothyronine and
thyrotrophin concentrations were within the
normal range.
No subject was on any medication at the time
of initial study, and none had any other known
disease or a family history of diabetes. All
subjects consumed in excess of 300 g of
carbohydrate daily for at least 48 h before the
study. Informed oral consent was obtained from
every subject for the study, which was approved
by the Newcastle Area Health Authority (Teach¬
ing) and the D.H.S.S. Isotope Advisory Panel.
One subject from each group of patients was
unavailable for repeat study.
Protocol
After a 10 h (overnight) fast, indwelling
intravenous Teflon cannulae (Venflon; Viggo,
Helsinborg, Sweden) were positioned in both
antecubital veins at 08.00 h. Subjects remained
recumbent throughout, the test and basal samples
for hormones and metabolites were taken at
08.25 and 08.30 h. Bolus intravenous injections
of 50 nC\ (1-85 mBq) of [3-3H[glucose and 25
//Ci (0-925 mBq) of [l-14C]glucose (The Radio¬
chemical Centre, Amersham, Bucks., U.K.) were
given at 08.30 h. Blood samples (10 ml) were
taken at 1, 2, 3, 4, 5, 6, 8, 10, 12-5, 15, 20, 30,40,
50, 60, 75, 90 and 120 min after injection for the
determination of glucose specific radioactivity,
intermediary metabolites and hormones.
Chemical methods
Blood (1 ml) for glucose, lactate, pyruvate and
glycerol determinations was taken into chilled
perchloric acid (0-3 mol/1) and assayed by
automated fluorimetric enzymic methods [15].
Serum insulin [16], thyrotrophin [17] and tri¬
iodothyronine [18] were assayed by double-
antibody radioimmunoassay and serum thyrox¬
ine by radioimmunoassay (Malinckrodt-RIA
MAT). Blood samples (2-25 ml) for glucagon
were taken into chilled tubes containing 0-25 ml
of aprotinin (2500 kallikrein-inhibitory units) and
25 ,umol of EDTA and assayed by wick
chromatography [19]. For measurement of
radioactivity in glucose samples were taken into
heparinized tubes and the plasma was separated
and stored at —20°C until assay. Plasma (0-5
ml) was deproteinized by adding 1 ml of 5-36%
(w/v) Ba(OH)2, 1 ml of 5% (w/v) ZnS04,7H20
[20] and 7-5 ml of distilled water. The supernatant
was passed through a column containing 5 ml of
ion-exchange resin (AG2-X 8/B; Bio-Rad
Laboratories, Richmond, CA, U.S.A.). The
column was washed with 10 ml of distilled water,
and the eluate was freeze-dried, resuspended in
toluene-based scintillant (Cocktail T; Hopkin
and Williams, Chadwell Heath, Essex, U.K.) and
its radioactivity counted in a scintillation counter
(Intertechnique, St Albans, Herts., U.K.), with
the use of an external standard to correct for
efficiency and overlapping. Recovery of stan¬
dards was 93% (range 90-100%) for [3-
3H]glucose and 94% (91-100%) for [1-
14C]glucose.
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Calculations
Curves for [3H]glucose and [14C]glucose
specific radioactivity (SA) against time were
constructed. Values for glucose turnover, mean
residence time, glucose pool and glucose space
were calculated as described by Shipley & Clarke
[21] by the formulae:
Glucose turnover (RT)
Injected dose
f Glucose SA x dr
Mean residence time (MRT)
I (t x Glucose SA x dt)
■f Glucose SA x d/
o
Glucose pool = Glucose RT x MRT
Glucose space
Glucose pool x 100
Body wt. x Glucose concentration





Values for glucose mean residence time, pool size,
space and metabolic clearance rates quoted in the
text are those calculated from the data given by
analysis of [3-3H]glucose specific radioactivity.
Radioactive glucose 'recycling', as defined by
Streja et al. [22], was estimated by the difference
between glucose turnover calculated by [3-
3H]glucose and that by [l-14C]glucose [Re¬
cycling = RT(3H) — RT(14C)]. 'Recycling' was






Double-exponential functions were fitted to the
specific radioactivity (SA) — time (t) curves for
[3H[- and [ 14C]-glucose by linear least-squares
regression by using an iterative program on a
mini-computer (Apple II Europlus; Cupertino,
CA, U.S.A.). For the number of data points
(n = 17) polyexponential regression provided a
better estimate of t than did the trapezoidal rule
where SA approximated towards zero. The
correlation of curve fit was 0-95 (0-92-0-99).
Statistical analyses were performed by using
Student's paired and unpaired t tests as ap¬
propriate. Serum insulin and plasma glucagon
concentrations showed logarithmic distribution,
and statistical analyses were performed on
log-transformed data. Correlations were sought
by the least-squares method or the Spearman
ranking method as appropriate. Values in the text
are given as means ± sem or as means and
ranges.
Results
In both hyperthyroid and hypothyroid subjects
serum thyroxine, tri-iodothyronine and thyro-
trophin concentrations returned to normal with
treatment (Table 1). Fasting blood glucose
concentrations and blood concentrations of the
gluconeogenic precursors lactate, pyruvate and
alanine were similar in hyper- and hypo-thyroid
subjects and control subjects and were unaltered
by therapy (Table 2). In hyperthyroidism fasting
blood glycerol concentrations were elevated
compared with control values (0-12 + 0-02 vs
0-06 ± 0-02 mmol/1, P < 0-05) and fell to normal
with therapy. Blood glycerol concentrations were
normal in hypothyroidism. Serum insulin and
plasma glucagon concentrations were similar in
all groups. Total glucose turnover [RT(3H)[ was
increased in hyperthyroidism (18-1 + 1-0 vs
12-4 + 0-9 ,umol kg-1 min"1, P < 0-01) and
decreased in hypothyroidism (8-2 + 0-3 vs
11-7 ± 1-2 //mol kg-1 min"1, P < 0-01) (Tables 3
and 4) and returned to normal with treatment.
Glucose turnover rates derived from the [1
14C]glucose data [RT(14C)] were similar in
hyperthyroid and control subjects (hyperthyroid
13-4 ±1-1 vs control 11-2 + 0-9 //mol kg"1
min"1), although a small but significant decrease
was seen after antithyroid therapy (12-3 + 1-2
//mol kg"1 min-1, P < 0-05). In hypothyroid
subjects RT(14C) was decreased (6-9 ± 0-4 vs
10-2 + 0-8 //mol kg-1 min"1, P < 0-01) (Table 4)
and increased with thyroxine therapy (8-2 + 0-8
/zmol kg-1 min"1).
The difference between RT(3H) and RT(14C)
was increased 4-fold in hyperthyroidism
(4-7 ± 0-6 vs 1-3 + 0-3 .umol kg-1 min"1, P <
0-001) with a 2-7-fold increase in the % recycling
index
(RT(3H) — RT( 14C)
RT(3H)
x 100
(Table 3). Both returned to normal with therapy.
By contrast, apparent recycling was not signifi¬
cantly altered in hypothyroidism (Table 4).
Metabolic clearance rate for glucose was also
increased (3-5 + 0-3 vs 2-4 ± 0-2 ml kg"1 min"1,
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Table 1. Characteristics ofhyper- and hypo-thyroid patients before and during therapy and ofcontrols






Sex 3M, 3F 3M, 2F 4M, 2F 2M, 5F 2M,4F 4M, 2F
Age 46 ± 3 44 ± 3 43 ± 6 59 + 3 58 ±4 45 ±6
% of ideal body wt. 90± 3 99 ± 1 95 ± 2 122 ± 3 110 + 2 111+4
Serum thyroxine (nmol/1) 197 ± 17*** 84 ± 8+tt 90 ± 8 24 ± 7*** 110 ± 5ftt 104 ± 10
Serum tri-iodothyronine (nmol/1) 6-2 ±0-7*** 2-4 ± 0-2ttt 1-6 ±0-2 0-8 + 0-1*** 2-0 ± 0-1 ttt 2-0 + 0-2
Serum thyrotrophin (m units/1) 1-3 ± 0-6 3-3 ± 1-5 2-9 ±0-5 26-0 ± 2*** 3-7 ±0-9ttt 2-9 ±0-5
Table 2. Fasting metabolite and hormone concentrations in hyperthyroid and hypothyroid subjects and controls shown as
means + sem or means (and ranges)
*P < 0-05 hyperthyroid subjects vs controls, fP < 0-05 hyperthyroid subjects before vs during therapy.
Hormone or Hyperthyroid Hyperthyroid Controls Hypothyroid Hypothyroid Controls
metabolite before therapy during therapy before therapy during therapy
Blood glucose (mmol/1) 5-4 ±0-3 5-3 ±0-5 5-2 ±0-9 5-1 ± 0-1 5-0 ±0-2 4-9 ±0-2
Blood lactate (mmol/1) 0-67 ± 0-10 0-84 ±0-11 0-91 ± 0-08 0-91 ± 0-05 0-79 ±0-04 0-75 ±0-05
Blood pyruvate (mmol/1) 0-06 ± 0-01 0-07 ± 0-01 0-10 ±0-01 0-08 ±0-01 0-07 ±0-01 0-07 ±0-01
Lactate/pyruvate ratio 11-3 ± 0-2 12-1 ±2-3 10-7 ± 2-6 12-4 ± 0-6 11-4 ± 0-8 9-2 ± 1-2
Blood alanine (mmol/1) 0-27 ±0-03 0-29 ± 0-03 0-34 ±0-02 0-36 ± 0-01 0-34 ±0-02 0-33+0-02
Blood glycerol (mmol/1) 0-12 ±0-02* 0-05 ± 0-0If 0-06 ± 0-02 0-07 ± 0-01 0-07 ±0-01 0-07 ±0-01
Serum insulin (m units/1) 5 (1-10) 7 (0-12) 6(1-8) 7(1-14) 5(2-11) 7(0-11)
Plasma glucagon (pg/1) 28 (12-40) 30 (18-50) 26 (13-36) 21 (10-30) 28 (2-57) 26 (20-31)
Table 3. Glucose turnover rates, 'recycling', mean residence time, pool, space and metabolic clearance rates in hyperthyroid
subjects before and during therapy and in controls
*P < 0-05, **P < 0-01 and ***P < 0-001, untreated patients vs treated patients, j"P < 0-05, ft-P < 0-01 and TtT-P < 0-001,
untreated patients vs controls.
Absolute UC-derived RT(3H) - RT(3H) — RT(I4C) 100 Mean Glucose Glucose Metabolic
glucose glucose RT(UC) RT(3H) residence pool space clearance
turnover turnover (amount of glu¬ (% of glucose time (//mol/kg) (% of rate
1RT(3H)1 |RT(,4C)1 cose 'recycled') 'recycled') (min) body wt.) (ml kg-1 min-1)
(//mol kg"1 (//mol kg-1 (//mol kg-1
min-1) min-1) min-1)
Hyperthyroid (n = 6) 18-1 ± l-0tt 13-4 ± 1-1 4-7 ± 0-6+tt 27 ± 3t+t 74 ± 4ft 1330 ± 93 26 ± 3 3-5 ± 0-3t
Hyperthyroid during 13-7 ± 1-3*** 12-3 ± 1-2* 1-3 ±0-4* 10 ± 3* 81 ± 3 1113 ± 87** 23 ± 2 2-7 ± 0-4**
therapy (« = 5)
Control (n = 6) 12-4 ± 0-9 11-2 ± 0-9 1-3 ±0-3 10 ± 2 97 ± 5 1183 ± 56 24 ± 1 2-1 ± 0.2
Table 4. Glucose turnover rates, 'recycling', mean residence time, pool, space and metabolic clearance rates in hypothyroid
subjects before and during therapy and in controls
For symbols and conditions see the legend to Table 3.
Absolute 14C-derived RT(3H) - RT(3H) — RT(14C) .. ,nn Mean Glucose Glucose Metabolic
glucose glucose RT(14C) RT (3H) residence pool space clearance
turnover turnover (amount of glu¬ (% of glucose time (//mol/kg) (% of rate
(//mol kg-1 (//mol kg-1 cose 'recycled' 'recycled') (min) body wt.) (min kg-1
min-1) min-1) (//mol kg-1 min-1)
min-1)
Hypothyroid (n = 7) 8-2 + 0-3+t 6-9 ± 0-4tt 1-3 ± 0-8 16 ± 3 146 ± 14+ 1195 ± 102 24 ± 2 1-6 ± 0-1+++
Hypothyroid during 9-9 ± 0.6* 8-7 ±0-8 1-2 + 0-3 13 ± 3 119 ± 13 1172 ± 110 24 ± 1 2-0 ± 01*
therapy (n = 6)
Control (n = 6) 11-7 ± 1-2 10-2 ±0-8 1-5 ± 0-4 12 ± 2 101 ± 7 1190 ± 134 24 ± 2 2-3 + 0.2
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P < 0-05) and decreased (1-6 ± 0-1 vs 2-3 ± 0-2
ml kg-1 min-1, P < 0-001) in hyper- and hypo¬
thyroidism respectively. Glucose space was simi¬
lar in all groups and was unaffected by treatment.
In hyperthyroid subjects the glucose pool was not
significantly different from control values, al¬
though a 15% decrease (P < 0 01) was observed
after antithyroid therapy. Values for the glucose
pool were normal in hypothyroid subjects. Mean
residence time was decreased in hyperthyroid
subjects. Mean residence time was decreased in
hyperthyroid subjects (74 ±4 vs 97 ± 5 min,
P < 0-01) and increased in hypothyroid subjects
(145 ± 14 vs 107 ± 7 min, P < 0-05). Normal
values were restored with therapy.
Serum thyroxine and tri-iodothyronine con¬
centrations did not correlate within patient or
control groups with any parameter of glucose
metabolism assessed. Similarly no correlations
were observed for body weight in the hypo¬
thyroid group and their controls, where the latter
tended to be younger and lighter than the
hypothyroid group before treatment.
Discussion
Glucose tritiated in the 3-position measures total
glucose turnover in post-absorptive man [13, 22].
The tritium on [3-3H]glucose is lost at the triose
phosphate level, so that turnover estimates made
with the use of this labelled glucose represent
glucose metabolized to this level and beyond.
Turnover estimates made with the use of [1-
14C]glucose are lower owing to carbon-recycling
back to glucose at any level in the glyco¬
lytic-gluconeogenic pathway [22, 23, 24], al¬
though the bulk of this is considered to occur
from lactate and pyruvate [22]. The difference
between the turnover estimates with these two
forms of labelled glucose is therefore thought to
provide an index of the amount of glucose cycled
to C3 intermediates and back.
Total glucose turnover was increased by 48%
in hyperthyroidism and decreased by 30% in
hypothyroid subjects. Similar findings have been
obtained by other workers using isotopic methods
in man [13] and animals [11]. Some 60% of the
increase in glucose turnover noted in this study
could be accounted for by the increase in
recycling and only 40% by an increase in glucose
metabolism by other routes. In contrast with our
findings, a decrease in hepatic glucose production
has recently been observed in hyperthyroid man
with the use of catheterization techniques to
obtain estimates of splanchnic glucose exchange
[14]. The reason for these disparate findings is
unclear, as the hyperthyroid subjects studied
appear to be similar in age, weight and severity of
disease. In other conditions, both techniques may
be expected to produce similar estimates of
glucose production [25] and there is no evidence
for an increase in renal glucose output in
hyperthyroidism. A possible explanation may
reside in the dietary preparation before study. A
carbohydrate intake in excess of 300 g daily for
48 h before investigation may have ensured
greater glycogen stores in the patients reported in
the present study.
Increased glucose turnover may result from an
increase in either glycogenolysis or gluconeo-
genesis. After an overnight fast, hepatic glycogen
stores are diminished in hyperthyroidism [26],
and increased gluconeogenesis is considered the
major factor [14]. Rat liver perfusion experi¬
ments have shown thyroid-hormone-dependent
increases in glucose production from lactate [27],
alanine [28] and glycerol [29], and the activities
of certain gluconeogenic enzymes [27, 30],
particularly pyruvate carboxylase [31], are raised
in the livers of hyperthyroid animals. In the
present study, fasting blood glycerol concen¬
trations were elevated in hyperthyroidism, as
found by other workers [32, 33]. Glycerol is
metabolized largely to glucose and its uptake is
proportional to blood concentration [34], Cir¬
culating concentrations of the other gluconeo¬
genic precursors were normal in the present
study, but flux was not measured. Others have,
however, reported increased splanchnic frac¬
tional uptake of these substrates in hyperthyroid
man, with a return to normal with treatment [14].
Absolute amounts of glucose recycled were
increased 3-6-fold in hyperthyroidism, and per¬
centage recycling also rose (2-7-fold). This
process is energetically wasteful but represents
only a trivial amount of energy lost: 43-9 kJ
(10-5 kcal)/24 h, assuming ATP equivalent of
31-4 kJ (7-5 kcal)/mol and wastage of 4 ATP
molecules per molecule of glucose recycled as the
sole energy deficit. However, isotopic estimation
of recycling may underestimate total chemical
recycling because of interchange between labelled
and unlabelled carbon atoms in substrate pools
such as that for oxaloacetate [35]. Furthermore
the isotopes used in the present study will not
estimate glucose cycled in 'futile' cycles such as
that between glucose and glucose 6-phosphate,
activity of which may be increased by thyroid
hormones [11]. The mechanisms controlling such
'futile' cycles are unclear but are independent of
catecholamine action in thyroid excess in animals
[36],
Increased hepatic glucose production has been
attributed to increased glucagon secretion [37].
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Circulating glucagon concentrations were, how¬
ever, normal in the present and one other study
[14], Alternatively increased secretion or in¬
creased sensitivity to catecholamines has been
postulated [38]. Catecholamine concentrations
were not measured in the present study, but
glucose turnover in hyperthyroidism is not
restored to normal by //-adrenergic blockade [13].
Similarly, alterations in circulating insulin
concentrations cannot be implicated, in that we
and others [39] have found them to be normal.
However, changes in portal insulin and glucagon
concentrations cannot be excluded. It has been
suggested that alterations in insulin-sensitivity
may occur, although the evidence is conflicting,
with enhanced [40, 41], normal [42] and
diminished [2, 43] insulin-sensitivity all having
been reported in hyperthyroidism. We have
recently found normal sensitivity to insulin in
hyperthyroid subjects with the use of a glucose
clamp technique (unpublished observations).
In the present study peripheral disposal of
glucose, assessed by glucose clearance, was
diminished in hypothyroidism and elevated in
hyperthyroidism, with both abnormalities re¬
versed by treatment. However, a major abnor¬
mality of insulin action is unlikely in view of the
normal blood glucose concentrations in both
hyperthyroid and hypothyroid subjects.
Finally, body weight is a determinant of
glucose turnover and glucose turnover may be
diminished in the grossly obese [44]. In the
present study, with a smaller range of body
weights, no correlation between weight and
glucose turnover was seen within the control
subjects. Patients were matched by weight to
separate control groups, and differences in
turnover are therefore more likely to be related to
thyroid status.
In conclusion, glucose turnover and recycling
were markedly enhanced in hyperthyroid sub¬
jects. The greater proportion of the increase in
turnover was due to the increase in recycling of
C3 intermediates. These abnormalities could not
be accounted for by alterations in glucose space
or changes in the two main glucoregulatory
hormones insulin and glucagon. In hypothyroid
subjects glucose turnover, representing both
production and utilization, was decreased. In
both groups of subjects values returned to normal
with treatment. The precise mechanisms of these
changes remain to be elucidated.
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INSULIN SENSITIVITY IN HYPERTHYROIDISM:
MEASUREMENT BY THE GLUCOSE CLAMP TECHNIQUE
A. J. McCULLOCH, P. D. HOME, R. HEINE, M. PONCHNER, •
I.HANNING, D. G. JOHNSTON, F. CLARK and K. G. M. M. ALBERTI
Department ofClinicalBiochemistry andMetabolic Medicine andDepartment ofMedicine,
Royal Victoria Infirmary, Newcastle upon Tyne and Department ofMedicine, Freeman
Hospital, Newcastle upon Tyne
Sensitivity to porcine insulin has been compared in overnight fasted hyper-
thyroid and control subjects using a euglycaemic clamp technique. Basal values
for blood glucose, lactate, pyruvate, alanine, serum insulin and C-peptide were
similar in the two groups, whilst blood glycerol (hyperthyroid 0-11 ± 0 02 (mean
+ S.E.) vs. control 0-06±0-01 mmol/1, PcO-Ol) and blood 3-hydroxybutyrate
(0-28 [0 03-0-79, range] vs 0-09 [0-01-0-29] mmol/1, i3 < 0-05) were increased in
hyperthyroidism. During the 2 hour insulin infusion (0-05 U/kg/h), serum
insulin plateaued at the same level (44 ± 4 vs 44 + 1 mU/1) and insulin metabolic
clearance rates were similar (M9±0-10 vs 1 -25 ± 0-03 1/min). Serum C-peptide
levels also decreased by simirar amounts (40 ±8 vs 47 ± 6%). The amount of
glucose infused tomaintain euglycaemia was identical during the second hour of
insulin infusion (290 + 50 vs 330 ± 30 mg/kg) as were the increments in lactate
and pyruvate concentrations. Blood glycerol values decreased in both groups
although values in hyperthyroid patients remained significantly higher than in
controls. 3-Hydroxybutyrate concentrations fell to similar values in the two
groups. These findings suggest that insulin-stimulated glucose metabolism and
inhibition of ketogenesis is normal in hyperthyroidism.
The blood glucose concentration of hyperthyroid man has been reported to be elevated
following the ingestion of glucose (Holdsworth & Besser, 1968; Kreines el al. 1965) and
mixed meals (McCulloch et al. 1982) in most, but not all (Macho 1936; Gorowski &
Wolanska 1957) studies. The cause of this hyperglycaemia remains uncertain. Insulin
sensitivity in hyperthyroidism has been assessed as normal (Ambrosolini et al. 1956),
diminished (Doar et al. 1969; Holdsworth and Besser, 1968) or enhanced (Elgee &
Williams, 1955; Maracek & Feldman 1973; Elrick et al. 1961). This probably reflects the
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variety of techniques used to measure insulin sensitivity as well as species differences
between man (Holdsworth & Besser 1968; Kreines et al. 1965; McCulloch et al. in press)
rat (Ambrosalini et al. 1956; Elgee & Williams, 1955) and rabbit (Maracek & Feldman,
1973). Where glucose tolerance is impaired, the finding of normal (Holdsworth & Besser,
1968, McCulloch et al., 1982) or elevated (Doar et al. 1969) peripheral insulin levels has
been taken to indicate insulin resistance, even where the pattern of insulin secretion has
not been examined. Measurement of the rate of fall or nadir of blood glucose
concentrations after injection of exogenous insulin in man has produced contradictory
results, sometimes suggesting enhanced (Elrick et al. 1961) and sometimes decreased
(West et al. 1975) sensitivity to insulin. Such studies are however complicated by the
counter-regulatory response to hypoglycaemia which is very variable in both time and
degree.
The euglycaemic clamp technique allows assessment of insulin sensitivity in the absence
of stimulated counter-regulatory hormone secretion (Alberti et al. 1979; De Fronzo et al.
1979; Home et al. 1982). We have therefore used this technique, with the aid of a blood
glucose-controlled glucose infusion system (Biostator, Miles) to compare insulin
sensitivity in normal and hyperthyroid subjects. Insulin sensitivity is defined as the rate of
glucose infusion required to maintain the blood glucose level in the face of a constant




Six female patients (age [mean + SE] 28 + 2 years, % ideal body weight 100 + 3) with
hyperthyroidism due to Graves' Disease (diffusely enlarged hyperaemic thyroid glands
with no nodules on Technicium scanning) were compared with a matched group of seven
healthy female controls (age 24+ 1 years, % ideal body weight 100 ±2). The study was
approved by the local Ethical Committee and informed consent obtained from all
subjects. Patients and controls were all within 10% of ideal body weight, and their ages
ranged from 22-36 years. They were asked to maintain their normal diet for three days
before the study and to fast from midnight on the evening beforehand.
No subject was taking oral contraceptive pills or any other drug and none was known to
be suffering from any disease other than thyrotoxicosis.
Protocol
On the morning of the study, three PTFE cannulae (Venflon, Viggo, Helsinborg) were
inserted i.v. into each subject. One cannula, in an antecubital fossa, was used for
intermittent blood sampling for hormones and metabolites and was flushed with 015
mol/1 saline after use. A second cannula, inserted retrogradely and more distally on the
same arm was used for continuous sampling of arterialised blood by the biostator.
Arterialisation of venous blood was achieved using a heated hand warming system
(Abumrad et al. 1981). The third cannula, on the contralateral arm, was used for all
infusions. A period of one hour was allowed for equilibration following cannulation,
calibration of the machine and to achieve stability of the glucose sensor response.
At the end of calibration (time 0 min) highly purified porcine insulin (Actrapid, Novo)
was infused i.v. at a rate of 0-05 u/kg/h body weight. The biostator constants and
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clamping technique were as described previously (Home et al. 1982). Blood glucose was
clamped 0-28 mmol/1 (5 mg/dl) below fasting levels to avoid stimulation of endogenous
insulin during oscillation around the intended clamp value. The insulin infusion
continued for 120 min and blood samples were taken at —30, 0 and every 15 min
thereafter for 2 h. Blood for glucose, lactate, pyruvate, alanine, glycerol and 3-hydroxy-
butyrate was taken into chilled 0- 5 mol/1 perchloric acid and the extract stored at — 20°C
until analysis by fluorimetric methods (Lloyd el al. 1978). Serum insulin was measured by
double antibody radioimmunoassay (Soeldner and Slone, 1965) (sensitivity 2 mU/1:
intraassay coefficient of variation (CV) 7%) using human insulin as standard. C-peptide
was measured by radioimmunoassay with ethanol precipitation (Heding, 1975) (sensiti¬
vity 0-02 nmol/1 within assay CV 3%). Serum triiodothyronine (T3) was measured by
double antibody radioimmunoassay (Hesch and Evered, 1973) and serum thyroxine (T4)
by radioimmunoassay (Mallinkrodt RIA-MAT (R) T4).
Statistics
Results were analysed by standard parametric methods and expressed as mean
+ standard error unless otherwise indicated. Blood 3-hydroxybutyrate concentrations
were log normally distributed and statistical analysis was performed on log transformed
data. Student's independent /-test was employed to detect differences between groups.
Insulin sensitivity was calculated as the amount of glucose infused to maintain
euglycaemia in the second hour of insulin infusion (60-120 min) when the glucose
infusion rate was relatively constant.
RESULTS
Serum thyroxine (hyperthyroid 276 + 33 vs control 107 ±4 nmol/1 P< 0-001) and
triiodothyronine (8-5+ 1-6 vs 2 0±0-l nmol/1, RcO-OOl) were increased in hyperthyroid
subjects.
Basal values for blood glucose, (Fig. 1), lactate (Fig. 2), pyruvate (hyperthyroid
0-06 + 0-005 vs control 0-07 + 0-01 mmol/1) and alanine (hyperthyroid 0-23±0-03 vs
control 0-28 ±0-03 mmol/1) were similar in the two groups, but blood glycerol
(hyperthyroid 0-11 ±0-02 vs control 0-06 + 0-01 mmol/1, Re0-01) and blood 3-hydroxy-
butyrate (0-28 [0-03-0-79] vs 0-09 [0-01-0-29] mmol/1 (mean and range), f><0-05) were
increased in hyperthyroidism (Fig. 2). Basal serum insulin (hyperthyroid 7 + 1 vs control
6 + 2 mu/1 and C-peptide levels (0-32 + 0-06 vs 0-33 + 0-03 nmol/1) were however identical
(Fig. 1). During insulin infusion, plateau serum insulin values were similar in the two
groups (hyperthyroid 44+ vs control 44+ 1 mU/1) (Fig. 1). Insulin metabolic clearance
rates were also identical (1-21 ±0-10 vs 1-25 + 0-03 1/min). The degree of suppression of
endogenous insulin secretion, as reflected by the fall in C-peptide levels (Fig. 1) was
indistinguishable between patients and controls (hyperthyroid 40 + 8 vs control 47 + 6%).
Blood glucose levels were satisfactorily controlled by the biostator (Fig. 1) with a mean
deviation from intended values of 0-04 mmol/1. The coefficient of variation of blood
glucose values for the period of the clamp was similar in both groups (hyperthyroid
6-3 + 1-5 vs control 5-1 ± 1-6%). During the last 60min blood glucose was 4-6+ 0-3 mmol/1
in hyperthyroid subjects and 4-4+ 0-1 mmol/1 in controls (Fig. 1). Feedback glucose
infusion increased throughout the 2 h study period but most of this change occurred in the
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rain) in hyperthyroid (•) and control (O) subjects. Values for glucose delivery are expressed as
mmol/kg/min and are shown as the mean of each 15 min infusion period.
first hour (Fig. 1). No significant difference was seen in the glucose required to maintain
the clamp value at any time.
Blood lactate levels rose to the same extent in both groups (Fig. 2), and blood pyruvate
followed a similar pattern. Blood alanine levels were unchanged in both groups during
insulin infusion. Blood glycerol concentrations fell in both groups (Fig. 2), although levels
in the hyperthyroid patients remained significantly higher than in the controls. Blood
3-hydroxybutyrate levels decreased to similar values in both groups (Fig. 2).
DISCUSSION
Glucose clamp techniques allow assessment of insulin activity on glucose metabolism
without the interference ofcounter-regulatory responses to hypoglycaemia (De Fronzo et
al. 1979; Olefsky & Kolterman 1981). For ethical reasons we have not performed repeated
studies to obtain dose response curves, but the single dose chosen (0-05 u/kg/h) lies on the
straight part of the curve in normal subjects (Massi-Benedetti et al. 1981). This infusion
rate also gives circulating insulin levels comparable to those seen during glucose tolerance
tests (Sestoft & Heding, 1981) and after normal meals (McCulloch et al. 1982). The highly
purified porcine insulin used in this study is known to be identical in activity with human
insulin when assessed using the same technique (Home et al. 1982).
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a combination of insulin-induced inhibition of hepatic gluconeogenesis and increased
hepatic and peripheral glycolysis. Blood alanine concentrations were unchanged by
insulin infusion in both groups reflecting a balance of the hepatic and peripheral effects of
insulin. 3:Hydroxybutyrate levels were, however, increased in hyperthyroid subjects but
suppressed rapidly to control values during insulin infusion. Fasting hyperketonaemia
has previously been reported in these patients (Beylot et al. 1980; Bartels et al. 1979) and
ketone body levels are known to fall to normal values after mixed meals (McCulloch et al.
1982) as a result of the suppression of lipolysis and ketogenesis. Fasting blood glycerol
levels were increased in the hyperthyroid patients but, in contrast to ketone bodies, did
not decline to normal values during insulin infusion, although a significant decrease was
apparent. This is consistent with recent studies using adipocytes from hyperthyroid
patients which demonstrated impairment of the normal insulin-mediated suppression of
glycerol release (Wennlund et al. 1981). In accord with this we have recently shown that
blood glycerol levels fail to return to normal after mixed meals (McCulloch et al. 1982).
In summary insulin sensitivity in terms of overall glucose metabolism is normal in
hyperthyroidism. Lipolysis is however enhanced at normal fasting insulin levels, and may
not be totally suppressed by insulin levels effective in normal man.
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EVIDENCE THAT THYROID HORMONES REGULATE
GLUCONEOGENESIS FROM GLYCEROL IN MAN
A.J. MCCULLOCH. D. G. JOHNSTON, P. H. BAYLIS,
P. KENDALL-TAYLOR, F. CLARK, E.T.YOUNG and K. G. M. M.
ALBERTI
Department ofClinical Biochemistry and Metabolic Medicine, and Department of
Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, and Department ofMedicine,
Freeman Hospital, Newcastle upon Tyne
We have previously reported that glucose production assessed using radioiso¬
topic methods is 50% increased in hyperthyroidism but 30% decreased in
hypothyroidism. These studies, however, do not distinguish between glycogeno¬
sis and gluconeogenesis. In fasting man more than 80% of circulating glycerol
is cleared by the liver and enters the gluconeogenic pathway. We have therefore
measured glycerol clearance following bolus intravenous glycerol administra¬
tion as an indirect assessment of gluconeogenic capacity. Hyperthyroid and
hypothyroid subjects were compared with separate matched controls after an
overnight fast. In hyperthyroid subjects blood glucose and blood glycerol were
increased but lactate, pyruvate, and alanine concentrations were normal.
Glycerol clearance was increased in hyperthyroidism and followed a double
exponential decay with a shortened second component half-time. Endogenous
glycerol production was increased three-fold. In hypothyroidism fasting
circulating levels of glucose, lactate, pyruvate, alanine, and glycerol were normal
but glycerol clearance was diminished. Both first and second component
half-times were prolonged in hypothyroidism and endogenous glycerol produc¬
tion was decreased by 50%. Thus in hyperthyroidism glycerol clearance is
greatly enhanced whilst in hypothyroidism glycerol clearance is diminished. The
magnitude of the changes suggests that alterations in gluconeogenesis are
probably the major factors concerned in the reported increase and decrease in
glucose production in hyperthyroidism and hypothyroidism respectively.
Total glucose production is increased in hyperthyroidism (Perez et al., 1980; Saunders et
al., 1980; McCulloch et al., 1983) and decreased (McCulloch et al., 1983) or normal
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(Saunders et al., 1980) in hypothyroid man and blood glycerol concentrations may be
elevated in the former state (Tibbling, 1969; McCulloch et al., 1982). The relative
contributions of glycogenolysis and gluconeogenesis to these changes in glucose
production, however, are not known.
Animal and in vitro studies have suggested that thyroid hormones may regulate
gluconeogenesis from the major gluconeogenic precursors lactate (Menahan & Weiland,
1969; Weinberg & Utter, 1979; Okajima & Ui, 1979), alanine (Ness et al., 1969), and
glycerol (Sestoft et al., 1977). In the rat, thyroid hormones cause the induction of
L-glycerophosphate dehydrogenase in liver mitochondria (Lee et al., 1959), the activity of
this enzyme playing a central role in the regulation of glycerol utilization by determining
the rate of carbon transfer into gluconeogenesis (Schimassek et al., 1963; Sestoft et al.,
1977). In normal man and animals glycerol is highly gluconeogenic (Nikkila & Ojala,
1964; Bortz et al., 1972) and is metabolized to glucose in preference to the other
gluconeogenic precursors (Steele et al., 1971). In the fasting state 90-100% of circulating
glycerol is converted to glucose (Bortz et al., 1972; Shaw et al., 1976), conversion
increasing as blood concentrations rise (Winkler et al., 1970). The liver is responsible for
70-90% of total glycerol uptake (Larsen, 1963; Gidez & Karnowsky, 1954; Swick &
Nakao, 1954; Schambye et al., 1954) with the remainder metabolized by the kidneys
(Borchgrevink & Havel, 1963; Swanson & Thompson, 1969), small intestine and other
tissues (Saunders & Dawson, 1967; Haessler & Isselbacher, 1963; Lin, 1977). Clearance of
glycerol from blood following intravenous glycerol loading may therefore provide an
estimate of the gluconeogenic capacity of the liver in normal man and in patients with
thyroid dysfunction.
We have therefore examined glycerol in patients with thyrotoxicosis, primary thyroid
failure and in normal controls using a bolus intravenous technique with subsequent
analysis of decay of blood glycerol levels.
MATERIALS AND METHODS
Seven hyperthyroid (six female, one male) and six hypothyroid (six female) patients were
comparedwith separate groups ofmatched controls (seven male and eight female) (Table
1). Hyperthyroidism was due to Graves' disease in all cases (on the basis ofclinical features
and the absence of thyroid nodules on "Tc scanning). Hypothyroidism was due to
autoimmune thyroid failure in all patients (on the basis of clinical features and the
presence of circulating antibodies to thyroid tissue). No subject had any evidence of
hepatic or renal impairment and none was taking any drug prior to the study. Informed
consent was obtained from all subjects for the study which was approved by the Newcastle
Area Health Authority (Teaching) Ethical Committee.
Studies were performed on recumbent subjects after an overnight (10 h) fast. Subjects
had abstained from alcohol for at least 48 h and had a daily carbohydrate intake in excess
of 250 g for this period. Bilateral indwelling intravenous cannulae (Venflon, Viggo
Heisinborg) were inserted using 1% lignocaine as local anaesthetic. Cannula patency was
maintained by flushing with 0-154 mol/1 saline after every sample.
Basal samples for hormones and metabolites were withdrawn 25 and 30 min after
cannulation. An intravenous bolus injection of glycerol (0-1 mmol/kg body weight)
diluted with water to isotonicity was then administered over 15 s and further blood
samples were taken 1, 2, 3, 4, 5, 6, 8, 10, 12-5, 15, 20, 30, 40, 50, and 60 min after injection.
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Venous blood (1-0 ml) was mixed with chilled 0-5 mol/1 perchloric acid. Blood glucose,
glycerol, lactate, pyruvate alanine, and 3-hydroxybutyrate were measured by an
automated fluorimetric enzymatic method (Lloyd et a/., 1978). Serum insulin (Soeldner &
Slone, 1965), triiodothyronine (Hesch & Evered, 1973), and thyroid stimulating hormone
(Hall et al., 1971) were measured by double antibody radioimmunoassay and serum
thyroxine by radioimmunoassay (Mallinkrodt, RIA-MAT (R) T4).
Results are expressed as mean ± standard error of the mean (SEM). Statistical analysis
was performed using Student's unpaired /-test. Correlations were sought by the
least-squares method. 3-Hydroxybutyrate concentrations were log-normally distributed
and statistical analyses were performed on log-transformed data.
Mathematical analysis
The decay of blood glycerol following bolus intravenous injection was closely
approximated by a double exponential function of the form Aw — k[t + Bc —k2t, where A,
B, K(, and k2 are constants. Curve-fitting was performed by computer to the points of the
blood glycerol decay curve, after subtraction of basal glycerol concentrations. The area
under the curve was calculated by integration of the equation for curve fit (Bateman et al.,
1981). Metabolic clearance rate (MCR) is equal to the dose ofglycerol injection divided by
the area under the glycerol decay curve:
mmol/injected t w .v .*V-7MCR (1/min) =
(mmol/l/min)
Endogenous glycerol production (EPR) is equal to the product ofmetabolic clearance and
basal glycerol concentration:
EPR (mmol/min) =MCR x Basal [glycerol].
It is assumed in these calculations that the endogenous production rate ofglycerol remains
constant throughout the experimental period. Volume of distribution of glycerol was
calculated using the intercepts and exponents for the a and /? phases of the glycerol decay
curve (Gibaldi, 1969).
RESULTS
Serum thyroxine and triiodothyronine concentrations were increased in hyperthyroid and
decreased in hypothyroid patients when compared to controls (Table 1). Serum thyroid
stimulating hormone concentrations were increased in hypothyroidism.
Peak blood glycerol concentrations following glycerol injection ranged between 0-35
and 1-20 mmol/1 and were not significantly different between the groups. Glycerol
injection had no effect on any of the other metabolite concentrations measured in any
group nor on peripheral insulin levels.
Hyperthyroid subjects
Fasting blood glucose (5-4 + 0-2 v. 4-6 + OT mmol/1, PcO-Ol) (Table 2) and blood
glycerol (0T2 + 0-01 v. 0-07 + 0-01 mmol/1, p<0-0l) (Table 3) concentrations were
increased in hyperthyroid subjects but basal circulating lactate, pyruvate, alanine,
3-hydroxybutyrate, and insulin levels were similar to controls (Table 2).
The double exponential decay curve for injected glycerol is clearly demonstrated in Fig.
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Table 1. Clinical details of hyperthyroid, hypothyroid, and control subjects. Results
are mean + SEM
Serum
Serum thyroid
Per cent of Serum triiodo¬ stimulating
Age ideal body thyroxine thyronine hormone
(years) weight (nmol/1) (nmol/i) (mU/1)
Hyperthyroid 34 ±4 104 + 3 . 181+13*** 4-5 ±0-3*** 1-0 + 0-02
Control 34 ±3 108 ±4 97 ±9 20±0-2 1-5 + 0-2
Hypothyroid 48 ±1 123± 5 28±9»»* 0-9 + 0-2** 40-1+7-1***
Control 45 ±2 U8±4 89 + 8 2-0 + 0-2 1-6 + 0-5
** P <0-01 v. appropriate controls.
*** ?<0-001 y. appropriate controls.
IA
Table 2. Fasting hormone and metabolite concentrations (mean±SE) in hyperthyroid, hypothy¬
roid, and control subjects. For 3-hydroxybutyrate mean (range) is given
Blood Blood Blood Blood Blood Serum
glucose lactate pyruvate alanine 3-hydroxybutyrate insulin
Subjects (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mU/1)
Hyperthyroid 5-4 + 0-2** 0-94 + 0-15 0-09 + 0-01 0-28 + 0-02 0-08(0-03-0-18) 7-8+1-0
Control 4-6 + 0-1 0-88 + 0-16 0-07 + 0-01 0-30 + 0-04 0-08(0-03-0-18) 8-8+1-5
Hypothyroid 5-1+0-4 1-10 + 0-07 0-10 + 0-01 0-31+0-02 0-04(0-01-0-14) 9-4+1-8
Control 4-9 + 0-2 0-99 + 0-15 0-08 + 0-04 0-34 + 0-04 0-05(0-005-0-14) 8-4+1-3
** PcO-Ol hyperthyroid subjects v. controls.
1 (/• = 0-98 ±0-003). Values for the second exponential constant (k2) were increased in
hyperthyroidism (0-138 + 0-022 v. 0-070 + 0-010, p<0-05) and as a result the second
component half-time was shorter (5-9 ± 1 -0 v. 11 -9 ± 0-3 min, P < 0-05). Glycerol clearance
rate was also increased in hyperthyroidism (48-7 ± 5-7 v. 27-2 ± 2-6 ml/kg/min, P < 0-005)
as was endogenous glycerol production (5-7 + 0-8 v. 2-1+0-3 /tmol/kg/min, P<0-01)
(Table 3).
Hypothyroid subjects
In hypothyroidism, fasting circulating concentrations of glucose, lactate, pyruvate,
alanine, glycerol, 3-hydroxybutyrate, and insulin were similar to control values (Table 2).
Both the first (P<0-05) and second component (P<0-01) half-times were significantly
prolonged in hypothyroidism (Table 3). Glycerol clearance rate was decreased (hypothyr¬
oid 17-1 ±0-7 v. control 25-0±1-8 ml/kg/min, PcO-01) and endogenous glycerol
production rate was diminished (1-1+0-5 v. 2-1+0-3 /rmol/kg/min, PcO-Ol) in
hypothyroid patients. 0-7, 0 -T~
Table3.Glycerolkineticd taihyperlhyroid,hy ot r i ,ndrespectiveco lsubj s
Subject group
Basalblood glycerol (mmol/1)
Metabolic clearance. rale (ml/kg/min)
Volume of distribution (l/kg)
ki (min-1)
k2 (min-1)
Half disappearance timefor1st component (min)
Half disappearance limefor2nd component (min)































































































































Fig. 1. Change in blood glycerol concentration from basal levels following bolus intravenous
glycerol ((H mmol/kg) administration in (a) hyperthyroid (■) and control (□) and (b)
hypothyroid (•) and control (O) subjects. Blood glycerol is shown on a logarithmic scale.
Correlations
Correlations between glycerol kinetic data, metabolic status, and thyroid hormone
ieveis did not reach significance in either patient or control groups.
DISCUSSION
These studies show that in man hyperthyroidism is associated with enhanced glycerol
clearance after bolus injection of glycerol. No estimate of basal glycerol clearance is
possible from our data but a 170% increase in endogenous production with only a 70%
increase in fasting levels implies enhanced basal glycerol clearance and hence, perhaps,
increased gluconeogenesis. Converse changes were noted in hypothyroid subjects.
Fasting blood glucose concentrations were increased in hyperthyroidism in this, as in
other studies (Ikejiri et al., 1978; McCulloch et al., 1982) whilst lactate pyruvate and
alanine concentrations were normal. Alone amongst the gluconeogenic precursors,
glycerol levels were increased, presumably secondary to enhanced lipolysis (Rich et al.,
1959; Brodie et al., 1966; Tibbling, 1969; McCulloch et al., 1982). In hypothyroidism
blood glucose, lactate, pyruvate, and glycerol levels were normal, as has previously been
reported (McCulloch et al., 1981).
Hepatic glucose production measured isotopically has been shown to be increased in
hyperthyroidism (Perez et al., 1980; Saunders et al., 1980; McCulloch et al., 1983) and
diminished (McCulloch et al., 1983) or normal (Saunders et al., 1980) in hypothyroidism.
Such data does not distinguish between glycogenolysis and gluconeogenesis nor does it
give information about the capacity of those two processes. In fasting man, glycerol taken
up by the liver enters the gluconeogenic pathway and thus clearance of an intravenous
glycerol load may provide an estimate of gluconeogenic capacity. Previous studies of
gluconeogenesis in patients with thyroid disease are few. In hyperthyroidism, splanchnic
balance studies suggest that hepatic uptake of all the major gluconeogenic precursors is
increased (Wahren et al., 1981). For lactate, pyruvate, and the alanine this is achieved by
an increase in fractional extraction whilst for glycerol, increased arterial concentrations
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combined with a 20% increase in hepatic blood flow are responsible. Apart from a single
study of congenital hypothyroidism (Hayek, 1979) showing normal gluconeogenesis from
from alanine, there have been no estimates of gluconeogenesis in hypothyroid man.
The metabolic clearance rate for glycerol is the best index of glycerol disappearance in
the kind of study used here, as its measurement -
(amount of glycerol administered / A blood glycerol)
is independent of any descriptive compartmental model and its estimate is valid even if
glycerol elimination occurs outside the sampling compartment (Wilkinson & Shand,
1971). The amount of glycerol used in this study was chosen to give peak blood glycerol
values between 0-4 and 1-5 mmol/1. This avoided the very high blood glycerol levels which
have been reported to cause renal damage in man and animals (Hagnevick et al., 1974;
Anderson et al., 1950). Much higher doses than those used in this study have been used
therapeutically in man without adverse effects (Senior & Loridan, 1968).
Glycerol clearance rate was increased by 80% in hyperthyroidism and decreased by 30%
in hypothyroidism. The mechanism(s) underlying these changes are uncertain. Glycerol
taken up by the liver is first phosphorylated by glycerol kinase and enters the
gluconeogenic pathway after oxidation by glycerol-3-phosphate dehydrogenase (G3PD).
Glycerol kinase is subject to feedback inhibition by glycerol-3-phosphate (Robinson &
Newsholme, 1969; Sestoft & Fleron, 1975). In the rat, the activity ofmitochondrial G3PD
is thyroid hormone dependent (Hoch, 1974). It has long been considered an intracellular
marker of thyroid hormone action and alteration of mitochondrial G3PD activity in our
subjects is thus a possible explanation of the observed changes in glycerol metabolic
clearance rates. However, Nolte et al. (1972), in an as yet unconfirmed study, failed to
demonstrate any increase in mitochondrial G3PD activity in thyrotoxic man.
Altered hepatic blood flow may also contribute to our findings. A 20% increase in
hepatic blood has previously been directly demonstrated in hyperthyroid patients
(Wahren et al., 1981). Circulating (albeit venous) glycerol concentrations of glycerol were
increased by 70% in our thyrotoxic subjects. Assuming a similar 20% increase in hepatic
blood flow, this would provide a 100% increase in hepatic glycerol delivery in
hyperthyroidism. Fractional Glycerol extraction need not therefore be increased to
account for increased glycerol clearance rates of 80%. This is compatible with the data of
Tibbling (1969) who demonstrated that fractional glycerol turnover was not significantly
increased in thyrotoxic humans. Similarly, in hypothyroidism cardiac output, stroke
volume (Graetinger et al., 1958) and flow through many organs is diminished (Scott et al.,
1962; Stewart & Evans, 1942; Zondek, 1967) and may contribute to the decreased glycerol
clearance rates reported here. In keeping with the changes in glycerol clearance rates, the
fractional rate constants (ki and k2) were approximately doubled in hyperthyroidism and
halved in hypothyroidism with appropriate reciprocal changes in the calculated first and
second half disappearance times. These changes may result from either haemodynamic
factors, primary changes in hepatic glycerol uptake, or a combination of these two factors.
Calculated endogenous glycerol production rates for normal subjects (2T pmol/kg/'
min) were similar to those quoted in other studies using different methods (2-2
/imol/kg/min: Johnston et al., 1983; 1-6 /imol/kg/min: Bortz et al., 1972). Endogenous
production rates were increased three-fold in hyperthyroidism and decreased by 50% in
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hypothyroidism. These results are entirely consistent with previous studies showing
lipolysis to be increased in hyperthyroidism (Rich et al., 1959; Brodie et al., 1982;
McCulloch et al., 1982) and decreased in hypothyroidism (McCulloch et al., 1981;
Goodman & Bray, 1966).
Volumes of distribution for glycerol, although variable, were not significantly different
between the groups suggesting that the changes in glycerol elimination were not secondary
to altered distribution space in any patient group.
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The kinetics of ketone bodies was studied in normal humans by
giving a combined bolus intravenous injection of labeled ace-
toacetate ([uC]AcAc) and d(—)-/Miydroxybutyrate (yS-[14Cj-
OHB) to seven subjects after an overnight fast, on two different
occasions, and by collecting frequent blood samples for 100 min.
Kinetic data were analyzed with both noncompartmental and
compartmental modeling techniques. A four-compartment
model, representing AcAc and /3-OHB in blood and two equili¬
brating ketone body compartments, inside the liver and extra-
hepatic tissues, was chosen as the most reliable mathematical
representation; it is physiologically plausible and was able to
accurately fit the data. The model permitted evaluation of the
in vivo rate of ketone body production in the liver, the individ¬
ual plasma clearance rates of AcAc and /2-OHB, their initial
volumes of distribution, and the transfer rate parameters among
the four ketone body compartments. Moreover, the model
provided estimates of the components of the rates ofappearance
of AcAc and /3-OHB in plasma due to newly synthesized ketone
body from acetyl-CoA in the liver, and to interconversion and
recycling in the liver and extrahepatic tissues. The model also
was used to evaluate other methodologies currently employed
in the analysis of ketone body turnover data: the conventional
approach based on use of the combined specific activity of AcAc
and /i-OHB required assumptions not satisfied in vivo, leading
to substantial errors in key parameter estimates.
ketone body turnover; acetoacetate; hydroxybutyrate; mathe¬
matical modeling; compartmental model; model identification;
parameter estimation; tracer kinetics
in the postabsorptive state, ketone bodies play a
minor role in supplying energy needs in mammals (35),
but in other metabolic conditions ketone bodies are a
major metabolic substrate (32). Isotopic techniques pro¬
vide relatively noninvasive methods for measuring rates
of production and utilization of ketone bodies in vivo
(11), and infusion of either [3-14C]acetoacetate ([14C]-
AcAc) or d(—)-/?-[3-14C]hydroxybutjrate (yS-[14C]OHB)
has been widely used in animals and in humans (4, 6, 11,
22, 23, 33). However this approach is possibly not without
serious difficulties. Acetoacetate (AcAc) and d(—)-/?-hy-
droxybutyrate (/?-OHB) are interconverted too rapidly to
be considered independent substrates, but too slowly for
their specific activities (SA) to become equal (8). All
investigators except Barton (6, 7), Heath and Barton
(20), and Bates (10) attempt to circumvent this difficulty
using the combined SA of AcAc and /2-OHB for quanti¬
fying total ketone body (TKB) turnover. But it is not
clear whether this approach is valid. It has recently been
suggested that this approach may lead to incorrect dis¬
posal rates and plasma clearance rates (8).
Despite these unsolved methodological issues TKB
kinetics has been investigated both in steady and non-
steady state in a variety of metabolic conditions (3, 5).
Moreover conflicting results have been reported concern¬
ing several kinetic parameters such as volume of distri¬
bution, ranging from 10 to 50% of body weight (5); num¬
ber of compartments, ranging from 1 to 3 (3, 9, 20, 23),
and ratio of plasma clearance rates of AcAc and yS-OHB
ranging from 1 to 3 (4, 8). Whereas in rats a variety of
models have been proposed and quantified in the steady
state (6-9, 20), a thorough quantitative analysis of ketone
body kinetics has never been performed in man.
Barton (8) recently suggested that either separate in¬
jections of [14C]AcAc and /?-[14C]OHB at different times
or simultaneous administration of doubly labeled ketone
bodies could provide a more accurate means of estimating
the individual plasma clearance rates and more generally
the kinetics of the two ketone bodies in steady state. In
this study we have adopted the first of these two sugges¬
tions along with appropriate mathematical modeling
techniques. Our results indicate that a four-compartment
model can describe adequately the kinetics of AcAc and
yS-OHB in normal humans after an overnight fast, thus




Four male and three female volunteers [46 ± 1 (SE)
yr] were each judged normal on the basis of medical
history and physical examination. Preliminary blood
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tests, which were normal in each subject, included blood
urea nitrogen, Na+, Ca2+, blood sugar, total protein, total
bilirubin, serum glutamine-oxalacetic transaminase, he¬
moglobin, and white cell count. All subjects were within
10% of ideal body weight but subject GB, who was 21%
overweight, according to Metropolitan Life Insurance
Table (1967). All subjects followed a normocaloric diet
with at least 250 g of carbohydrates in the 4 days before
the study. No subject was taking any form of medication
and they were all afebrile at the time of the study. No
alcohol was consumed in the 24 h before the study. All
subjects were advised of the nature, scientific goals, and
possible hazards of the studies prior to consenting to
participation.
Experimental Procedures
The day of the experiment the subjects were admitted
at 7 a.m. to the Metabolic Units after a 12-h overnight
fast. Lidocaine [Xylocaine, Astra; 1% weight/volume
(wt/vol)] was used to anesthetize the skin and one Venflo
cannula (1.1 mm OD) was inserted into an antecubital
vein for the 8 a.m. bolus intravenous injection of the
tracer. A second cannula (1.1 mm OD) was inserted into
a dorsal hand vein of the other arm in a retrograde
manner to the most distal site from which sampling was
possible, and the hand was placed in a warming chamber
at 60°C (18, 27). The cannula was filled with 0.5-0.7 ml
of isotonic saline and the first 1 ml of blood sampled was
subsequently discarded at each sample time. At 7:30 a.m.
a 12-ml blood sample was taken for the radioactivity
recovery calculation. Two basal samples (6 ml) were
collected just before the tracer was injected. Other 6-ml
samples were collected 1, 2, 3, 4, 5, 6, 8, 10, 12.5, 15, 20,
25, 30, 40, 50, 60, 70, 80, and 100 min after the injection
of the tracer.
Subjects were asked to urinate before the study, and
at the end of the study new urine was collected and
immediately neutralized and chilled. The seven subjects
were injected the first time with about 50 pCi sodium
[14C]AcAc diluted in 10 ml saline. Under the same met¬
abolic and experimental conditions, about 50 pCi of so¬
dium /?-[14C]OHB diluted in 10 ml saline was similarly
injected. The order of injections was performed ran¬
domly. During the experiment, the subjects remained at
rest in an armchair.
Preparation of Tracer Infusate
Ethyl[3-14C]acetoacetate (250 pCi, sp act 8.9 mCi/
mmol, Radiochemical Center, Amersham, UK) was
added to 100 pmol of freshly redistilled carrier ethyl
acetoacetate. Hydrolysis was accomplished as described
elsewhere (28). After neutralization with 0.2 M HC1 and
addition of 5 ml of saline, the solution was washed 6
times with 15 ml of diethylether and treated for 45 min
with a stream of N2, keeping the solution in crushed ice.
To check whether acetone was still present in the solu¬
tion, 5 /xCi of [2-14C]acetone (sp act 59 mCi/mmol, Ra¬
diochemical Centre, Amersham, UK) were added to 5 ml
of saline and passed through the steps cited above. No
residual radioactivity was found in the solution after such
treatment. The radiochemical purity of sodium [3-14C]-
acetoacetate was determined in each experiment (21
and was between 92 and 96% (28) after extraction wit
10 ml ether 6 times.
d-/1-[3-14C]OHB (250 pCi) (sp act 56 mCi/mmol, R<
diochemical Center, Amersham, UK) were diluted wit
25 ml of saline containing 100 pmol of dl-sodium /LOHI
Labeled AcAc and /LOHB solutions were passed twic
through a Millipore filter (0.22 /um), kept frozen in steri
syringes at —20°C, and used within 7 days. The concei
tration of cold carrier AcAc and /1-OHB was determine
in the tracer solution of each subject (28). The mat
magnitude of both carriers was about 15-20 /xmol, bot
in the linear perturbation range.
Analytic Procedures
Each 6-ml blood sample was immediately and thoi
oughly mixed with 5 ml 20% (wt/vol) perchloric aci(
kept in crushed ice until the end of the study, an
neutralized with 20 and 5% (wt/vol) KOH. The radioa*
tivity concentrations of [14C]AcAc and of /?-[14C]OH
and the cold AcAc and /1-OHB concentrations were d<
termined as described elsewhere (28). Neither [14C]ac<
tone nor acetone was measured. Recoveries of [14C]AcA
and /?-[14C]OHB were determined within each set c
analyses by adding portions of diluted infusates to who!
blood. Recoveries of [14C]AcAc were 82-87% when co:
rected for radiochemical purity and 79-86% for /?-[14C
OHB. Efficiency of the liquid-scintillation counting pre
cedure was determined by use of [14C]toluene as a
external standard, and each sample count was thus co:
rected for quenching. The SA of AcAc and /?-OHB i
urine was measured in the same manner as in blood. A
analyses were performed in duplicate within 8 h after th
end of blood sample collection.
Data Analysis
Two linear modeling methods were used to account fc
the kinetic data of labeled AcAc and yS-OHB after injec
tion of [14C]AcAc and /?-[14C]OHB, namely th
"noncompartmental" (or "model independent") and th
compartmental modeling approach (14) (see modelin
studies. rationale and results).
Noncompartmental analysis was carried out as pre
posed by Rescigno and Gurpide (34) and the compute
tional aspects of the method are briefly summarized i
the appendix. This approach extracts information esser
tially from the areas under the experimental curves witl
out proposing a specific model structure. A number (
assumptions are however necessary to carry out th
analysis (appendix). In this study these were 1) extraf
olation to t —» oo was done through an exponential fun<
tion determined from the last four data points; 2) extra}
olation to t —» 0 and initial slope were obtained throug
an exponential function determined from the first thre
points; 3) linear interpolation between data points wi
performed.
Compartmental modeling involves the assumption (
a specific model structure and its numerical quantifier
tion from the experimental data. A variety of physioloj
ically based linear compartmental models of ketone bod
kinetics was examined. The general theoretical modelir
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framework and the identification/validation techniques
employed in this study are described in Cobelli et al. (16).
More specifically a priori identifiability of the various
models has been examined according to techniques de¬
scribed by Cobelli and DiStefano (15). Parameter values
of the models were estimated, using all available a priori
constraints, using a nonlinear weighted least-squares pa¬
rameter estimation technique (17). Errors in measure¬
ments of labeled AcAc and /8-OHB concentrations were
assumed to be uncorrelated and Gaussian, with zero
mean and an experimentally determined standard devia¬
tion. The coefficient of variation of the data was inversely
proportional to the square root of the measurements; a
typical mean value of the range was 5%. Parameter
accuracy estimates were obtained from the Fisher infor¬
mation matrix, the inverse of which is a lower bound on
the parameter covariance matrix (19). The practical ap¬
plicability of this Fisher information matrix approach
was tested using Monte Carlo simulation techniques (14).
Goodness-of-fit was expressed in terms of the weighted
residual sum of squares of the differences between ob¬
served and predicted values (1). The Akaike information
criterion (2) also was used to account for the relative
contributions of goodness-of-fit and the number of pa¬
rameters in evaluating the competing mathematical de¬
scriptions.
experimental results
Fourteen experiments were used in our kinetic model¬
ing studies, involving seven injections of [14C]AcAc and
seven of /3-[14C]OHB. In all subjects both the iv bolus
injection of labeled AcAc and yS-OHB were performed in
random order on two different occasions. The mean
concentrations of cold AcAc and /1-OHB during each
experiment are shown in Table 1. A steady-state condi¬
tion was met during each experiment, and good experi¬
mental control of the subjects was obtained so that it
could be reasonably assumed that the same (within 1
SD) steady state was achieved in each of the two exper¬
iments performed in each subject. A "mean steady state,"
ci, c2, was used in subsequent computations. A number
of representative studies are shown in Fig. 1. For each
subject the measured time courses of labeled AcAc and
/S-OHB after the two injections are shown. Labeled AcAc
and y8-0HB were not detectable in the urine of two
subjects (ED and GB), whereas in the other five, it
averaged 1.2 ± 0.3 (SE) % of the injected dose.




ED 0.036±0.006 0.027+0.010 0.046+0.010 0.057±0.003
GB 0.044±0.013 0.036±0.007 0.028±0.011 0.024±0.003
CF 0.048+0.011 0.073±0.018 0.108±0.042 0.106+0.028
EM 0.121±0.039 0.151±0.076 0.221±0.061 0.216±0.050
MS 0.140±0.059 0.116±0.049 0.113±0.054 0.147±0.044
AG 0.134±0.020 0.112±0.020 0.246±0.048 0.345±0.106
LT 0.115±0.032 0.104+0.026 0.238±0.038 0.250+0.059
modeling studies. rationale and results
A Noncompartmental Analysis
The availability of data obtained from experiments
involving intravenous tracer injection of AcAc and /?-
OHB and measurement of concentrations in blood of
labeled AcAc and /S-OHB allow estimation of various
parameters of ketone body metabolism by the "two ac¬
cessible pools" approach proposed in Rescigno and Gur-
pide (34). The approach is often referred to as noncom¬
partmental, as it does not require a compartmental struc¬
ture, i.e., only the two accessible compartments are evi¬
denced (blood AcAc and blood /3-OHB), embedded in a
network of an undetermined number of connected com¬
partments.
The model is shown in Fig. 2. A similar structure has
been originally quantified in the rat, using a somewhat
different set of experimental conditions, by Barton and
colleagues (6, 7). We have quantified this model in the
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Values are means ± SD of concentrations determined at each
sampling time after labeled AcAc and /S-OHB injection.
fig. 1. Blood concentration of labeled acetoacetate and d-/S-hydrox-
ybutyrate in 4 subjects following tracer injection of acetoacetate
([uC]AcAc) and d-/?-hydroxybutyrate (/3-[MC]OHB). e e, Blood con¬
centration of [,4C]AcAc; O—o, blood concentration of /L['4C]0HB.
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(appendix), and the estimated parameters of AcAc and
/?-OHB metabolism are reported in Table 2. These in¬
clude: the rate of appearance (Rai, Ra2) of AcAc and /?-
OHB in plasma, decomposed into their components due
to recycling (Rair, Ra2r), interconversion (Ran, Ra2i), and
de novo synthesis (Rain, Ra2n); the compartment sizes
(Qi, Q2) of AcAc and yS-OHB; and the plasma clearance
rates (PCRi, PCR2) of AcAc and /?-OHB per se, i.e., not
due to interconversion (8). While providing a quantitative
picture of ketone body metabolism, this approach implies
a number of structural and computational assumptions
that are not necessarily valid (13). Moreover, the ap¬
proach does not make full use of the information availa¬
ble from kinetic studies. This led us to propose more
detailed, physiologically based models.
Ra u
Compartmental Modeling
The use of a structured compartmental approach has
definite advantages when the purpose of modeling is
understanding of the system (14). A schematic of the
biochemical pathways of ketogenesis is shown in Fig. 3,
and the specific interactions between AcAc and /3-OHB
are indicated in Fig. 4. We have examined, starting with
the basic structure of Fig. 4, a number of physiologically
based linear compartmental models. The six-compart¬
ment model was too complex to be resolved from our
kinetic data (unpublished observations).
A four-compartment model. Evidence exists that AcAc
and yd-OHB rapidly equilibrate within the liver, and also
inside extrahepatic tissues (24, 29). Therefore the four-
compartment model of Fig. 5 was considered. This model
depicts the two individual ketones in blood and assumes
the existence of two other compartments (liver and ex¬
trahepatic tissues), where the two ketone bodies inter-
convert very rapidly. This configuration is consistent (16)
with the experimental finding of isotopic disequilibrium
following infusion (or injection) in blood of labeled ke¬
tones (26) as the tracer enters in a compartment different
from blood, which is the accessible pool for test input
and measurement. The equations of the model are
FIG. 2. Model structure adopted for rioncompartmental analysis of
AcAc and /1-OHB kinetics. AcAc and ,8-OHB accessible pools are
represented embedded in a multicompartment system. Rai„, Ra2„ de¬
note the de novo synthesized AcAc and /S-OHB appearing in blood;
Rair, Ra2r rate of AcAc and /5-OHB recycling; Ran, Ra» rate of inter¬
conversion of 2 ketones; Roiirr, Roan- their irreversible rate of removal,
and Qi, Q2 the AcAc and /?-OHB compartment sizes.
Qi(t) — ~(k3i + kti)q\{t) + k\3q3(t) + k\4q4(t)
+ Ui(t), qi(0) = 0
qi{t) = ~(k32 + k42)q2{t) + k23q3(t) + k24q4(t)
+ u2(t), q2(0) = 0





table 2. Rate of appearance ofAcAc(Rax) and of (3-OHB(Ra2) in plasma
/xmol-min' '-m"2 ^imol -min" '-nT2 mmol-■ m~2 mi-min '•m"2
Rai Rai, Ran Rain Ra2 Ra-i, Ra-ii Ra!n Q, Q2 PCRi PCR,
ED 68.93 11.27 22.98 34.68 115.31 43.32 13.93 58.06 0.140 0.151 1410.5 951.7
GB 57.99 8.54 8.71 40.74 35.78 11.35 5.41 19.02 0.163 0.081 1100.8 605.0
CF 98.68 16.70 41.54 40.44 122.18 13.51 5.84 102.83 0.276 0.617 1258.4 627.5
EM 354.50 47.22 178.22 129.06 467.74 141.71 161.65 164.38 1.048 1.276 1070.8 676.5
MS 409.61 27.86 101.67 280.07 346.11 119.24 115.21 111.66 1.360 0.499 2082.3 963.1
AG 410.16 67.98 243.47 98.70 613.97 200.63 138.86 274.48 1.170 0.700 1653.0 574.9
LT 3-31.11 68.52 173.25 89.34 474.51 163.58 95.51 215.41 0.931 0.539 1525.8 564.3
Mean 247.28 35.44 109.98 101.86 310.80 99.05 76.63 135.12 0.726 0.552 1443.1 709.0
±SD ±163.87 ±25.85 ±90.42 ±86.30 ±221.37 ±76.18 ±67.03 ±89.19 ±0.518 ±0.395 ±353.6 ±173.6
Components due to recycling (Rair, Ra2r), to interconversion (Ran, Ra2i), and to newly synthetized ketone bodies (Rai„, Raa.); compartment
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FIG. 3. Biochemical pathways of ke¬
tone body metabolism in whole animal.
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where q,(t) is the amount of tracer in the ith compart¬
ment; ui(t), u2(t) are the impulsive inputs of [l4C]AcAc
and /?-[l4C]OHB, respectively; yfif), y2(t) are the meas¬
urements (outputs) of labeled AcAc and /?-OHB concen¬
tration after [14C]AcAc injection, andy3(t),y4(t) are those
after /?-[14C]OHB injection; ktJ are the nonnegative trans¬
fer rate parameters, and Vi, V2 are the initial distribution
volumes of the two ketones.
The unknown parameters of this model are the distri¬
bution volumes, Vi, V2, and the transfer rate parameters,
kij. This model is uniquely identifiable (15); parameter
estimates and their accuracies are shown in Table 3. The
four-compartment model exhibits very good performance
fig. 4. A 6-compartment model of AcAc and /6-OHB kinetics. U\(t),
u2(t) are tracer injection inputs of [14C]AcAc and ^-['"CJOHB.
in terms of quality of identification results (i.e., parame¬
ter accuracy). It is of interest to note that, in four cases,
a negligible recycling of either AcAc (ku) or /S-OHB (k24)
resulted, from extrahepatic tissues back to blood.
A three-compartment model. Negligible recycling of
both AcAc and /?-OHB from extrahepatic tissues back to
plasma has been reported in the rat (10, 21, 26). We have
tested this possibility with the model, i.e., parameters ku
and k24 were both set equal to zero, thus leading to the
three-compartment model of Fig. 6 (16). This model is
uniquely identifiable (15), is consistent with the isotopic
disequilibrium evidence (26), and has already been pro¬
posed for the rat (10). The identification results for this
model are shown in Table 4. For each subject very
accurate parameter estimates were obtained, and it is of
interest to note that this model provides, for those indi¬
viduals with negligible recycling from extrahepatic tis¬
sues (subj ED, MS, AG, and LT of Table 3), parameter
values in good agreement with the corresponding param¬
eters of the four-compartment model.
Comparison of the four- with the three-compartment
model. The identification results support well the point
u,(t)
FIG. 5. A 4-compartment model. This model, besides taking into
account acetoacetate and /3-hydroxybutyrate in blood, depicts 2 ketone
body compartments, liver and extrahepatic tissues. It is assumed that
in liver (compartment 3) and extrahepatic tissues (compartment 4), the
2 ketones equilibrate rapidly. R30 is rate of production of acetoacetate
and /I-hydroxybutyrate inside liver; *31, *13, k4i, k\4, *32, *23, £42, *24, and
£04 are transfer rate parameters and U\(t), u-At) as in legend to Fig. 4.
table 3. Numerical estimates and their accuracies of initial distribution volumes and transfer rate




v, v2 A31 *13 *23 *32 *42 *14 *24 *!M
ED 3.2 (8)* 2.1 (4) 0.464 (6) 0.200 (6) 0.056 (6) 0.114 (6) 0.529 (4) 0.527 (4) 0.282 (38) 0-t 2.546 (43)
GB 3.9 (4) 3.2 (3) 0.387 (4) 0.083 (10) 0.050 (10) 0.029 (10) 0.117 (8) 0.316 (4) 1.073 (48) 0.288 (52) 3.360 (52)
CF 3.8 (10) 3.7 (6) 0.508 (10) 0.016 (28) 0.013 (14) 0.028 (14) 0.097 (8) 0.234 (6) 0.120 (10) 0.017 (10) 0.263 (8)
EM 6.4 (3) 3.0 (4) 0.356 (6) 0.138 (10) 0.106 (6) 0.137 (6) 0.534 (6) 0.467 (8) 0.233 (12) 0.531 (12) 0.721 (18)
MS 3.4 (6) 1.6 (4) 0.450 (4) 0.256 (4) 0.090 (6) 0.080 (6) 0.697 (4) 0.749 (4) 0. 0.072 (36) 0.925 (36)
AG 3.7 (5) 2.4 (4) 0.548 (4) 0.332 (6) 0.034 (13) 0.106 (13) 0.498 (4) 0.455 (7) 0.157 (11) 0. 0.306 (13)
LT 2.7 (6) 1.8 (5) 0.513 (3) 0.395 (6) 0.049 (10) 0.120 (10) 0.652 (4) 0.495 (9) 0.075 (17) 0. 0.337 (25)
Mean 3.9 2.5 0.461 0.203 0.050 0.088 0.446 0.463 0.277 0.130 1.204
±SD ±1.2 ±0.8 ±0.070 ±0.135 ±0.037 ±0.044 ±0.242 ±0.164 ±0.363 ±0.205 ±1.242
* Accuracy of parameter estimates expressed as % coefficient of variation in parentheses, i.e., (standard deviation of parameter estimate/
parameter estimate) X 100. f In f°ur cases the parameter was set equal to zero (k24 in ED, AG, and LT; ku in MS) as suggested by the
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that the four-compartment model, which is also more
plausible in terms of physiological structure, is a robust
representation of ketone bodies metabolism in vivo.
When significant recycling of AcAc and /3-OHB from
extrahepatic tissues are present, the model is able to
detect them. Also, from the results shown in Table 5, the
four-compartment model emerges as the best represen¬
tation, as it exhibits significantly lower values of AIC, the
Akaike criterion for model discrimination (2). The ability
of the four-compartment model to predict the kinetic
data in two subjects is illustrated in Fig. 7.
Use of the four-compartment model for quantifying in
vivo ketone body metabolism. Besides providing esti¬
mates of the initial distribution volumes and of the
transfer rate parameters, the four-compartment model
allows estimation of a number of important parameters
of ketone body metabolism.
In addition to the sizes of the AcAc and /2-OHB blood
compartments, given by
Qi — CiVj (9)
Q2 — C2V2 (10)
the steady-state Eqs. 1-8 give the extrahepatic compart¬
ment size (Q4), the rate of production of ketone bodies
inside the liver (R30), and the liver compartment size (Q3)
&llQl + k42Q,2
0.4 -
k\4 + Al24 + ko4
R30 = A204Q4







Also, the plasma clearance rates PCRi and PCR2, of




k\4 + k-2.4 + k(,4
k\2 • ko4
k\4 + A:24 + A04
V1
v2 (15)
The model also provides an estimate of the true total
distribution volume, Vd, of TKB. The total mass ofAcAc
plus /J-OHB present in vivo is known and thus the true
total distribution volume of TKB is given by




Finally, the model provides some insight into the relative
role of liver and extrahepatic tissues in the interconver-
sion and recycling of AcAc and yS-OHB. The rates of
appearance in plasma of AcAc, Rai, and yS-OHB, Ra2
(Fig. 1), can be split into their liver components
(RaV, Rak) and extrahepatic tissue components
(RaT, Raj). More precisely
fig. 6. A 3-compartment model. In this kinetic representation, be¬
sides blood ketone body compartments, a rapidly equilibrating liver
compartment for acetoacetate and /J-hydroxybutyrate is assumed. R30,
u2{t) as in legend to Fig. 5; kt3, k31, k23, km, koi are transfer rate
parameters. This model is a direct simplification of 4-compartment
model (Fig. 5) with ku = 0 and ku = 0. Also, as parameter kM is not
identifiable it cannot be explicitly considered. Note that parameters ku
and ki2 of Fig. 5 are indicated here as km and k02.









&23 ^ kl3 + ^23 ^13 + ^23
kuk4\ ^ k\4k42
(17)
k\4 + A24 + ko
- qi +
k\4 + A24 + ko
02
table 4. Numerical estimates and their accuracies of initial distribution volumes and transfer rate




V, v2 Ayi km Au ka km ko2
ED 1.6 (6)* 1.8 (3) 0.637 (4) 0.272 (6) 0.056 (4) 0.136 (4) 0.669 (4) 0.575 (4)
GB 3.3 (4) 2.7 (4) 0.327 (4) 0.155 (8) 0.146 (4) 0.082 (4) 0.225 (4) 0.294 (4)
CF 5.3 (4) 3.0 (10) 0.278 (4) 0.036 (6) 0.109 (6) 0.174 (6) 0.226 (8) 0.271 (12)
EM 4.5 (3) 3.1 (3) 0.232 (4) 0.513 (4) 0.167 (4) 0.223 (4) 0.676 (4) 0.223 (4)
MS 3.0 (4) 1.7 (6) 0.441 (4) 0.309 (4) 0.078 (4) 0.080 (4) 0.645 (4) 0.647 (4)
AG 4.8 (4) 3.0 (4) 0.288 (4) 0.324 (4) 0.055 (4) 0.114 (4) 0.573 (4) 0.264 (4)
LT 3.3 (4) 1.9 (4) 0.368 (4) 0.387 (4) 0.061 (4) 0.121 (4) 0.739 (4) 0.392 (4)
Mean 3.7 2.5 0.367 0.285 0.096 0.133 0.536 0.381
±SD ±1.3 ±0.6 ±0.137 ±0.155 ±0.046 ±0.051 ±0.218 ±0.167
' Accuracy of parameter estimates expressed as % coefficient of variation in parentheses, i.e., (standard deviation of parameter estimate/
parameter estimate) x 100.
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+ &24 + &04 ku + ^24 + ^04
In these equations L and T denote liver and extrahepatic
table 5. Akaike Information Criterion (AIC) for








tissues, respectively; Rair, Ra2r are the fractions of AcAc
and /3-OHB appearing in plasma due to recycling; Ran,
Ra2i are the fractions of AcAc and /3-OHB appearing in
plasma due to their interconversion; and Rain, Ra2n are
the fractions of AcAc and /8-OHB appearing in plasma
from newly synthetized AcAc in the liver. Tables 6 and
7 show the numerical values of all these parameters for
the seven normal humans.
It is of interest to compare the parameter values ob¬
tained from the noncompartmental approach and the
four-compartment model (Tables 2, 6, and 7). The differ¬
ences are almost entirely attributable to the different
estimates that the two approaches provide for the initial
distribution volumes (Vi, V2) and the initial fractional
rates of disappearance of labeled AcAc and /3-OHB, yi (0) /
yi(0) and y4(0)/y4(0); see appendix. These are shown in
Table 8. It appears that Vi and V2 are about the size of
the blood volume in the four-compartment model.
DISCUSSION
The present study was undertaken to quantify ketone
body metabolism in the normal human in steady state.

























fig. 7. Predictions of 4-compartment model for labeled acetoacetate (continuous line) and for labeled /?-hydroxybutyrate (dashed line)
concentrations in blood in 2 representative studies (A and B). Experimental data of [14C]AcAc (•) and /?-[14C]OHB (O) are also shown.
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ketone body kinetics have been investigated in a variety
of other ways, both in steady and nonsteady states. We
were prompted by wide discrepancies reported by several
investigators for several parameters, such as initial and
total distribution volumes, plasma clearance rates, and
number and definition of ketone body compartments (3,
6, 9, 22, 23, 33). Another motivation was to investigate
the validity of the generally accepted use of the combined
SA of TKB, because, as stated recently (8), there is no
proof that this mode of calculation is correct. It has been
demonstrated in dogs in steady state that TKB turnover
determined using TKB combined SA is, on the average,
not too different from values obtained by hepatic cathe¬
terization (22). Because of the impossibility in the human
of sampling in portal vein to obtain true portal vein/
hepatic vein differences, we decided to circumvert this
difficulty using a less invasive technique, injection of
table 6. Rate ofproduction of ketone bodies inside
liver (R3o), compartment sizes (Qi, Q>, Qi, Qi), plasma
clearance rate ofAcAc and fi-OHB per se (PCRi, PCRi),








1/m2Q. Q2 Qa Q< PCRi PCR*
ED 93.64 0.101 0.109 1.006 0.037 1,356.3 1,001.8 15.27
GB 61.36 0.156 0.083 1.068 0.018 1,063.9 723.2 20.01
CF 137.35 0.231 0.391 4.349 0.521 1,276.3 562.0 32.69
EM 295.68 0.862 0.646 3.133 0.410 1,096.7 670.6 11.80
MS 320.86 0.429 0.204 3.379 0.347 1,400.3 1,089.3 16.90
AG 376.14 0.458 0.697 6.286 1.229 1,352.5 709.9 20.74
LT 304.74 0.301 0.441 4.221 0.905 1,151.7 732.1 16.62
Mean 227.11 0.363 0.367 3.349 0.495 1,242.5 784.1 19.15
±SD ±125.88 ±0.257 ±0.247 ±1.876 ±0.442 ±136.9 ±189.2 ±6.67
labeled AcAc and yS-OHB in the same subjects, together
with careful kinetic modeling. For each subject the time
course of the four labeled AcAc and /1-OHB concentra¬
tions after injection of both tracers have been simulta¬
neously considered and used to develop what we propose
as an adequate mathematical representation of ketone
body metabolism. We have shown the four-compartment
model to be an appropriate mathematical representation
for studying the individual kinetics of AcAc and /3-OHB
in vivo: it is plausible from a physiological point of view,
it is able to accurately predict the kinetic data, and its
parameters can be accurately estimated. This model
provides new quantitative insight into ketone body me¬
tabolism, allowing a number of variables and parameters
to be estimated otherwise unaccessible to direct meas¬
urement.
Both noncompartmental and compartmental ap¬
proaches have been evaluated. Noncompartmental
modeling was carried out by the "two accessible pools"
analysis proposed in Resigno and Gurpide (34). We have
quantified this model (Fig. 1) from the four sets of labeled
AcAc and /3-OHB data. A similar model was proposed
for the rat by Barton (6, 7), who used a different kinetic
experiment to quantify it. Whereas this approach pro¬
vides quantitative insight into the individual kinetics of
AcAc and /3-OHB, it implies a number of structural and
computational assumptions, which are not necessarily
valid (13). Particularly critical in this study were the
required extrapolation to t —» 0 of the disappearance
curves of labeled AcAc and /1-OHB, and the computation
of their derivatives, thus confirming an intrinsic compu¬
tational difficulty of the noncompartmental method
noted in the original paper (34). The intrinsic ambiguity
in these parameter estimates (Table 8) affects the esti¬
mation of all the parameters, but particularly the rate of
recycling and the compartment sizes, which depend
table 7. Rate of appearance ofAcAc (Rai) and fi-OHB (Raz) in plasma due to liver (Ra\, Rak) and














ED 56.50 6.65 18.98 30.87 114.88 38.58 13.53 62.77
10.39 4.67 5.72 0. 0. 0.
GB 53.01 8.09 6.15 38.76 30.90 3.59 4.72 22.59
19.62 13.61 6.01 5.27 1.62 3.66
CF 58.56 1.25 12.37 44.95 120.39 25.42 2.56 92.40
62.63 35.21 27.42 8.83 3.87 4.96
NM 330.66 51.77 150.18 128.72 428.90 194.79 67.15 166.96
95.50 48.18 47.33 217.89 107.97 109.92
GS 303.05 58.10 75.16 169.79 269.63 66.87 51.69 151.07
0. 0. 0. 25.09 11.07 14.02
AG 211.30 36.76 83.72 90.82 663.79 262.99 115.48 285.32
192.37 85.08 107.29 0. 0. 0.
LT 205.06 34.25 82.98 87.83 506.45 204.94 84.60 216.91
68.07 28.17 39.90 0. 0. 0.
Mean 174.02 28.12 61.36 84.53 304.99 113.88 48.53 142.57
±SD ±119.25 ±22.93 ±52.11 ±51.34 ±234.97 ±104.04 ±43.58 ±91.15
Mean 64.08 30.70 33.38 36.73 17.79 18.94
±SD ±66.37 ±29.44 ±37.34 ±80.38 ±39.96 ±40.43
Rates are decomposed into their components due to recycling (r), interconversion (i) and de novo synthesis (n).
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table 8. Initial distribution volumes ofAcAc (V\)
and ft-OHB (V2) and initial fractional rate of
disappearance ofAcAc [y\(0)/y\(0)f and /3-OHB
[yi(0)/yi(0)J estimated by noncompartmental
and compartmental approach
Noncompartmental Analysis Four-Compartment Model
Subj 1/m2
min"1 1/m2 min '
v, V. Xi(0)/ yM/ v, v.. r,(0)/ M0)/
Xi(0) *(0) ;y>(0) *<0)
ED 4.5 2.9 0.492 0.765 3.2 2.1 0.664 1.056
GB 4.1 3.1 0.356 0.440 3.9 3.2 0.470 0.433
CF 4.6 5.8 0.357 0.198 3.8 3.7 0.524 0.331
NM 7.7 5.8 0.338 0.367 6.4 3.0 0.494 1.001
GS 10.6 3.8 0.301 0.693 3.4 1.6 0.706 1.446
AG 9.5 2.4 0.350 0.877 3.7 2.4 0.880 0.953
LT 8.5 2.2 0.356 0.880 2.7 1.8 0.908 1.147
Mean 7.1 3.7 0.364 0.603 3.9 2.5 0.664 0.910
±SD ±2.7 ±1.5 ±0.060 ±0.268 ±1.2 ±0.8 ±0.178 ±0.395
strongly on extrapolations to t —> 0.
T0 avoid these limitations, and to make full use of the
available kinetic information, physiologically based com¬
partmental models appear to be more appropriate, and
a four-compartment model (Fig. 3) provided the most
accurate representation for studying the individual ki¬
netics of AcAc and /J-OHB. Two compartments refer to
AcAc and /8-OHB in blood, and the remaining two to
lumped AcAc-/?-OHB compartments in the liver and
extrahepatic tissues, i.e., AcAc and /3-OHB intcrconver-
sion is assumed to be sufficiently rapid to consider AcAc
and /3-OHB as a single compartment.
The four-compartment model incorporates recycling
of AcAc and /3-OHB through the liver and extrahepatic
tissues. Contradictory experimental evidence has been
reported on the quantitative role played by these recy¬
cling processes in various metabolic conditions. Some
authors found negligible recycling of /3-OHB for the
kidney in long-fasted humans (31). Others reported neg¬
ligible recycling of AcAc from extrahepatic tissues in the
rat (12) and, in other studies, both recycling fluxes have
been neglected (9, 21, 26). Our modeling-based results
confirm that, in some cases, the recycling flux of AcAc,
and more often of /3-OHB, from extrahepatic tissues are
negligible.
We have also tested a simpler model structure, a three-
compartment model (Fig. 4), which assumes negligible
recycling of both AcAc and /3-OHB from extrahepatic
tissues back to plasma. This kinetic representation, orig¬
inally proposed in rats (9), but afterwards ignored (10),
has been shown to be inferior to the four-compartment
model.
The four-compartment model provides a new quanti¬
tative description of ketone body metabolism in vivo. In
addition to the initial distribution volumes (V1( V2) of
AcAc and /3-OHB, and the intercompartmental transfer
rate parameters (kij) (Table 3), the model provides the
following (Tables 6 and 7): compartment sizes of AcAc
and /3-OHB in plasma (Qi, Q2), and ketone bodies in liver
(Q3) and extrahepatic tissues (Q4); the rate of production
of ketone bodies inside the liver (R30); and also the
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plasma clearance rates of the individual ketones (PCRi,
PCR2). Moreover, the rates of appearance of AcAc (Rai)
and /3-OHB (Ra2) in plasma can be split into their liver
(Rah Ra2) and extrahepatic (RaT, Raj) components,
which in turn may be decomposed into their fractions
due to recycling, interconversion, and de novo synthesis
(Raj, Raj Rah, Rah, Rah, Rah), as well as recycling
and interconversion only (Raj, Raj; Ral,, Raj). Useful
information could be provided by the investigation of the
relationships of these different sources in different met¬
abolic conditions, such as starvation, diabetes, and obe¬
sity. For instance, a much larger increase in /3-OHB than
in AcAc in circulation has been reported in several ketotic
states (35). The proposed model could provide some
insights to explain at least partially this metabolic be¬
havior. It allows quantitation of the individual PCR of
the two ketones, and the rates of recycling and intercon¬
version of AcAc and /3-OHB, both in the liver and extra¬
hepatic tissues.
The four-compartment model has been used to evalu¬
ate methodologies currently employed in the analysis of
ketone body turnover data, in terms of physiological
parameters. The conventional approach for quantitating
ketone body metabolism is based on use of the combined
specific activity of AcAc and /3-OHB (3, 10, 23, 26); total
ketone body concentration is considered directly and is
used to estimate total ketone body production and
plasma clearance rate. Inspection of Eqs. 11-15 suggests
that the conventional approach gives correct estimates
of ketone body kinetics if and only if Vi = V2, An = k42,
and &3i = A12. These conditions are not generally satisfied
(Table 3). For instance, plasma clearance rates of AcAc
and /3-OHB (assumed to be equal in the conventional
approach) are significantly different; in particular, the
PCR of AcAc (PCRi) is up to 100% greater than the PCR
of /3-OHB (PCR2, Table 6). Even more remarkable dif¬
ferences in the PCR of the two ketones, e.g., PCR of
AcAc = 2.5 PCR of /3-OHB have been reported in humans
fasted for 3 days (8). Thus use of the conventional ap¬
proach based on the combined SA could lead to substan¬
tial errors both in assessing rates of production and
plasma clearance rates, which could be even more
marked in other metabolic conditions such as starvation
and diabetic ketosis (35). Recently, Keller et al. (22)
reported that tracer-determined TKB production using
combined SA was higher by 3 and 8% in 48-h fasting
dogs, and 11% lower in diabetic dogs, than net hepatic
production as assessed by A-V difference techniques.
However, it has to be pointed out that differences larger
than 50% are present in individual data (22). Thus, cal¬
culations based upon the SA of total ketone bodies may
be able to detect gross changes in production and utili¬
zation rates, but they can be seriously misleading in
individual cases.
As cited above, conflicting results have been reported
in the literature as concerns a number of parameters
related to distribution volumes of ketone bodies. Our
model serves to elucidate this matter. The estimated
initial distribution volumes of AcAc (Vi) and of /3-OHB
(V2) indicate that the blood compartment is essentially
involved (Table 3).
The model also provides an estimate of the true total
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distribution volume (Vd) of TKB (Table 6). Care must
be taken in interpretation of the conventional recirculat¬
ing volume (30) as the true total distribution volume of
TKB (4, 23), because the recirculating volume gives only
a lower bound on the true total distribution volume. The
two coincide if and only if the plasma is the only com¬
partment from which the substance can irreversibly dis¬
appear (personal communication, J. J. DiStefano III),
which is not the case for ketone bodies. Available esti¬
mates on the recirculating volumes of TKB [=20% of
body weight (23)] seem to consistently underestimate the
true total distribution volume provided by the model
(=52% of body weight).
In conclusion, the present study demonstrates that
either separate injections of [14C]AcAc and /?-[14C]OHB
at different times in the same subject, or simultaneous
administration of doubly labeled ketones are probably
necessary to provide an adequate data base for kinetic
modeling. A four-compartment model appears to be nec¬
essary for describing kinetic data in the normal human
after an overnight fast. This model provided estimates of
ketone body production in the liver, the plasma clearance
of individual ketones, the initial and total distribution
volumes, and the transfer rate parameters among the
four ketone body compartments. Quantitative informa¬
tion is also provided on the compartment sizes and on
the relative roles played by the liver and extrahepatic
tissues in interconversion and recycling of the two ke¬
tones. This approach provides a new basis for the inves¬
tigation of ketogenesis in a variety of metabolic condi¬
tions.
APPENDIX
For easier reference, the computational sequence adopted in the
noncompartmental analysis of AcAc and /J-OHB kinetics is reported.
Symbols
Vij rate of interconversion between pool j and pool i per unit
of concentration in pool j (ml/min)
v0i rate of irreversible removal from pool i per unit of concen¬
tration in pool i (ml/min)
w, rate of recycling around pool i without going through the
other accessible pool, per unit of concentration in pool i
(ml/min)
Di dose of [uC]AcAc introduced in pool 1 at time t = 0 as an
impulsive injection Ui(t) = DiS(t) where S(t) is the Dirac
function
D2 dose of /3-[1'1C]OHB introduced in pool 2 at time t = 0 as
an impulsive injection u2(t) = D28(£)
yi(f), >2(0 concentrations of labeled AcAc and /1-OHB in pools 1 and
2, respectively, after the injection Ui(t)
yo(t), y*(t) concentration of labeled AcAc and /5-OHB in pools 1 and
2, respectively, after injection u2(t)
ci, c2 concentrations of cold AcAc and jS-OHB in pools 1 and 2
By conservation of the tracers during the two experiments, the
following four integral equations hold
D, = I uoiyi(f)dt+ no2y2(t)d<
Jo Jo
(f02 + Vn)y2(t)dt = J u2iyi(t)dt




r (voi + u2i)y3(t)dt: ■r Vi2y4(t)dt
The solution of the linear equation set A1-A4 is given by
i>oi = (D1A4 — D2A2)/(A1A4 — A2A3)
VQ2 — (D2A1 — D1A3)/(A1A4 — A2A3)
U21 — D2A2/(AiA4 ~~ A2A3)
fl2 = D1A3/(A1A4 — A2A3)








To estimate the values of Wi, W2, consider the following differential
equations
Vjyih) = -Oitotjyi + fi(t)
V2y4(f) = -£>2 K, ,y4 + h(t)
(A10)
(All)
where v, tot is the total rate of exit from compartment i, f,(t ) is the total
input into i of tracer from the other pools, and V, is the initial
distribution volume ofpool i.





Therefore, Wi and w2 both depend on the values of the decaying curves
at time t = 0 and on their derivatives
w 1
ji(0)
; Oi tot — V01 — V21 —— V1




V01 ~ o2i (A14)
V2 — V02 ~ V12 (A15)
Plasma clearance rates, rates of appearance, recycling and irreversible
loss of AcAc and /3-OHB can be estimated from v0i, V02, v2i, 0,2, wh w2,
ci, and c2 as follows
PCRi = O01 (A16)
pcr2 = V02 (A17)
Rati = V,2C2 (A18)
Ralr = W1C1 (A19)
Roiirr = V01C1 (A20)
Rain = (voi + f2i)ci — V12C2 (A21)
R,.i. = V21C1 (A22)
R«2r = W2C2 (.A23)
Ro2irr = V02C2 (A24)
Ra2n = (V02 + Ul2)c2 — O21C1 (A25)
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